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ABSTRACT 
 
Occupational asthma accounts for 1 in 6 cases of new-onset adult asthma and is associated 
with an estimated societal cost in the UK of £100 million per annum. The cost is somewhat 
avoidable if workers with occupational asthma are identified quickly and removed from 
exposure to a sensitizing agent.  However many workers with occupational asthma go 
undiagnosed or experience a lengthy delay in diagnosis.  The aim of this work was to identify 
the barriers to diagnosis of occupational asthma on the part of the worker and of the 
healthcare professional.  The first study evaluated current practice in assessing working-age 
asthmatics for occupational asthma in a West Midlands primary care population, using UK 
national guidelines as a reference standard.  The recorded prevalence of occupational asthma 
was much lower than expected (0-0.8%) and there was poor enquiry regarding occupation 
(14% of cases) and the effect of work on asthma symptoms (2% of cases) by primary 
healthcare professionals.  The second study used a qualitative methodology to explore and 
define health beliefs and behaviours in workers with occupational asthma symptoms.  The 
major influences on workers’ health seeking behavior were determined from four themes: (1) 
workers’ understanding of their symptoms, (2) working relationships, (3) workers’ course of 
action with symptoms and (4) workers’ negotiation with healthcare professionals.  The third 
study aimed to define the important barriers to identifying occupational asthma from the point 
of view of healthcare professionals.  High levels of enquiry about the nature of patients’ work 
and work-relatedness of symptoms were reported by GPs, nurses and non-occupational lung 
specialist physicians, though the sample was biased towards enthusiasts.  Despite this, low 
awareness and adherence to occupational asthma guidelines was evident in all non-specialist 
groups.  The fourth study evaluated the feasibility of introducing an electronic occupational 
asthma screening tool for primary care.  Healthcare professionals who used the tool found it 
to be quick and easy to implement and user-friendly (clear, concise, logical), without 
impacting on the length of a consultation.  With adequate training for users the screening tool 
could be rolled out nationwide in the UK and its clinical effectiveness measured. 
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 1 
CHAPTER 1: INTRODUCTION 
 
1.1 Defining occupational asthma 
1.1.1 Overview 
Occupational asthma is a disease characterized by variable airflow limitation and/or hyper-
responsiveness that is caused by inhalation of an agent in the workplace (Baur et al., 2012).  It 
is the most frequently reported occupational respiratory disorder in western industrialized 
populations (McDonald, 2000) and represents 1 in 6 cases of new-onset adult asthma in the 
UK (Nicholson et al., 2010).  Occupational asthma includes: 
 
1. Occupational asthma by sensitization: cases with an allergic mechanism where there 
is sensitization to an agent by an Immunoglobulin E (IgE) mediated, or different 
immunological or non-immunological mechanism, which occurs after a latent period 
of exposure (Baur et al., 2012), and 
 
2. Irritant-induced asthma: resulting from a single high exposure to a major respiratory 
irritant without a latent period (Brooks et al., 1985), known classically as the Reactive 
Airways Dysfunction Syndrome (RADS).   
 
Occupational asthma, along with work-exacerbated asthma which is characterized by 
worsening of pre-existing asthma caused by, but not arising de novo, from workplace 
inhalational exposures (Tarlo et al., 2008), come under the broad umbrella term of work-
related asthma.   
 
It is helpful to consider some general aspects of asthma, since identifying a case of 
occupational asthma requires a physician to diagnose a worker with asthma, as well as 
establish the relationship with work.  The majority of workers will present to a physician with 
asthma symptoms, that is, any of chest tightness, cough, wheeze and breathlessness, the 
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nature of which are not specific to occupational asthma (BTS/SIGN, 2012).  Work-related 
asthma should be considered in any adult with new onset asthma symptoms, worsening 
asthma symptoms or recurrence of childhood asthma (Fishwick et al., 2012; Nicholson et al., 
2010; Tarlo et al., 2008).  The Global Initiative for Asthma (GINA) (Bateman et al., 2008) 
defines asthma as a: 
 
“chronic inflammatory disorder of the airways in which many cells and cellular 
elements play a role. The chronic inflammation is associated with airway hyper-
responsiveness that leads to recurrent episodes of wheezing, breathlessness, chest 
tightness, and coughing, particularly at night or in the early morning. These episodes 
are usually associated with widespread, but variable, airflow obstruction that is often 
reversible either spontaneously or with treatment”.   
 
There is considerable heterogeneity in the clinical presentation of asthma, and diagnosis 
requires a thorough clinical history and physical examination, as well as pulmonary function 
testing (BTS/SIGN, 2012).  Variable and reversible airflow obstruction is a key feature of 
asthma, though lung function is often normal between exacerbations, or with treatment (Tarlo 
et al., 2008).  However a >400ml increase in forced expiratory volume in 1 second (FEV1) as 
a response to inhaled beta-agonist or a treatment trial of corticosteroid (Hunter et al., 2002), 
or a peak expiratory flow (PEF) diurnal variation of >20% after PEF monitoring 
(Quackenboss et al., 1991), are strongly supportive of a diagnosis of asthma.  In patients with 
normal or near-normal spirometric values, assessment of airway responsiveness by 
inhalational challenge with histamine or methacholine should be undertaken. A methacholine 
PC20 (provocative concentration inducing a 20% fall in FEV1) of <8 mg/ml, or PD20 
(provocative dose) of <4 micromols, has a sensitivity of between 60-100% in detecting 
asthma (BTS/SIGN, 2012).  In addition a prior history of atopy, family history of asthma 
and/or atopy, or peripheral blood eosinophilia make a diagnosis of allergic asthma more likely 
(BTS/SIGN, 2012).   
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1.1.2 Occupational asthma by sensitization  
More than 400 respiratory sensitizers causing occupational asthma have been identified, with 
new agents continually reported (Pralong et al., 2013a; Lemière et al. 2012).  Compendia of 
causative agents can be found in publications (Malo and Chan-Yeung, 2009; Fishwick, 2012; 
Currie and Ayres, 2005; Baur 2013) or on websites (OASYS group, 2013).  Common causes 
of occupational asthma by sensitization are shown in Table 1.1.   
 
 
Table 1.1.  Common causes of occupational asthma by sensitization, along with 
occupations where exposure usually occurs.  Adapted from Currie and Ayres (2005), 
Nicholson et al. (2010) and Walters et al. (2013).   
 Agent Occupational exposure 
High-molecular 
weight agents 
Flour, grain and baking enzymes 
Laboratory animals 
Seafood (fish, molluscs, crustacea)  
Flower pollen 
Green coffee and castor bean 
Latex 
Wood dust (Western red cedar, pine, 
iroko) 
Baking, pastry making, food processing 
Laboratory workers, animal handlers 
Seafood workers 
Gardening industries 
Food production 
Healthcare workers 
Woodworkers, millworkers 
Low-molecular 
weight agents 
Isocyanates 
  
 
Platinum salts 
Colophony (pine resin) 
Acid anhydrides 
Acrylates 
 
Drugs (antibiotics, cimetidine, anaesthetic 
agents)  
Dyes 
Persulphate 
Metals chromium, nickel, cobalt, zinc 
Metalworking fluid 
Cleaning agents (enzymes, quaternary 
ammonium compounds) 
Glutaraldehyde 
Spray painting, moulding, core making, 
printing, assembly, printing, rubber 
manufacture 
Platinum refinery, chemical manufacture 
Soldering  
Spray painting, epoxy manufacturing 
Plastics manufacturing, orthopaedic surgery, 
dentistry 
Chemical manufacturing, healthcare workers 
 
Textile workers 
Hairdressers 
Metalworkers, metal production, welding 
Metalworkers 
Cleaners, healthcare workers 
 
Healthcare workers 
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The agents can be categorized on size, as either high molecular weight (HMW) and >10,000 
Dalton, or low molecular weight (LMW) and <1000 Dalton (Lummus et al., 2011).  HMW 
agents, of which about 190 have been identified (Lummus et al., 2011) are molecules, usually 
proteins but some are complex polysaccharides, which are capable of inducing specific IgE 
antibody-responses and are usually associated with sensitization to animals, plants, or 
microorganisms. Some agents have functional characteristics that promote their allergenicity, 
such as protease activity in the case of detergent enzymes (Schweigert et al., 2000; Jacquet, 
2011); others possess receptors that enhance the innate immune response, such as toll 
receptors in the case of house dust mites (Nathan et al., 2009).  The majority of HMW agents 
have been purified and expressed recombinantly to make solutions useful for allergy testing 
(Lummus et al., 2011).  Approximately 80 LMW agents have been described as causes; these 
are usually chemical molecules and include methylene diphenyl diisocyanate (MDI), acid 
anhydrides, amines, metals, and reactive dyes (Nicholson et al., 2010; Lummus et al., 2011).  
In the case of LMW agents, certain characteristics promote reactivity and allergenicity, 
particularly functional groups containing 2 or more reactive nitrogen or oxygen atoms, or the 
ability to conjugate with lysine (Jarvis et al., 2005).  Isocyanate and acid anhydride functional 
groups have been demonstrated to form conjugates with larger molecules such as human 
albumin protein (haptens), causing rearrangement changes which are then capable of causing 
sensitization (Lummus et al., 2011).   
 
Many cases of occupational asthma are due to specific IgE-mediated sensitization, where IgE 
binds to mast cell receptors, leading to degranulation and release of asthmatic mediators in 
susceptible individuals.  Sensitization occurs by inhalation and uptake of the antigen by 
antigen-presenting cells, often dendritic cells, which then migrate to regional lymph nodes 
where they are presented to CD4 T-helper cells that initiate an immune response (Lummus et 
al., 2011).  However cell-mediated immunity or delayed-type hypersensitivity has been 
postulated as a possible mechanism for some LMW chemical induced asthma, for example, 
due to persulphates (Yawalkar et al., 1999), or hexamethylene diisocyanate (HDI) 
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(Wisnewski et al., 1999). Additionally there is evidence that suggests that some isocyanate 
chemicals stimulate innate immune responses and this may contribute to sensitization 
(Lummus et al., 1998; Wisnewski et al., 2008).  Holgate has suggested that the primary defect 
is in airway epithelium (Holgate, 2008; Holgate, 2010), and the immune response is a 
secondary phenomenon to impaired barrier function, allowing greater access for 
environmental allergens, microorganisms, and toxicants; which in turn triggers allergic-type 
inflammation (Holgate et al., 2000; Holgate et al., 2009).  There may be internal (genetic) or 
external factors (occupational exposures) that modulate the normal epithelial damage-repair 
cycle of the human airways (Holgate et al., 2007).   
 
1.1.3 Irritant-induced asthma 
Occupational asthma with latency is usually caused by sensitization (Newman Taylor, 1980).  
However Brooks et al. (1985) described the Reactive Airways Dysfunction Syndrome 
(RADS), that is, acute onset of new asthma symptoms within 24-hours of a sudden exposure 
to a major respiratory irritant (vapour, gas, fume or smoke) and persistence of symptoms and 
bronchial hyper-responsiveness for at least 3-months after the incident. Workers with RADS 
do not become sensitized to the causative agent and so subsequent low-dose exposures do not 
cause problems.   
 
RADS is now included in the spectrum of irritant induced asthma (IIA). Agents in the 
workplace causing IIA are many and include acids (sulphuric, hydrochloric), alkalis (sodium 
hydroxide, calcium oxide), gases (chlorine, bromine, ammonia), organic solvents, diesel 
exhaust, aluminium pot-room fumes, sulphur dioxide from apricot sulphurization, and also 
known sensitizers such as glutaraldehyde and metalworking fluid in very high concentrations 
(Brooks, 2013; Shakeri et al., 2008).  Crucially almost all cases are associated with 
unanticipated release often after explosion or fire, or in confined spaces, therefore it is rarely 
possible to quantify the level of exposure causing IIA.   
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Brooks et al. (1998) subsequently reported a series of cases they described as "not-so-sudden-
onset" IIA, with a latent period of days or weeks between repeated inhalation exposures and 
new onset asthma symptoms.  The exposures could be intermittent and less intense than those 
of RADS when it was originally described, but symptoms needed to occur within 4-months of 
initial exposure.  Burge et al. (2012) described a third group of IIA with low-level irritant 
exposure and development of asthma symptoms after a symptomless latent interval, which 
could be several years. When so-called “IIA with latency” has developed, usual level 
exposures trigger asthma symptoms, as for occupational asthma with hypersensitivity.  At 
diagnosis, IIA with latency is indistinguishable from hypersensitivity occupational asthma 
with respect to any pre-existing asthma or atopy, smoking, latent interval and non-specific 
reactivity (Adewole et al., 2009; Burge et al., 2012).  Whether the prognosis of IIA with 
latency differs from hypersensitivity occupational asthma is unknown and requires further 
study. 
 
1.1.4 Differential diagnosis of occupational asthma 
The symptom profile of chest tightness, breathlessness, cough and wheeze is not specific for 
asthma and there are a number of conditions that co-exist with, exacerbate or mimic asthma, 
which must be considered when making a diagnosis; many of these can also be work related.  
Following odorant and irritant exposures, a spectrum of clinical syndromes can occur, termed 
“sensory hyper-reactivity” (Tarlo et al., 2008) which include increased cough reflex (Gordon 
et al., 1998), odour-driven panic, increased sensory awareness (Shusterman et al., 1991; 
Dager et al., 1987) and more ill-defined upper airway symptoms (Ternesten-Hasseus et al., 
2002), none of which are associated with increased bronchial hyper-responsiveness.   
 
Additionally, vocal cord dysfunction (VCD) closely mimics asthma by vocal cord adduction 
during inspiration leading to airflow obstruction.  Odorants and irritants can precipitate 
episodes of VCD (Tarlo et al., 2008), so episodes may be work-related. The mechanisms of 
VCD are unknown, though gastro-oesophageal reflux and psychogenic factors are likely to 
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contribute.  Diagnosis of VCD is through direct visualization of the vocal cords by 
laryngoscopy.   
 
Another differential diagnosis is eosinophilic bronchitis, a condition where subjects 
experience asthma symptoms accompanied by sputum eosinophilia, but without 
demonstration of airway hyper-responsiveness to methacholine or histamine (Cartier and 
Sastre, 2011; Pala et al., 2012).  It has been reported in workers exposed to methyl 
methacrylate (Quirce et al., 2004), latex (Quirce et al., 2003), mushroom spores (Tanaka et 
al., 2002) and lysozyme (Escudero et al., 2003). 
 
1.1.5 Occupational asthma guidelines 
Preconditions for making a diagnosis of occupational asthma are the typical diagnostic 
findings of asthma, along with an association of asthma symptoms with exposure at work 
(Aasen et al., 2013).  A detailed occupational history should be taken (Baur et al., 2012; 
Nicholson et al., 2010; Fishwick et al., 2012) which will enable the physician to determine the 
degree of pre-test probability of occupational asthma.  In its evidence review and guidelines, 
the British Occupational Health Research Foundation (BOHRF) details work that it considers 
to be high-risk (see Table 1.1), which should create a high index of suspicion; this includes 
spray painting, health and dental care, chemical processing, baking and pastry making, food 
processing, welding, soldering, metalworking, woodworking, plastics and rubber 
manufacture, laboratory animal work, textiles, farming and hairdressing (Nicholson et al., 
2010).   
 
European Respiratory Society (ERS) guidelines assert that the diagnosis of occupational 
asthma should be made in 3 steps: (1) make the diagnosis of asthma, (2) identify the 
workplace as the cause of the patient’s asthma and (3) identify the specific agent causing 
occupational asthma (Baur et al., 2012; Aasen et al., 2013).  In UK hospitals the availability 
of resources necessary for full investigation of a patient with occupational asthma varies 
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between 3% and 100% depending on the resource examined (Barber et al., 2008).  For 
example, only 3% of centres have the ability to perform specific bronchial challenge or 
workplace challenge, and only 15% have computerized peak expiratory flow (PEF) analysis 
software.  Therefore, if a diagnosis of occupational asthma is suspected, the British Thoracic 
Society (BTS) recommends early referral to a specialist centre (Fishwick et al., 2012). 
 
A diagnosis of occupational asthma should not be made on history alone and objective 
evidence should be gathered and triangulated: (1) objective evidence of exposure to known 
sensitizers (or airway irritants in the IIA), (2) demonstration of an association between 
exposure and airflow limitation at work, by serial PEF measurement, and (3) demonstration 
of a specific immunological reaction to the occupational agent (Baur et al., 2012; Aasen et al., 
2013; Fishwick et al., 2012).   
 
1.2 Epidemiology of occupational asthma 
1.2.1 Reporting schemes  
Occupational asthma has become the most frequently reported occupational respiratory 
disease in industrialized populations (Elder et al., 2004; McDonald et al., 2000; McDonald et 
al., 2005; Provencher, 1997; Newman Taylor, 2002).  Its prevalence is not clearly defined due 
to inconsistent case definitions and a lack of surveillance data in the general population and 
exposed populations (Nicholson et al., 2010).  Potential sources of data include workers’ 
compensation records and health surveys; however these were often established to serve other 
functions, and therefore occupational information is incomplete or not collected, limiting the 
ability to identify cases (Hannaford-Turner et al., 2010).  A number of reporting registries for 
occupational asthma exist worldwide, the majority of which are voluntary rather than 
mandatory. 
 
One of the first voluntary reporting schemes was the Surveillance of Work related and 
Occupational Respiratory Disease (SWORD) scheme in the UK (Meyer et al., 2001), with 
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monthly submission of newly diagnosed cases of occupational respiratory illness which, in 
the opinion of specialist chest and occupational physicians, are caused by work.  SWORD is 
coupled with a separate scheme, Occupational Physicians Reporting Activity (OPRA), which 
takes submissions from a larger number of occupational physicians (Cherry et al., 2000).   
 
The Midland Thoracic Society's Rare Respiratory Disease Registry Surveillance Scheme of 
Occupational Asthma (Shield) is the only regional voluntary reporting scheme for 
occupational asthma in the UK, and is based in the West Midlands (Gannon and Burge, 1991; 
Gannon and Burge, 1993), taking reports from regional occupational health physicians and 
respiratory physicians.   
 
In Finland it is mandatory for all cases of occupational asthma to be notified to the statutory 
Finnish Registry of Occupational Diseases (Karjalainen et al., 2000), and in Norway 
physicians are obliged to report occupational diseases, including occupational asthma, to a 
national compensation scheme (Leira et al., 2005).  Elsewhere, the Surveillance of Australian 
workplace Based Respiratory Events (SABRE) exists in some Australia regions (Elder et al., 
2004; Hannaford-Turner et al., 2010), the project SENSOR exists in Michigan, USA (Baker, 
1989), and there are other schemes in Canada (Provencher et al., 1997), South Africa (Hnizdo 
et al., 2001) and Spain (Orriols et al., 2006).  Incidence estimates are available from these 
surveillance schemes, and asthma rates vary between countries and regions depending on the 
distribution of industry and occupation, the case definition for occupational asthma and 
method of data collection.     
 
1.2.2 Incidence data 
Blanc and Toren (1999) carried out a synthesis of the available literature to estimate the 
proportion of adult asthma in the general population attributable to workplace factors, by 
calculating the population attributable risk (PAR) for occupational asthma, when considering 
new-onset disease and reactivation of pre-existing asthma.  They obtained 43 PAR estimates 
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from 19 countries and the median value was 9%, though this increased to 15% when using 
studies of higher quality.  The estimated incidence of occupational asthma varied widely 
among countries from 1.2-17.4/100,000 person-years with a median incidence of 4.7 
cases/100,000 person-years.  The highest rate of 17.4/100,000 was observed in Finland from 
asthma medication registry data  (Karjalainen et al., 1998).   They noted that where PARs 
were calculated from incidence data, values were lower than those derived from available 
population data, which suggested under-reporting of incident cases of occupational asthma 
(Blanc and Toren, 1999).  The same authors updated their calculation of median PAR for 
occupational asthma to 17.6% (Toren and Blanc, 2009), using newer large general 
population-based longitudinal studies, allowing for more reliable risk estimates.  Thus 1 in 6 
cases of new-onset adult or recurrent-childhood asthma is likely to be due to workplace 
factors (Toren and Blanc, 2009; Nicholson et al., 2010; Baur et al., 2012). 
 
Incidence measures should be interpreted with caution for a number of reasons.  Systematic 
changes in membership of surveillance schemes over time can produce false trends: for 
example, early scheme entrants may have more of an interest in occupational lung disease 
than later entrants, and new members will report prevalent cases initially as well as incident 
cases.  Additionally there is variation in case definition between specialist centres and 
individuals: Baldwin et al. (2002) showed that even occupational asthma experts interpret 
diagnostic tests differently.  There is also variation in method of reporting, whether 
compulsory or voluntary, as well as differences in the exposed populations between regions 
or countries, and changes over time.   
 
The incidence of occupational asthma was 174 cases per million workers in Finland, 
according to what is considered to be the most complete surveillance system (Karjalainen et 
al., 2000).  However other estimates have varied: in a prospective pan-European population-
based cohort of young adults aged 20-44 (European Community Respiratory Health Survey: 
1990–1995) the annual incidence of occupational asthma was 248–303/million workers per 
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annum, estimated using asthma-specific job exposure matrices (Kogevinas et al., 2007).  
From 1996-1999, mean annual incidence of occupational asthma was 24 cases per million 
workers calculated from the French Observatoire National des Asthmes Professionnels 
(ONAP) voluntary surveillance programme for occupational and chest physicians.  This 
number of reported cases was two-fold higher than the number of cases of occupational 
asthma compensated over the same period in France (Ameille et al., 2003).  Similar figures 
were retrieved from SWORD 1992-2001 (22 cases per million workers; McDonald et al., 
2005), SHIELD 1991-2005 (42 cases per million workers; Diar Bakerly et al., 2008), project 
SENSOR from Michigan, USA (27 cases per million workers; Henneberger et al., 1999), a 
mandatory physician reporting scheme in California (25 cases per million workers; Reinisch 
et al., 2001) and from the Belgian workers’ compensation board (29 cases per million 
workers; Vandenplas et al., 2011).   
 
1.2.3 Under-reporting of occupational asthma 
Data from Europe shows that occupational asthma is under-reported to surveillance schemes.  
Leira et al. (2005) showed that occupational asthma is grossly under-reported to the 
mandatory Labour Inspection Authority registry in Norway, where only 223 reports were 
made between 1995 and 1999, from an expected 1,110 reports per annum based on estimates 
from a population-based cohort study (Karjalainen et al., 2001).  A voluntary surveillance 
system implemented in Catalonia in Spain taking reports from 142 chest and occupational 
physicians was noted to give a four-fold higher total number of cases of occupational asthma 
in 2002 (174 cases) than the Catalonian compulsory reporting system (42 cases), implying a 
large degree of under-reporting (Orriols et al., 2006).  In 2003 after the voluntary register had 
been adopted by 3 provinces (Orriols et al., 2010), the discrepancy persisted as a two-fold 
increase in cases (166 voluntary versus 80 compulsory).  A wide variation in the incidence of 
occupational asthma was noted (median incidence=57 cases per million workers/annum; 
range 35.6-161.4).   
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1.2.4 Incidence trends 
There has been a decline in notifications to various reporting schemes for occupational 
asthma in the UK.  Carder et al. (2012) analyzed reports of work-related respiratory disease 
from the SWORD reporting scheme for respiratory physicians (1996-2011), and observed that 
the mean annual decrease in the incidence of occupational asthma was greater than that 
observed for total respiratory disease at -7.7% (95% CI: -9.2 to -6.2), with reporter fatigue 
indicated by a sharper decline in notifications from general respiratory physicians (-9.1%; 
95% CI: -12.7 to -5.3) when compared with core specialist reporters (-7.4%; 95% CI: -9.0 to -
5.7), and by an increase in nil returns and non-response.  McNamee et al. (2008) had 
previously compared more limited SWORD data (1996-2005) with that of OPRA and 
observed that the magnitude of annual change in incidence was often inconsistent: for 
occupational asthma it was -1.9% (95% CI: -5.2 to 1.4) and -12.1% (95% CI: -19.5 to -4.1) 
using respiratory physician and occupational physician reports, respectively. The authors 
concluded that the differences were in part consistent with differential reporting behaviour, 
specifically greater reporter fatigue in occupational physicians than in core reporting 
respiratory physicians.  However, it should be noted that preventative workplace interventions 
would likely be more prevalent in workplaces with attending occupational physicians than in 
the general workforce, and referral patterns to specialist respiratory physicians within the 
NHS may be subject to change over time.   
 
Stocks et al. (2013a; 2013b) demonstrated that preventative workplace interventions and 
control measures could, at least partly, account for reduced incidence of occupational asthma 
in the UK.  A significant reduction in SWORD notifications of short latency respiratory 
disease (SLRD - including occupational asthma) was seen for all agents where work-exposure 
limits (WELs) had been introduced through COSHH (2002) legislation.  Reductions in SLRD 
were also observed with colophony, attributed to a Health and Safety Executive (HSE) 
inspection pack for exposed workers, and with glutaraldehyde and latex in healthcare 
workers, attributed to substitution in National Health Service (NHS) clinical areas.  
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Diar Bakerly et al. (2008) reported that the incidence of occupational asthma in the West 
Midlands was stable between 1991 and 2005 (median incidence=42 cases per million 
workers; 95% CI=37 to 45).  However, a more up to date analysis showed a statistically 
significant 5.5% year-on-year decrease in annual incidence (1991-2011) when a negative 
binomial regression model was applied (Walters et al., 2013).  Incidence was highest in 1995 
(58 cases per million workers), and fell to 14 cases per million workers per year by 2011.  
Notifications to the SHIELD surveillance scheme due to most causative agents declined year 
on year, with the largest reductions seen for latex, glutaraldehyde and colophony, where 
workplace substitution has been possible.  Only the incidence of occupational asthma due to 
cleaning agents showed a year-on-year increase, which is consistent with similar reports from 
the SWORD surveillance scheme and from a French registry (Stocks et al., 2012a; Paris et al., 
2012).  Some cleaning agents have been demonstrated to be respiratory sensitizers, 
principally quaternary ammonium compounds (Vandenplas et al., 2013a).  However, it 
remains unclear as to whether increasing reports represent better awareness amongst 
healthcare professionals or greater biocide potency (Pechter et al., 2005; Arif et al., 2012; 
Delclos et al., 2007).  Reporter fatigue amongst occupational physicians and general 
respiratory physicians was observed, with very few notifications from anywhere other than 
the Birmingham specialist occupational lung disease clinic seen after 2000.  Overall 
notifications from the specialist clinic fell significantly year-on-year by 3.9% after the effect 
of reporter fatigue had been taken into account.  The authors suggested that for many agents 
this demonstrated increasing lack of recognition in the workplace and amongst healthcare 
professionals, rather than a true reduction in incidence due to control measures.  This was 
illustrated by a 5.3% year-on-year decline in notifications due to bakers’ asthma (due to flour 
and enzymes) from industries in the West Midlands, where it was argued that the number of 
exposed workers and control measures were unlikely to have changed considerably over the 
study period (Walters et al., 2013).   
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In Europe, Vandenplas et al. (2011) observed a downward trend in incidence using a negative 
binomial regression analysis of Belgian Workers’ Compensation Board data from 1993-2002.  
Mean average annual incidence of occupational asthma was 29.4 new cases per million 
salaried workers (95% CI: 27.6 to 31.3) during the study period, and there was a significant 
decline in the overall incidence rate of occupational asthma from 35.5 new cases per million 
salaried workers in 1993 to 25.8 in 2002.  Paris et al. (2012) assessed annual trends from 
notification data from the French national surveillance network, Reseau National de Vigilance 
et de Prevention des Pathologies Professionnelles (RNV3P), and demonstrated an overall 
decrease in incidence of work-related asthma over the period 2001-2009 (Kendall tau= -
0.722; p=0.0006).  A significant decrease was observed for some agents such as isocyanates 
(tau=-0.41; p<0.001), aldehydes (tau=-0.40; p<0.001) and latex (tau=-0.24; p=0.001), while a 
significant increase was observed for quaternary ammonium compounds (tau=0.34; p<0.001).  
Data from the Finnish Register of Occupational Diseases (1986-2002) indicated that 
notifications increased from 1986 to 1995, decreased markedly between 1995 and 1998, and 
remained stable thereafter.  This sharp downward trend was attributed to a decrease in cases 
due to HMW agents (for example, cow dander, flour and grain, and storage mites), which was 
in turn related to a decrease in agricultural activities and improvements in dairy farming 
processes (Piipari and Keskinen, 2005). 
 
1.2.5 Under-recognition in primary care 
The apparent decline in bakers’ asthma in the West Midlands has provided some evidence for 
under-recognition by healthcare professionals.  There is also evidence that general 
practitioners (GPs) do not identify potential cases and refer for specialist opinion.  In a small 
cross-sectional study of adult asthmatics in one primary care practice in Oxfordshire, 32% of 
adult new-onset asthmatics were in jobs known to be at significant risk of occupational 
asthma, yet a potential link between occupation and symptoms had only been recorded in 
18% of patients (de Bono and Hudsmith, 1999). 7 out of 182 (4%) of the patients with adult 
onset asthma had been given a diagnosis of occupational asthma, although in nearly half (3 
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out of 7) of these cases a GP had made the diagnosis without referral to a specialist.  A cross-
sectional study from Sheffield, UK revealed that 50% of patients diagnosed with occupational 
asthma have seen their GP more than 5 times with work-related asthma symptoms before 
specialist referral occurs (Fishwick et al., 2007).  Furthermore Hoyle et al. (2010) reviewed 
cases of undetermined work-related respiratory illnesses that had been reported to The Health 
& Occupation Reporting network in General Practice (THOR-GP) at the University of 
Manchester, UK and found that only 26% were referred for specialist opinion and diagnostic 
clarification despite uncertainty over diagnosis: of those 85% were exposed to known 
asthmagens. 
 
Lack of enquiry about work exposures has also been shown to delay the diagnosis of 
occupational asthma, and in studies from the UK and Canada mean delays of 3-4 years from 
symptom onset to diagnosis or referral to a specialist have been identified (Fishwick et al., 
2007; Santos et al., 2007; Poonai et al., 2005).  In a cross-sectional study using chart reviews 
and telephone interviews from Canada, the mean time from symptom onset to diagnosis was 
4.9 years and patients waited 7.4 months before discussing the work-relation of symptoms 
with a doctor.  The most commonly reported reason for this was lack of enquiry by the 
attending doctor (Poonai et al., 2005).  In closed question responses from cross-sectional 
studies, GPs have cited insufficient time, lack of expertise and poor access to specialist 
services as barriers to the diagnosis of occupational asthma on their part (Parhar et al., 2011; 
Holness et al., 2007; Poonai et al., 2005).  In response to such findings, BOHRF has 
published guidance for GPs and primary care nurses on assessment and management of 
patients with suspected occupational asthma (BOHRF, 2010a).  
 
Workers are reluctant to consult healthcare professionals with new or worsening asthma 
symptoms, and asthmatic workers have been shown to endure work practices known to 
expose them to respiratory hazards, despite being aware of the health risks (Slater et al., 
2000).  Poonai et al. (2005) found that there was a mean delay of 8 months from symptom 
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onset before workers consulted a physician, where many workers (32%) had anticipated the 
likely diagnosis from the onset of symptoms.  Fear of losing work time or employment, and 
lack of awareness of respiratory hazards at work have been cited as potential reasons for these 
phenomena (Poonai et al., 2005; Santos et al., 2007; Gordon et al., 1997).  In a qualitative 
study of attitudes towards workplace health in symptomatic workers with occupational 
asthma from the UK, workers identified fear of losing work time and income, or fear of 
unemployment, as themes that hindered engagement with management and occupational 
health services on health issues (Bradshaw et al., 2007).   
 
1.2.6 Occupational risk factors 
The occupational history should focus particularly on exposures occurring at the time that 
asthma symptoms started or worsened at work.  The latency for LMW agents and a few 
HMW sensitizers (for example, laboratory animals) is typically within 2 years of ongoing 
exposure (Malo et al., 1992; Malo et al., 2001), whilst it is usually longer for most other 
HMW sensitizers: for example, there is an average symptom latency of 5 years for flour or 
latex after initial exposure (Allmers et al., 1996; Malo et al., 2001).  There are >400 reported 
workplace sensitizers and many documented at-risk occupations.  The most frequently 
reported agents include isocyanates, flour and grain dust, colophony and fluxes, latex, 
animals, aldehydes, adhesives, metals, resins and wood dust (Nicholson et al., 2010; Bakerly 
et al., 2008; Ameille et al., 2003; McDonald et al., 2005; Orriols et al., 2006; Toren and 
Blanc, 1999).  The occupations most commonly reported to surveillance schemes of 
occupational asthma are animal handlers, bakers and pastry makers, chemical workers, food 
processing workers, hairdressers, paint sprayers, nurses and other health professionals, timber 
workers and welders (Bakerly et al., 2008; McDonald et al., 2005; Nicholson et al., 2010; 
Tarlo et al., 2008).   
 
A number of population-based studies have also identified occupations with an increased risk 
of developing occupational asthma: in a pan-European cohort of 6837 workers aged 20-44 
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high risk occupations for developing asthma were nursing, cleaning, baking and spray 
painting (Kogevinas et al., 2007).  In a case-control study by Jaakkola et al. (2003) asthma 
risk was increased for workers employed in a variety of occupations (illustrated in Table 1.2) 
when using professionals, clerks and administrative workers as the reference category.  
 
Occupational group Men Women Total 
1OR 95% CI 1OR 95% CI 1OR 95% CI 
Bakers and food processors 8.62 0.86, 86.5 0.83 0.22, 3.05 1.71 0.58, 5.10 
Forestry and related workers 6.00 0.96, 37.5 - - - - 
Chemical industry workers 5.56 0.48, 64.7 5.69 0.58, 55.8 5.69 1.08, 29.8 
Dentists and dental workers - - 4.74 0.48, 46.5   
Textile workers 4.70 0.29, 77.1 0.88 0.34, 2.26 1.19 0.49, 2.88 
Metalworkers 4.52 2.35, 8.70 - - - - 
Waiters - - 3.03 1.10, 8.31 - - 
Rubber and plastic workers 2.70 0.58, 12.7 2.52 0.58, 10.9 2.61 0.92, 7.42 
Electrical and electronic 
production workers 
2.83 0.82, 6.93 0.61 0.11, 3.51 1.52 0.61, 3.80 
Wood and paper workers 1.73 0.60, 4.99 2.03 0.33, 12.4 1.72 0.71, 4.17 
Laboratory technicians 1.66 0.17, 16.6 0.44 0.05, 4.00 0.75 0.15, 3.74 
Storage workers 1.57 0.40, 6.19 0.98 0.27, 3.60 1.21 0.47, 3.12 
Cleaners - - 1.42 0.81, 2.48 - - 
Professionals, clerks, and 
administrative 
1.00 
 
Table 1.2.  Adjusted odds ratios of asthma in different occupational groups from the 
Finnish Environment and Asthma Study, 1997-2000 (Jaakkola et al., 2003).  
Professionals, clerks, and administrative workers were considered the reference 
category.  For male workers, risk was increased for bakers and food processors, textile 
workers, electrical and electronic production workers, laboratory technicians and 
storage workers, forestry work, and metalwork.  For women, asthma risk was increased 
for waiters, cleaners and dental workers. 1Odds ratios were adjusted for age and 
smoking.  OR=odds ratio; CI=confidence interval.   
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The risk of sensitization is typically greater with higher and more frequent exposures, and a 
positive exposure-response relationship has been demonstrated for many agents, for example, 
organic acid anhydrides (Nielsen et al., 2001), bakery enzymes (Brant et al., 2005a), 
laboratory rat urine (Heederik et al., 1999), and platinum salts (Merget et al., 2000).  
 
Respiratory protective devices may be used to reduce exposure to sensitizers but do not 
provide complete protection, as sensitization can still occur despite use or where measured air 
levels are extremely low or undetectable (Baur et al., 1998a). However, if exposure levels of 
some allergens fall short of determined limit values, they are not associated with an increased 
risk of occupational asthma: Baur et al. ascertained lower limit threshold values for a number 
of agents: wheat flour (1-2.4 mg/m3), fungal alpha-amylase (0.25 ng/m3), natural rubber latex 
(0.6 ng/m3), Western red cedar (0.4 mg/m3) and rat urine (0.7 microg/m3).  
 
1.2.7 Other risk factors 
Atopy describes a tendency to hypersensitivity, and is demonstrated by the propensity to 
produce specific IgE to common aeroallergens, which can then be measured or demonstrated 
by skin prick testing.  Atopy has been reported to increase the risk of occupational asthma and 
sensitization caused predominantly by high molecular weight agents such as animal dander 
(Krakowiak et al., 2007), flour and amylase (De Zotti and Bovenzi, 2000; Walusiak et al., 
2004) and shellfish (Jeebhay et al., 2008; Cartier et al., 1984; Desjardins et al., 1995).  
Rhinitis and rhino-conjunctivitis symptoms (runny nose, itchy nose, nasal blockage, and 
sneezing) occur frequently with occupational asthma (45-100% cases; Nicholson et al., 2010) 
and have been attributed to LMW agents such as organic acid anhydrides (Grammer et al., 
2002; Nielsen et al., 2006), lasamide (Klusackova et al., 2007) and persulphates (Moscato et 
al., 2005), and to HMW agents such as wheat flour (Gautrin et al., 2002), snow crab (Cartier 
et al., 1984) and laboratory rats (Cullinan et al., 1999).  However, rhinitis symptoms are more 
intense when associated with HMW agents (Malo et al., 1997) and, indeed, features of 
occupational rhinitis are more likely to precede IgE-associated occupational asthma (Castano 
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et al., 2009), where the risk of developing asthma is highest in the year after the onset of 
rhinitis symptoms (Cortona et al., 2001; Gautrin et al., 2001; Grammer et al., 2002; Gross, 
1980; Karjalainen et al., 2003).   
 
Cigarette smoking has been shown to increase the risk of sensitization to a number of agents, 
including platinum salts, seafood, flour and green coffee and castor bean (Nicholson et al., 
2010), and increase the risk of occupational asthma for isocyanates, platinum salts and 
seafood, though its role is unclear for many agents.  Venables et al. (1989a) showed a 
significant dose-response effect of cigarette smoking on the risk of sensitization, as 
demonstrated by skin-prick testing to platinum salts. 
 
1.3 Diagnosis of occupational asthma 
1.3.1 Expert opinion 
The symptoms of occupational asthma are on the whole indistinguishable from non-
occupational asthma.  Deterioration of asthma symptoms on workdays is poorly predictive for 
occupational asthma, with only 31-46% of those with clinical suspicion going on to have 
positive specific inhalation challenge (SIC) tests (Axon et al., 1995; Baur et al., 1998b, 
Koskela et al., 2003; Malo et al., 1991; Cote et al., 1990).   Some factors may be useful in 
discriminating however: those with occupational asthma are less likely to report seasonal or 
allergic exacerbations, pet-related or stress triggers or a family history of asthma, than those 
with non-occupational asthma (Axon et al., 1995).   Two authors have described high 
sensitivities (93-100%) for the general expert history in the diagnosis of occupational asthma 
(Cote et al., 1990; Ricciardi et al., 2003), and in a prospective study of 45 patients, 
Vandenplas et al. (2001) reported a high sensitivity (87%) and low specificity (14%) when 
compared with SIC as the gold standard.   
 
  
 20 
1.3.2 Questionnaires 
Several questionnaires have been validated for screening asthma in occupational settings: for 
office workers (Venables et al., 1993), laboratory animal and flour processing workers 
(McKinlay and Venables, 1993), healthcare workers (Delclos et al., 2006) and woodworkers 
(Schlunssen et al., 2004).  However one such questionnaire had low sensitivity (28%) and 
specificity (73%) in detecting asthma measured by non-specific bronchial responsiveness 
(NSBR) in shipyard workers (Stenton et al., 1993), warranting caution in interpretation of 
such questionnaires in surveillance or specific workplace settings.   
 
A few studies have looked at questionnaires to identify specifically occupational asthma.  
Malo et al. (1991) used an open questionnaire undertaken by interview with 162 workers.  
The overall sensitivity of the open questionnaire was 87%, but specificity was 27% when 
compared with SIC.  When examining individual items concerning work effect on symptoms, 
improvement of symptoms away from work at the weekend or on holiday, had sensitivities of 
77% and 88% respectively although speciﬁcities were low at 44% and 24%.  More recently 
Vandenplas et al. (2005) undertook structured interviews and examined the performance of 
individual items on diagnosis, and found that ‘wheeze at work’ particularly, in addition to 
being sensitive (88%) [written in what appears to be an error in the Vandenplas et al. paper as 
40%], was also 85% specific for occupational asthma, and was the symptom most associated 
with a positive diagnosis (OR=3.8; 95% CI: 1.7 to 8.6).  The item ‘symptoms worse at work’ 
was sensitive (90%) but not specific (9%), and sensitivity was lower for ‘symptoms at work 
everyday’ (55%) and for ‘symptoms progressively over the week’ (15%).  ‘Improvement of 
symptoms at weekends’ had a sensitivity of 76% and specificity of 54%, ‘improvement 
during holidays’ a sensitivity of 74% and specificity of 57%, and when both questions were 
asked together, overall sensitivity and specificity were 75% and 55% respectively. In a small 
study of 5 latex-exposed nurses with occupational asthma, sensitivity of ‘symptoms better on 
days away from work’ had a sensitivity of 100% (Vandenplas et al., 1995).  Most recently, 
using a self-administered occupational asthma screening-questionnaire, Pralong et al. (2013) 
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described optimum sensitivities of 70-90% for a variety of asthma symptoms worse at work, 
and a sensitivity of 79% for ‘improvement of symptoms away from work’.  However 
specificity was very low 13-28% for symptoms at-work, and 24% for improvement away 
from work.   
 
Thus describing a work effect on asthma symptoms has a high sensitivity but low specificity 
for identifying occupational asthma.  A number of guidelines advocate asking workers about 
the work effect on their asthma symptoms (Nicholson et al., 2010; Fishwick et al., 2012; Baur 
et al., 2012), although all recommend further tests to validate a diagnosis of occupational 
asthma.  Furthermore these questions can miss those workers with poor symptom perception, 
or possibly those with symptoms that worsen at the end of the shift and persist at home 
(Burge, 1979).  
 
1.3.3 Serial peak-expiratory flow measurements 
Peak expiratory flow (PEF) is the maximum flow achieved during an expiration delivered 
with maximum force, starting from the point of maximum lung inflation (Quanjer et al., 
1997).  It is quick to perform, inexpensive, and non-invasive using a PEF meter or portable 
spirometer (Moscato et al., 1995).  Serial PEF measurements are more helpful in the 
diagnosis of asthma since one-off lung function measurements are often normal at 
presentation; indeed at least four times a day readings are required to accurately reproduce 
diurnal variation (DV) of peak flow in asthmatics (Gannon et al., 1998; D’Alonzo et al., 
1995).  Serial PEF recording at work and away from work has long been proposed to 
investigate the relationship between work exposure and lung function (Burge et al., 1979a; 
Burge et al., 1979b).  Malo et al. (1993) compared hand reading of PEFs by three experts with 
SIC for unselected agents and achieved good concordance with expert opinion (83%), and a 
sensitivity of 72% and specificity of 78% when 2-hourly measurements were used.  Four 
times daily measurements were almost as good, with a concordance of 77%, sensitivity of 
70% and specificity of 78%, and were considered to be acceptable to the worker. Less 
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frequent readings produced higher specificity but low sensitivity. Anees et al. (2004) showed 
that the minimum criteria for optimal sensitivity/specificity using computerized interpretation 
were at least four readings a day, at least three consecutive workdays in each work period and 
at least three work-rest-work or rest-work-rest complexes (approximately three weeks), 
showing a sensitivity of 78% and specificity of 92% when tested.  When data were collected 
less frequently, the sensitivity and specificity fell to 64% and 83% respectively.  Beach et al. 
(2005) have undertaken a systematic review and meta-analysis of studies measuring 
performance of PEF measurements against SIC, and provided pooled estimates of sensitivity 
and specificity of 64% and 77% respectively, where both sensitivity and specificity were 
available.  
 
Acceptable PEF records are returned in at least 52-87% of workers who are asked to complete 
them (Nicholson et al., 2010; Moore et al., 2009a; Huggins et al., 2005; Sauni et al., 2009; 
Malo et al., 1995) and data quality is also better when specific occupational PEF charts 
containing prompts about shift times and exposures are used (Huggins et al., 2005). 
 
UK guidelines on the management of asthma (BTS/SIGN, 2012) suggest that all attending 
physicians, including GPs, attending should consider the diagnosis of occupational asthma in 
adult patients with new- or recurrent-onset asthma symptoms; additionally those in high-risk 
occupations should have a diagnosis of occupational asthma positively excluded, 
recommending serial PEF measurements with expert (including software) analysis, and 
referral to a specialist.   
 
1.3.4 Peak-expiratory flow analysis 
Burge (1989) observed that most PEF records for occupational asthma were viewed 
qualitatively and subjectively.  Perrin et al. (1992) demonstrated a sensitivity and specificity 
of 81% and 74% respectively for qualitative ‘visual analysis’ of PEF readings compared with 
SIC.  Qualitative analysis requires inter-observer agreement to be high, and a systematic 
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review by Nicholson et al. (2010) reported 80% concordance between expert assessors, with 
kappa values of at least 0.6 in most studies reviewed (Baldwin et al., Venables et al., 1984; 
Winck et al., 2001; Perrin et al., 1992), with the exception of 2 studies where inter-observer 
agreement was lower (Chiry et al., 2007: kappa=0.27 to 0.7; Girard et al., 2004: kappa=0.4 to 
0.6).   
 
A number of quantitative methods have been utilized.  Hayati et al. (2006) applied Shewart 
control charts and found that a lower control limit PEF at work (LCL(W)) of <60% of the 
personal best was 86% sensitive and 88% specific for identifying occupational asthma 
compared with SIC.  Other authors have used an arbitrary DV in PEF >20% on single days or 
prolonged periods at work (Smith et al., 1987; Smith et al., 1989; Cartier et al., 1989b).  Liss 
and Tarlo (1991) investigated performance of DV in PEF on days at work and days away 
from work, and that found a ≥20% fall in PEF, which happened more frequently or with 
greater variation on days at work than on days away, had a sensitivity of 72% and specificity 
of 53% for identifying occupational asthma.  By excluding those with ≥20% variation in PEF 
on one day only, the sensitivity and specificity increased to 93% and 77% respectively.  In a 
further study by Hayati et al. (2008), which used the ratio of DV in PEF at work compared 
with DV in PEF away from work, they found that a ratio of >15% was 94% sensitive and 
61% specific for identifying occupational asthma.   
 
Cote et al. (1993) compared qualitative serial PEF analysis (by agreement between 3 
physicians that work PEF was lower than rest PEF) with 3 quantitative methods: (1) variation 
in PEF between periods at work and away from work being outside the 95% confidence 
interval for 15 non-work-related asthmatics, (2) variation between maximum PEF at 
weekends (away from work) and minimum PEF on days at work against non-asthmatic PEF 
variation, and (3) DV in PEF greater on work days compared to rest days.  When compared 
with SIC, the qualitative analysis had a sensitivity of 87% and specificity of 90%.  Of the 
quantitative analyses, variation in maximum PEF at weekends and minimum PEF during 
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workdays was the only analysis that had higher sensitivity and specificity than qualitative 
analysis (93% and 90% respectively).  Anees et al. (2011) found that difference in mean PEF 
between rest and work periods best separated workers with occupational asthma from those 
with non-occupational asthma and normal subjects, and using this index, a difference in PEF 
of >16 l/min had a sensitivity of 70% in diagnosing occupational asthma.  An increase in DV 
on workdays of >7% over rest days had a sensitivity of only 27% for the diagnosis of 
occupational asthma. 
 
1.3.5 Software analysis of peak-expiratory flow measurements 
A computer software-based PEF analysis tool called OASYS-2 has been developed in 
Birmingham, UK to overcome inter-observer variation in qualitative (visual) analysis 
(Gannon et al., 1996).  Each work-rest-work and rest-work-rest complex from PEF 
measurements taken on days at work and away from work, was assigned a visual score by an 
expert, and a linear discriminant analysis identified the patterns associated with a positive 
record.  The scores were categorized into 4 groups (1-4), where 1=no occupational asthma, 
2=possible, 3=probable and 4=definite occupational asthma.  A mean work effect index 
(WEI) or “OASYS score” was calculated for the record.  When tested against gold standard 
cases of occupational asthma (ie. diagnosed with either SIC or immunological demonstration 
of sensitization) a WEI of >2.5 showed a sensitivity of 75% and specificity of 94% (Gannon 
et al., 1996; Burge et al., 1999).  Sensitivity and specificity became 78% and 92% 
respectively, once at least three complexes of data (approximately 3 weeks, 3 consecutive 
workdays in any work period) and at least four readings per day were obtained (Anees et al., 
2004).  In practice, the sensitivity was 79% in a group of workers with occupational asthma 
due to detergent enzymes (Moore et al., 2009a), despite many not having three consecutive 
days in each work period, a requirement for optimal sensitivity.   
 
A newly developed ABC score (area between the curves for PEF, at work and away from 
work) subsequently showed a sensitivity of 72% and specificity of 100% when a score of 
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15L/min/hour was used; this was applicable to all types of shift work (Moore et al., 2012).  
Elsewhere authors have been more critical: Girard et al. (2004) achieved a sensitivity of 35% 
and specificity of 65% in identifying occupational asthma from a WEI of >2.5, and Chiry et 
al. (2007) were unable to distinguish occupational asthma (mean WEI=2.42+/-1.0) from 
work-exacerbated asthma (mean WEI=2.06 +/- 1.4; p=0.4). 
 
A number of factors may interfere with interpretation by any method (Gannon and Burge, 
1997; Jares et al., 2012).  These include: 
 
1. Intermittent exposure to suspect agents at work  
2. Exposure to irritants 
3. Irregular administration of medications 
4. Irregular timing of the first reading after waking 
5. Respiratory tract infection  
6. Variable patient technique for PEF measurement   
7. Falsification of readings 
8. Patient compliance 
 
Falsification of readings has been considered as a limiting factor for interpretation of PEF 
measurements performed on hand-held manual meters with a linear scale.  Malo et al. (1995) 
reviewed paper and electronic PEF readings for 21 subjects undertaking investigation for 
occupational asthma.  Reported values corresponded precisely to stored values in 52% of 
readings, and 71% were recorded within 1 hour of the solicited time.   
 
Compliance was less satisfactory in workers referred by a compensation board.  However, 
electronic logging meters utilizing coiled springs, ultrasound or rotary turbine technologies 
are now in common usage, with automatic checking for reproducibility and quality criteria 
(Miller et al., 2005; Quanjer et al., 1993).    
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1.3.6 Cross-shift changes in peak expiratory flow and FEV1 
PEF and FEV1 are closely correlated in asthma (Troyanov et al., 1994) and have been shown 
to be as effective as each other in identifying early asthmatic responses to occupational agents 
(Weytjens et al., 1999).  In the workplace, cross shift comparisons are made by subtracting 
the daily post-shift FEV1 or PEF reading, made 1 hour after work, from the pre-shift reading, 
made 1 hour before work.  Cross-shift changes in PEF and FEV1 have often been used in 
epidemiological and clinical studies, though early studies failed to show discriminating 
changes in FEV1 (Gandevia and Ritchie, 1966; Gandevia 1963; Peters et al., 1968; Peters et 
al., 1970).  A single study by Park et al. (2009) has compared cross-shift changes in PEF with 
SIC testing.  A 5l/min cross-shift fall in PEF was found to be 91% specific for the diagnosis 
of occupational asthma, but with only 50% sensitivity; this was shown to be inferior to serial 
PEF monitoring when tested.   
 
Normal subjects and asthmatics exhibit diurnal variation in airway calibre that is acrophasic 
between 1400 and 1800 (the response is similar in phase but exaggerated in asthmatics) 
(Hetzel and Clark, 1980).  Therefore all workers on day shifts would experience co-incident 
increases in PEF across the shift, thus reducing the effect on PEF of an immediate asthmatic 
reaction.  A cross-shift change would also fail to identify a late asthmatic reaction where 
symptoms may not become evident for many hours after the start of the shift, or occur after 
the end of the shift.  Additionally workers’ symptoms may not improve overnight and can 
worsen progressively throughout the working week, which can reduce pre-shift readings 
(Burge et al., 1979a; Burge et al. 1979b; Burge et al., 1979c). 
 
1.3.7 Specific inhalation challenge testing 
Specific inhalation challenge (SIC) to occupational allergens was first described by Pepys and 
co-workers (Pepys and Hutchcroft, 1975; Pepys et al., 1972) and was based on the work of 
Colldahl on inhalation tests in allergy (Colldahl, 1967).  The rationale for SIC is to assess 
airway responsiveness to specific single sensitizing agents, as opposed to non-specific stimuli 
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such as methacholine, cold air and exercise, after control measurements have been made 
without exposure in the workplace, on separate days.  It can be carried out in two main ways: 
a controlled laboratory challenge in which suspected sensitizers are administered in controlled 
concentration by either inhalation chamber or closed-circuit (Vandenplas and Malo, 1997), or 
by realistic challenge - an attempt to reproduce actual work processes and exposures (Pepys 
and Hutchcroft, 1975; Aasen et al., 2013).  When the expertise to undertake a SIC is not 
available, the agent is not clear, or there is a negative SIC but high index of suspicion, an 
inhalational challenge in the workplace may be carried out under the supervision of a 
technician, by measuring lung function before and after usual workplace exposures (Rioux et 
al., 2008).  In the UK SICs to occupational agents are undertaken in a small number of 
specialist occupational lung disease centres (Ortega et al., 2002; Barber et al., 2008), and 
recent European Respiratory Society guidelines have attempted to standardize the 
methodology between centres (Vandenplas et al., 2014).   
 
A positive test is generally considered to be a fall in FEV1 of >15-20% from baseline on >1 
measurement (within 10-30 minutes for immediate asthmatic reactions and >1hour for late 
reactions) (Cartier et al., 1989b).  HMW agents generally cause immediate or dual asthmatic 
reactions and are on the whole simpler to administer, and dose–response curves are easier to 
generate (Rioux et al., 2008; Jares et al., 2012).  With LMW agents the reaction is often late, 
typical of the pattern originally described as a cornerstone of asthma by Herxheimer (1952), 
but it can be immediate, dual or atypical, and is therefore more difficult to predict (Jares et al., 
2012; Rioux et al., 2008; Talini et al., 2011).  Few studies have examined the criteria for a 
positive test.  Stenton et al. (1994) proposed criteria for detecting late asthmatic reactions 
from SICs, which they stated were not an all-or-none phenomena and could be identified by 
statistical method, by calculating pooled standard deviations for hourly FEV1 on at least 3 
control days without exposure.  A positive test required at least 2 consecutive measurements 
below the lower confidence limit for FEV1 following an active challenge  (Burge et al. (2009) 
also applied this method to unsupervised workplace serial PEF measurements, and found it to 
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have a sensitivity of 67% and specificity of 99% against other confirmed methods of 
sensitization). 
 
Although considered to be the gold standard for diagnosis of sensitizer-induced occupational 
asthma (Nicholson et al., 2010; Fishwick et al., 2012, Baur et al., 2012), SIC carries a small 
risk (3%) of precipitating a severe asthmatic reaction (Vandenplas et al., 2013b) and has a 
number of limitations which need to be considered in its interpretation: 
 
1. SIC has been reported to produce false negative results, when compared with a 
combination of expert opinion, suggestive serial peak flow measurements and 
immunological tests (Moscato et al., 1991; Cartier et al., 1989a; Burge et al., 1979, 
Lin et al., 1995),   
2. Once a worker is removed from exposure SIC tests can become negative, and this has 
been demonstrated after 2-6 years away from exposure (Lemière et al., 2000a; 
Paggiaro et al., 1994), 
3. It is often difficult to reproduce workplace conditions where exposures are complex, 
such as with welding fume or metalworking fluid, or where processes involve high 
temperatures, explosives or flammable substances (Aasen et al., 2013).  New 
methodology using closed-circuit devices has allowed control of level of exposure 
and increased safety of the procedure (Caron et al., 2010; Malo et al., 2004),  
4. SIC can only be performed in relatively stable workers (FEV1 >60-70 percent of 
predicted and/or >2L) (Cartier et al., 1989b),  
5. False positive results have occurred when workers are given large doses of allergen, 
beyond the usual occupational exposures that cause non-specific irritant reactions 
(Beach, 2005; Vandenplas and Malo, 1997), or when a worker has severe non-
specific bronchial reactivity (Burge, 1982; Malo et al., 2004).   
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1.3.8 Non-specific bronchial reactivity  
Inhalation challenge with methacholine is a measure of non-specific bronchial reactivity 
(NSBR) that can be performed before and/or after a period of work exposure.  Hyper-
responsiveness has been defined as the provocative concentration or dose of histamine or 
methacholine required to elicit a pre-determined change in FEV1, usually a 20% percent 
decline (PC20 and PD20, respectively) (Beach et al., 2005).  Beach et al. performed a meta-
analysis of 61 studies and reported the sensitivity and/or specificity of a single measurement 
of NSBR with SIC testing in the diagnosis of occupational asthma. In most cases, PC20 values 
<16 mg/mL were considered to reflect significant NSBR, however, cut-off values of <8 
mg/mL and <32 mg/mL were also reported.  The pooled estimate of sensitivity was 67% 
(95% CI: 58 to 74%) and specificity was 64% (95% CI: 56 to 71%), whereas the pooled 
estimate for studies that reported only sensitivity was higher (n=13; 77%; 95% CI: 59 to 
88%).  10 studies reported sensitivity and specificity of NSBR compared with SIC to HMW 
agents. The pooled estimates for sensitivity and specificity were 79% (95% CI: 68 to 88%) 
and 51% (95% CI: 35 to 67%) respectively.  2 studies suggested that the sensitivity of a single 
NSBR test could be improved by shortening the latency and measuring NSBR within hours of 
exposure (Perrin et al., 1992; Vandenplas et al., 2001).  The authors acknowledged that 
definitions of a positive SIC varied between studies, and different protocols were used to 
carry out SIC.  They also made no attempt to evaluate the differing methodologies.  
Subsequent studies have produced broadly similar results, with variable sensitivities when 
tested against different agents: all agents (96-98%; Maghni et al., 2004; Yacoub et al., 2007), 
isocyanates (76%; Piirila et al., 2008) and persulphates (57%; Moscato et al., 2005).  
Therefore a single measurement of NSBR has only a moderate sensitivity and specificity for 
the diagnosis of occupational asthma. 
 
1.3.9 Paired measurements of non-specific bronchial reactivity 
A number of studies have attempted to measure PD20 while exposed at work, and away from 
work.  Cote et al. (1990) demonstrated that a two-fold change in NSBR after work exposure 
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to Western red cedar had a sensitivity and specificity of 62% and 78% when compared to 
positive SICs to plicatic acid.  Tarlo and Border (1991) compared NSBR to methacholine at 
work, and after at least 10 days away from work, with SIC test for mixed agents.  Paired 
methacholine changes had a sensitivity of 56% and specificity of 83% in identifying 
occupational asthma.  Perrin et al. (1992) tested sensitivity and specificity of a 3.2-fold 
change in NSBR at work and 2-weeks away from work (where 3.2 was the 95% CI for NSBR 
test reproducibility), and demonstrated a sensitivity of 48% and specificity of 64%; reducing 
the required change to two-fold increased sensitivity to 67%, but reduced specificity to 54%.  
Therefore paired NSBR measurements only have a moderate sensitivity and specificity for 
identifying occupational asthma, and some authors cited difficulties for the worker in 
enabling enough time off work (2 weeks) to perform the test as limitations of its use. 
 
1.3.10 Sputum eosinophilia 
The normal cellular profiles of induced sputum have been described by Spanavello et al. 
(2000), who demonstrated that in healthy volunteers induced sputum was rich in macrophages 
(69.2 +/- 13% of cells) and neutrophils (27.3 +/- 13%), and poor in eosinophils (0.6 +/- 
0.8%), lymphocytes (1.0 +/- 1.2%), and epithelial cells (1.5 +/- 1.8%).  Asthma is 
characterized by airway eosinophilic inflammation, and marked sputum eosinophilia (>2.2% 
of non-squamous cells) occurs in most subjects with asthma (Pizzichini et al., 1997).  The 
cellular characteristics of induced sputum in occupational asthma are less well described 
however.  LMW agents are associated predominantly with late asthmatic reactions (Obata et 
al., 1999; Maestrelli et al., 1995; Maestrelli et al., 2009), which in turn are associated with 
increased number of airway eosinophils (Maestrelli et al., 2009).  Lemière et al (1999) 
showed that workers had a significant increase in eosinophils while exposed to a variety of 
predominantly LMW agents at work, but not away from work, and eosinophilia resolved after 
3-weeks away from work.   Indeed Girard et al. (2004) have proposed an increase of 1% in 
sputum eosinophils with work exposure as diagnostic for occupational asthma, but this only 
showed a sensitivity of 65% and specificity of 76%, and increasing the cut-off to 2% further 
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reduced sensitivity.  Furthermore, Anees et al. (2002) showed that the majority of cases of 
occupational asthma due to LMW agents are of the non-eosinophilic (predominantly 
neutrophilic) variant, and only 14/38 (37%) of cases demonstrated sputum eosinophilia 
(>2.2%) while exposed at work.  Indeed other studies have shown that some workers with 
occupational asthma have normal sputum eosinophil counts prior to SIC testing (Lemière et 
al., 2001, Obata et al., 1999). 
 
Most studies that have investigated sputum eosinophilia after SIC have shown a median 
increase in percentage eosinophil levels after positive challenges with HMW and LMW 
agents (Lemière et al, 2000b; Lemière et al., 2001; Obata et al., 1999; Krakowiak et al., 2005; 
Alvarez et al., 2001). In the study by Lemière et al. (2001) the best cut-off for predicting a 
20% fall in FEV1 was an increase in sputum eosinophils of ≥0.26 × 106/mL compared with 
baseline values (sensitivity 82%; specificity 91.7%); sensitivity was increased to 96% when 
combined with a two-fold increase in NSBR.  No accurate pooled estimates of sensitivity and 
specificity of sputum eosinophil counts have been made, and availability and resources 
required has limited their use to date. 
 
1.3.11 Fractional exhaled nitric oxide 
Fractional exhaled nitric oxide (FENO) is a simple non-invasive method of assessing airway 
inflammation (Dweik et al., 2011; Kharitonov et al., 1994), which correlates well with sputum 
eosinophilia (Jatakanon et al., 1998; Franklin et al., 2004; Langley et al., 2002).  However, 
FENO depends upon several other factors including inhaled corticosteroid (ICS) use, smoking, 
respiratory tract infections, atopy and height.  ICS use results in a fall in FENO levels in mild 
asthmatics (Kharitonov et al., 1996, Jatakanon et al., 1999; Silkoff et al., 2001), smoking 
lowers FENO (Bommarito et al., 2008; Verleden et al., 1999) and respiratory tract infections 
raise FENO (Kharitonov et al., 1995a; Proud 2005).  Atopics have increased levels compared 
to non-atopics (Franklin et al., 2004; Ho et al., 2000; Olin et al., 2006).   
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Recent guidelines recommend the application of FENO for monitoring airway inflammation in 
asthmatics and to support a diagnosis of asthma where further objective evidence is required 
(Dweik et al., 2011). Abnormal baseline FENO measurements are considered to be ≥ 22ppb in 
never- or ex-smokers and ≥14ppb in active smokers (Moore et al., 2010; Anees et al., 2002), a 
level equivalent with a raised sputum eosinophil count of ≥2.2%. FENO is in use in UK 
primary care practice as a complementary diagnostic tool in asthma, and as an aid to initiating 
or titrating asthma treatments (Price et al., 2013), but is currently not recommended as part of 
screening for occupational asthma (Fishwick et al., 2012).   
 
The role of FENO in occupational challenge testing remains unproven, though several 
prospective studies have investigated FENO changes after SIC in this setting.  Clinically 
relevant increases in FENO have been seen 24-hours after positive SIC (Piipari et al., 2002; 
Baur and Barbinova, 2005) and also in symptomatic patients with negative SICs (Barbinova 
and Baur, 2006).  Pedrosa et al. (2012) showed a significant 14ppb FENO change 24-hours 
after positive SICs (n=21), when compared to negative SICs (n=13), and receiver-operator 
curve analysis achieved a sensitivity of 81% and specificity of 92% in identifying a positive 
result, from a 12% increase in FENO.  3 other studies have demonstrated an increase in FENO 
24 hours after exposure to high and low molecular weight occupational agents, which 
correlated well with sputum eosinophil measurements (Lemière et al., 2010; Ferrazzoni et al., 
2009; Swierczynska-Machura et al., 2008).  However 2 studies reported that the predictive 
capacity of FENO change after SIC was low (Walters et al., 2014; Sastre et al., 2013).  FENO 
remains elevated up to 72 hours after challenge and the maximal FENO response is around 10-
hours post-exposure (Kharitonov et al., 1995b; Paredi et al., 1999); studies in the occupational 
setting have used post-exposure measurements at 20-24 hours.  The main limitation on most 
studies is the relatively small number of SICs available for analysis.  
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1.3.12 Specific IgE to occupational agents  
Asthma is classically thought of as an IgE-mediated disease that is prevalent in atopic 
individuals (Beach, 2005). Therefore skin-prick allergy tests (SPTs) and serological 
measurements of specific-IgE are in common usage in supporting a diagnosis of asthma.  
Specific IgE is measured using either the Radioallergoabsorbant test (RAST) or Enzyme 
Linked ImmunoSorbent Assay (ELISA) (Goodwin and How, 1976; Glovsky, 2007), which 
provide a graded marker of the degree of sensitization, and are used to monitor response to 
exposure over time.  A positive response to SPT is defined as a 3mm or greater wheal 
reaction to an allergen (Dreborg, 1991; Beach, 2005); this may be to common aeroallergens to 
signify atopy, or to specific occupational allergens where there is suspicion of sensitization.  
 
In occupational asthma induced by HMW agents, specific-IgE is usually present.  Several 
occupational allergens are commercially available for skin and serological testing and their 
sensitivity and specificity against SIC have been established.  These include natural rubber 
latex in healthcare workers (Vandenplas et al., 2001) wheat and rye flours in bakers (Van 
Kampen et al., 2008), animal epithelium in farmers (Koskela et al., 2003), and egg protein in 
laboratory workers (Jones et al., 2013).   Beach (2005) has undertaken a meta-analysis with 
pooled estimates of sensitivity and specificity for SPTs and serum-specific IgE against SIC.  
For SPTs to HMW agents, pooled sensitivity was 81% and specificity was 60%, from a total 
of 26 studies (9 of those reporting sensitivity only); for specific IgE the pooled sensitivity was 
74% and specificity was 79%, from 9 studies reporting both.   
 
Occupational asthma induced by LMW agents is generally not specific IgE-mediated, as 
LMW agents are too small to elicit an IgE-mediated response, and act as allergens by 
conjugation with carrier protein (haptens).  Consequently SPTs or measurements of specific 
IgE in this situation are not usually helpful, and importantly, there are few immunological 
tests available for the majority of LMW agents.  Some studies have assessed the performance 
of SPTs and specific-IgE for LMW agents with SIC however: for example, toluene 
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diisocyanate (TDI), MDI and HDI (Pezzini et al., 1984; Tee et al., 1998; Budnik et al., 2013), 
vinyl sulphone reactive dyes (Park et al., 2001), platinum salts (Merget et al., 1991) and 
anhydride dusts (Grammer et al., 1998; Baur and Czuppon, 1995).  Beach (2005) 
demonstrated a pooled sensitivity of 73% and specificity of 86% for SPTs to LMW agents 
from 5 studies, and a sensitivity 31% and specificity of 89% for specific IgE, from 11 studies.   
 
The presence of specific IgE confirms sensitisation but does not necessarily indicate the cause 
of occupational asthma, as sensitization can exist in the absence of occupational asthma, ie. 
its specificity is low.  The absence of commercially available allergens limits its use, 
particularly for LMW agents.  Also it is of no value in the diagnosis of irritant induced asthma 
or work-aggravated asthma. 
 
1.3.13 Occupational health surveillance 
The aim of health surveillance at work is to identify work-related disease at either pre-
symptomatic or early symptomatic stage, with the intention of improving health outcomes for 
affected workers (Nicholson et al., 2010).  Methods used in occupational asthma health 
surveillance are respiratory questionnaires, serial spirometry measurements, and detection of 
sensitization to a particular agent by either skin prick allergy tests or serum-specific IgE 
(Brant et al., 2005b, Gordon et al., 1997, Stenton et al. 1993).  There are no studies comparing 
the effectiveness of one component of health surveillance with another or randomized 
controlled trials of the effectiveness of health surveillance in practice.  However, a 
comparison between a health surveillance programme (using questionnaire and specific IgE 
to flour and fungal amylase) and an independent cross-sectional survey of employees was 
undertaken by Brant et al. (2005b) in supermarket bakery workers.  One percent of bakery 
workers had work-related symptoms and specific IgE, compared with 4% of employees from 
the survey; thus surveillance was judged to have underestimated the burden of occupational 
asthma.  Mackie et al., (2008) described a mean delay of 9 months between the detection of 
occupational asthma symptoms at health surveillance, and diagnosis; this contrasted with a 
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mean of delay of 4 years in a study of diagnostic delay in a UK multi-centre tertiary clinic 
population, where 86% of participants were not afforded health surveillance (Fishwick et al., 
2007). In Ontario, Canada, where a health surveillance programme for isocyanate-exposed 
workers was introduced in 1983, a comparison was made between cases of occupational 
asthma due to isocyanates and cases due to other agents where no such programme existed 
(Tarlo et al., 2002).  There was a shorter diagnostic latency (2.4 versus 3.4 years) and fewer 
hospital admissions in cases due to isocyanates when compared with non-isocyanate 
occupational asthma.  However, there is potential for confounding in this study, as no attempt 
was made to account for the effects of engineering controls or industrial hygiene measures 
(ie. reduction in isocyanate exposure).  Therefore there is some evidence that health 
surveillance for occupational asthma can shorten diagnostic latency and improve health 
outcomes, though health surveillance programmes have not been subjected to controlled 
trials.   
 
1.4 Outcomes of occupational asthma 
1.4.1. Health economics 
The burden of disease of occupational asthma is associated with significant societal costs.  
Ayres et al. (2011) performed a desktop study using cost-of-illness method to define direct 
and indirect lifetime costs of occupational asthma for six scenarios - a male and a female 
worker each exposed to: isocyanates, latex and glutaraldehyde, or flour.  2003 SWORD 
incidence data were then used to calculate costs for 209 cases of occupational asthma.  The 
cumulative lifetime costs were estimated to be £25.3-27.3 million (2004 prices), and when 
extrapolated for all causes in the UK in 2003, this came to £71.8-100.1 million.  Using this 
model each subsequent year would see a new cohort of newly diagnosed occupational 
asthmatics identified and added, each costing up to £100 million per annum. There was a 
marked gender difference, with the costs for male workers twice that of female workers, 
reflecting the number of men exposed to common causative agents in the UK, as well as their 
higher income in at-risk occupations.  About 49% of these costs were borne by the individual 
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worker, 48% by the state and 3% by the employer (although this estimate did not include 
costs of workplace modification, litigation or surveillance programmes).  As the economic 
burden appeared to fall on the state and individual, Ayres et al. concluded that there is 
currently little incentive for the employer to act.   
 
In the United States the total annual costs of occupational asthma have been estimated at $1.6 
billion (Leigh et al., 2002), comprising $1.2 direct costs and $0.4 billion indirect costs. To 
calculate costs Leigh et al. used the human capital method, which splits costs into direct 
categories such as medical expenses, as well as indirect categories such as lost earnings and 
lost home production.  They concluded that the majority of costs are born by the taxpayer 
(through Medicare) and the individual worker and their families, with a minority through 
contributions to workers’ compensation premiums.   
 
1.4.2. Socio-economic outcomes for the worker 
A number of studies have followed-up workers diagnosed with occupational asthma and have 
noted that roughly one-third of workers (range 25-44%) were unemployed at 1-6 years after 
diagnosis (Gannon et al., 1993; Venables et al., 1989b; Ross et al., 1998; Vandenplas et al., 
2002; Moscato et al., 1999; Ameille et al., 1997; Larbanois et al., 2002).  Goe et al. (2004) 
found that workers with occupational asthma were twice as likely to have left their employer 
than those with work-exacerbated asthma (47% v 23%), though other authors found no 
significant difference in employment status at follow-up between the same groups (Cannon et 
al., 1995; Larbanois et al., 2002).  Dimich-Ward et al. (2007) followed up 185 Western red 
cedar workers with occupational asthma who had remained employed after diagnosis, and 
found that the majority of subjects who were relocated to unexposed jobs within 1 year of 
diagnosis remained in their employment (74%) (with none quitting due to asthma), compared 
with 17% of workers who remained exposed leaving their employment because of their 
asthma.   
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62-85% of workers who leave employment (to either become unemployed or find alternative 
work) report suffering some loss of income (Vandenplas et al., 2002; Ameille et al., 1997; 
Moscato et al., 1999; Larbanois et al., 2002), and loss of employment has been associated 
with loss of income of 22-50% of baseline income (Moscato et al., 1999; Ameille et al., 1997; 
Larbanoir et al., 2002), all significantly greater than if the workers remained exposed or were 
relocated within the same company.  Financial loss may be greater for those with 
occupational asthma than those with non-occupational asthma (Santos et al., 2007); certainly 
workers with occupational asthma find employment more difficult to come by than non-
occupational asthmatics (Cannon et al., 1995; Larbanois et al., 2002).   
 
1.4.3 Health outcomes for the worker 
Patients with occupational asthma are significantly more likely to report poor physical 
activity, and poor physical and mental health, than patients with non-occupational asthma 
(Knoeller et al., 2013).  The likelihood of improvement or of resolution of symptoms and lung 
function is greater in workers who avoid ongoing exposure to the causative agent (Nicholson 
et al., 2010; Tarlo et al., 2008; Beach et al., 2008; Chan-Yeung et al., 1982; Moscato et al., 
1999), and continued exposure after diagnosis has been associated with a worsening of 
symptoms (Malo and Chan-Yeung, 2001; Ross and McDonald, 1998; Moscato et al., 1999) 
and lung function (FEV1) (Anees et al., 2006), even when workers are more heavily 
medicated (Marabini et al., 1993).  Rachiotis et al. (2006) have undertaken a systematic 
review of 39 studies that evaluated the symptomatic and functional outcomes of occupational 
asthma after avoidance of exposures to HMW and LMW agents. Reported rates of 
symptomatic recovery varied from 0-100%, with a pooled estimate of 32% (95% CI: 26 to 
38). These rates were lower with increased age and amongst clinic based populations. Patients 
with the shortest durations of employment (up to 76 months) had the highest rate of recovery 
(36%; 95% CI: 25 to 50), but this pattern was not sustained over longer durations; complete 
recovery was less common in those studies with an average duration of symptomatic exposure 
>26 months when compared to <26 months, though this was not statistically significant.   In 
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most cases NSBR detected at diagnosis persisted and the pooled estimate of persistent NSBR 
was 73% (95% CI: 66 to 79).  Patients with occupational asthma due to LMW agents were 
less likely to have persistent NSBR than those due to HMW agents, when age was accounted 
for.  In between-study comparisons, the authors found no clear patterns of recovery by 
duration of follow-up, by a crude index of study nationality, or when comparing disease 
attributed to LMW or HMW agents.  The majority of included studies recruited patients from 
specialist clinics, where there is considerable potential for bias, since patients with more 
severe disease may be referred more often for specialist assessment.  There was also an 
absence of any standardized methodology for follow-up studies, and the quality of the 
included studies was not assessed formally. 
 
The likelihood of resolution or improvement of symptoms is greater in workers who have had 
relatively normal lung function at diagnosis, and shorter duration of symptoms prior to 
diagnosis or removal from exposure, as seen for occupational asthma induced by isocyanates 
(Pisati et al., 1993; Pisati et al., 2007; Rosenberg et al., 1987; Park and Nahm, 1997; Piirila et 
al., 2000; Padoan et al., 2003), Western red cedar (Chan-Yeung et al., 1982), crab (Hudson et 
al., 1985) and reactive dyes (Park et al., 2006; Park et al., 2007).  Descatha et al. (2007) 
looked at diagnosis of a variety of causal agents and found that the severity of occupational 
asthma at diagnosis was associated with the duration of symptoms before diagnosis, but not 
with the type of causal agent.  
 
Reduction of exposure to sensitizing agents causing occupational asthma has been proposed 
as an alternative to total avoidance in order to minimize the adverse socio-economic impact of 
the condition.  Vandenplas et al. (2011) performed a systematic review of 14 studies 
examining the symptomatic and physiological outcomes of workers with occupational asthma 
after reduction or cessation of exposure to the causal agents. The meta-analysis of pooled data 
showed that a reduction of exposure was associated with a lower likelihood of improvement 
(OR=0.16, 95% CI: 0.03 to 0.91) or resolution of asthma symptoms (OR=0.30, 95% CI: 0.11 
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to 0.84), and a higher risk of worsening symptoms (OR=10.23, 95% CI: 2.97 to 35.28) and 
more severe NSBR (OR=5.65, 95% CI: 1.11 to 28.82), compared with complete avoidance of 
exposure.  There was potential for selection bias, since all studies were observational and the 
rationale for the intervention decision (reduction or avoidance of exposure) was largely 
unknown.  In most studies involving LMW agents the proportion of workers who avoided 
exposure was 2.3 to 3.2-fold higher than those who reduced exposure. Paradoxically, reduced 
exposure was 1.2 to 5.0-fold higher than avoidance for workers with occupational asthma due 
to latex (Vandenplas et al., 2002) and platinum (Merget et al., 1999).   
 
1.5 Conclusion 
The burden of occupational asthma in the UK is substantial, with 1 in 6 cases of new-onset or 
reactivated adult asthma being caused by an agent at work.  This currently costs the UK £1.1 
billion each decade, with most of this cost borne by the taxpayer and the individual worker.  
As industries change and work practices evolve, new asthmagens are identified and certain 
hazardous exposures become more prevalent than others.  In the past 3 decades there have 
been significant advances in the understanding of the patho-physiology of occupational 
asthma and in validated tools for screening and diagnosis, which have aided the management 
of the worker with asthma symptoms, although much work is still to be done on primary 
prevention and early detection of cases.   
 
Early diagnosis is the key to good prognosis and can prevent avoidable cost to the patient in 
terms of ill health, work-loss and unemployment; consequently there is considerable benefit 
to workers, to the health service and to society in making an early diagnosis of occupational 
asthma.  However occupational asthma is not well recognized by healthcare professionals in 
the UK, particularly in primary care populations where there appear to be as many 
undiagnosed cases of occupational asthma as diagnosed cases, and workers see their GP many 
times before referral to a specialist occurs.  In order to address this problem, a clear 
understanding of the behaviour of workers with occupational asthma symptoms, and the 
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barriers to diagnosis for the healthcare professional, is required.  
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CHAPTER 2: AIMS AND OBJECTIVES 
 
2.1 Background 
It is clear that occupational asthma is not well recognized by healthcare professionals, and 
that in addition to those workers who go undiagnosed, there is significant delay in diagnosis 
for many workers.  This delay exists in spite of the availability of specialist care, validated 
screening and diagnostic tests, and occupational asthma guidelines for all healthcare 
professionals who attend working-age asthmatics.  Under- and delayed diagnosis are 
associated with considerable health and financial costs to individual workers, who bear a 
significant proportion of those costs themselves.  Therefore there is an urgent need to improve 
recognition of occupational asthma and reduce the delay in diagnosis in the UK.  Data from 
the UK, Europe or North America concerning barriers to diagnosis for workers or healthcare 
professionals are sparse, and are currently limited to closed-question responses from cross-
sectional studies.  There have been no studies from the UK exploring barriers to the diagnosis 
of occupational asthma in detail. 
 
2.2 Overall aim of the research 
The over-arching aim of this research is to identify the barriers to diagnosis of occupational 
asthma on the part of the worker and of the healthcare professional, in order to determine a 
strategy for improving the diagnosis of occupational asthma in the UK. 
 
2.3 Hypotheses 
 
1. That poor recognition of occupational asthma in primary care is because primary 
healthcare professionals do not follow UK guidance for occupational asthma by 
asking working-age asthmatics about their work or the effect of work on their 
symptoms. 
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2. That delay in diagnosis of occupational asthma is partly due to multiple societal 
factors affecting whether an individual worker will disclose his or her occupational 
asthma symptoms to a healthcare professional or employer. 
 
3. That healthcare professionals lack knowledge and experience in managing cases of 
occupational asthma, which prevents them from screening and diagnosing 
occupational asthma in working-age adults. 
 
4. That there are a number of motivating factors for healthcare professionals (for 
example: perceived importance, resource constraints) which predispose to lack of 
consideration of the diagnosis of occupational asthma in adults. 
 
2.4 Specific Objectives 
 
1. To evaluate current practice in assessing working-age asthmatics for occupational 
asthma in a primary care population, using UK guidelines for occupational asthma as 
a reference standard (Fishwick et al., 2012).   
 
Study design: An audit of current practice in primary care practices in Birmingham, 
UK. 
 
2. To explore and define the beliefs that influence health-seeking behaviour in workers 
with symptoms of occupational asthma, and to establish a framework for 
understanding how these factors lead to delays in diagnosis. 
 
Study design: An inductive, phenomenological qualitative study of workers with 
occupational asthma, at a specialist occupational lung disease clinic in Birmingham, 
UK, generating data through semi-structured interviews. 
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3. To define the important barriers that prevent healthcare professionals from 
identifying cases of occupational asthma, and to see whether these differ between 
healthcare professions and medical specialties. 
 
Study design:  A cross-sectional questionnaire, distributed by e-mail to UK clinicians 
in the UK attending working-age asthmatic patients as part of their practice. 
 
4. To evaluate the feasibility of initiating an electronic screening tool for primary 
healthcare professionals, its utility in collecting data on work-effect, and the 
willingness of individual healthcare workers to use it.   
 
Study design:  A prospective feasibility study in primary care practices in 
Birmingham, UK.   
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CHAPTER 3: ASSESSMENT FOR OCCUPATIONAL ASTHMA IN PRIMARY CARE 
 
3.1 Introduction 
Occupational asthma is common, accounting for 1 in 6 cases of new-onset or reactivated adult 
asthma in the UK (Toren and Blanc, 2009; Nicholson et al., 2010; Baur et al., 2012).  
However it is under-reported to surveillance schemes, and often goes unrecognized, 
particularly in primary care (de Bono and Hudsmith, 1999; Hoyle et al., 2010), where mean 
delays in diagnosis of 4 years have been described (Fishwick et al., 2007; Santos et al., 2007; 
Poonai et al., 2005).  This is notwithstanding the publication of guidance for physicians, GPs 
and primary care nurses in the UK on the assessment and management of patients with 
suspected occupational asthma (Fishwick et al., 2012; Nicholson et al., 2010; BOHRF, 2010a; 
BOHRF, 2010b).  These suggest that all working-age patients with new onset or re-activated 
asthma symptoms should be asked (1) about their occupation in order to highlight high-risk 
work, and (2) two simple work-effect questions (“Are your symptoms better on days away 
from work?” and “Are your symptoms better away from work on holiday?”) which have a 
high sensitivity (74-100%), but low specificity (24-57%) for identifying occupational asthma 
(Malo et al., 1991; Vandenplas et al., 1995; Vandenplas et al., 2005; Pralong et al., 2013b).  
Any worker with a work-effect on asthma symptoms should be referred to an occupational 
lung disease specialist (Fishwick et al., 2012). 
 
In the UK occupational asthma is associated with a societal cost of £1.1 billion each decade 
due to poor health and employment outcomes; this is partially avoidable with early diagnosis 
and subsequent avoidance of exposure to causative agents.  In order to remedy the delay in 
diagnosis, it is important to understand how working-age asthmatics (the ‘at-risk’ population) 
are currently assessed and managed in primary care.  The hypothesis is that one important 
reason for delayed diagnosis may be a lack of enquiry about occupation, and the effect of 
work on asthma symptoms, by the primary healthcare worker (HCW).    
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3.2 Aim 
The aim of this study was to evaluate current practice in assessing working-age asthmatics for 
occupational asthma in a primary care population.   
 
3.3 Methods 
3.3.1 Study design 
A case-note audit was performed at 4 National Institute for Health Research (NIHR) Primary 
Care Research Network (PCRN) practices in Birmingham, UK.    
 
3.3.2 Practice recruitment 
Practices were recruited by the primary author (GW), through direct contact with the NIHR 
research nurse at each practice.   
 
3.3.3 Practice-level data 
Practice-level data on list size, gender, number of working-age patients (age-band=16-64), 
number of patients with a Read-code of ‘asthma’ and ‘occupational asthma’ (Health and 
Social Care Information Centre, 2013), were gathered by searching the practice databases 
(Egton Medical Information Systems Ltd., Yeadon, Leeds, UK).  Neighbourhood 
employment statistics were sought from Census data (ONS, 2011) and practice Index of 
Multiple Deprivation (IMD) scores and Townsend Index of deprivation scores were also 
obtained (Department for Communities and Local Government, 2007; Townsend et al., 
1988). 
 
3.3.4 Sample data 
A sample of 100 working-age adults (age 16-64) with a Read-code diagnosis of “asthma” was 
taken from each practice.  All working-age adults were listed by their registration number 
(unrelated to age or date of registration) and records were sampled by taking separate blocks 
of 10 adjacent numbers.  Using individual patients’ electronic records, the following data 
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were collected where available: (i) demographics (age, gender, reported co-existing airways 
disease), (ii) date and age at onset of asthma (adult-onset (≥16 year-old), prevalent childhood, 
reactivated childhood), (iii) date of last two asthma-reviews (urgent or routine), (iv) 
occupation, (v) work-effect (documented at all, at diagnosis, or within last two asthma-
reviews), (vi) lung function (peak-expiratory flow or spirometry).  Age was compared 
between samples by single-factor ANOVA, and the proportion of males in each sample was 
compared to the proportion of males from each practice population, by Chi-squared test with 
Yates’ correction. 
 
3.4 Results 
3.4.1 Practice-level data 
The sample population was 27295 patients in total from 4 practices, and mean practice-list 
size was 6824 (SD+/-3846) of which 64% were of working age (Table 3.1).  Practices used 
either the Telnet (EMIS LV 5.2) or web-based (EMIS Windows 3.1.7.11) versions of the 
EMIS electronic database.  The prevalence of asthma in working-age adults based on Read 
code was 12% (range 8-15%) of which 47% were male, and the prevalence of occupational 
asthma in working-age asthmatics was 0.3% (range 0-0.8%).  All 4 practices were situated in 
electoral wards where the most frequently reported industries of employment are associated 
with an increased risk of occupational asthma (detailed in Table 3.2).  Additionally all 
practices were located in the top 36% most deprived neighbourhoods in England, based on 
IMD ranking, and in the 5th quintile for Townsend Index of deprivation scores.   
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Table 3.1.  Summary data of patients with asthma and occupational asthma, by practice.  
EMIS=Egton Medical Information Systems. 116-64 years of age; 2patients who have a 
Read-coded diagnosis of “asthma”; 3patients who have a Read-coded diagnosis of 
“occupational asthma”.    
 
  
 Practice 1 
 
Practice 2 
 
Practice 3 
 
Practice 4 
 
Practice list size 
 
7142 5581 11885 2687 
Electronic 
database used 
EMIS LV 
5.2 
EMIS LV 
5.2 
EMIS 
Windows 
3.1.7.11 
 
EMIS LV 
5.2 
Number of 
patients of 
working-age1 
n (%) 
4452 (62) 3767 (68) 7599 (64) 1746 (65) 
Prevalence of 
asthma2 in 
working-age 
adults; number 
(%) 
609 (14) 575 (15) 601 (8) 260 (15) 
Number of male 
working-age 
patients with 
asthma  
n ( %) 
300 (49) 265 (46) 261 (44) 136 (52) 
Prevalence of 
occupational 
asthma3 in 
working-age 
asthmatics (%) 
0.2 0 0.8 0 
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 Practice 1 
 
Practice 2 
 
Practice 3 
 
Practice 4 
 
Electoral ward 
 
Billesley Bournville Aston King’s Norton 
Most frequently 
occurring 
industries of 
employment1 
 Manufacturing 
 Wholesale/ 
retail trade 
 Health and 
social work 
 Education 
 Real estate/ 
business 
 Manufacturing 
 Wholesale/ 
retail trade 
 Manufacturing 
 Wholesale/ 
retail trade 
 Health and 
social care 
Proportion of local 
population in 
skilled trades2 (%) 
14 9 12 13 
Proportion of local 
population in plant 
/ machine 
operations3 (%) 
11 9 15 12 
Weekly 
Household Total 
Gross Income4 
(£/week) 
410 470 280 400 
Townsend Index 
score5 (quintile) 
3.8 (5th) 2.3 (5th) 16.3 (5th) 5.0 (5th) 
IMD score6 
 
2874 4741 1009 11731 
IMD score rank 
(% top most 
deprived in 
England) 
9 15 3 36 
 
Table 3.2.  Summary of socio-economic data by practice and electoral ward.  
IMD=Index of Multiple Deprivation.  1Data taken from ONS, 2011.  2Average for 
England is 12%; 3average for England is 8%; 4average for West Midlands is £470 per 
week (ONS, 2011).  5Townsend Index is based on electoral ward and 6IMD is based on 
the postcode where practice is located (Department for Communities and Local 
Government, 2007).   
 
 
3.4.2 Sample data 
There were 396 working-age asthmatics in the sample (Table 3.3; 96-100 per-practice; 49% 
male; mean-age 39 (SD+/-14). Single factor ANOVA test revealed no significant differences 
between the 4 samples on the basis of age (p=0.06). Additionally there were no significant 
differences between the proportion of males in each sample and its parent practice population 
of working-age asthmatics (Practice 1: 59% audit sample versus 49% practice population 
(p=0.09; χ=2.9); Practice 2: 45% versus 46% (p=0.9; χ=0.02); Practice 3: 42% versus 44% 
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(p=0.87; χ=0.03); Practice 4: 49% versus 52% (p=0.66; χ=0.2).  There were no Read-coded 
cases of “occupational asthma” (one non-coded case of diagnosed occupational asthma was 
identified during data-gathering).  18 patients (2%) had co-existing diagnoses of additional 
airways diseases (COPD or bronchiectasis).  The onset of asthma in 234 patients (59%) was 
during working-age (≥16 years old), 95% having new-onset rather than reactivated childhood 
asthma.  Onset of asthma was most likely to occur between 25 and 34 years of age (66 cases; 
28%) and least likely between 55 and 65 years of age (14 cases; 6%); see Figure 3.1.  
 
 
 
 
 
Figure 3.1. All adult-onset asthma cases from the sample, by age at onset (n=234).     
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3.4.3 Recording occupation and work-effect 
Occupation was recorded in 55 out of 396 (14%) cases; of these 2 out of 55 were in an asthma 
review template, 17 out of 55 in free-text, and 36 were found incidentally, elsewhere in the 
patient record. 13 out of 55 (24%) patients were both in high-risk occupations for 
occupational asthma and experienced the onset of asthma in adult life (Table 3.3).   
 
 Practice 1 
 
Practice 21 Practice 3 Practice 4 Total 
Number of working-age asthmatics 
in sample 
100 96 100 100 396 
Number of male patients 
n ( %) 
59 (59) 43 (45) 42 (42) 49 (49) 193 (49) 
Mean age (+/-SD) 
 
36 (15) 40 (14) 41 (12) 37 (15) 39 (14) 
Co-existing COPD / bronchiectasis 
 
7 / 2 2 / 0 6 / 0 3 / 0 18 / 2 
Onset of 
asthma 
Number with adult-
onset of asthma2 
n (% of sample) 
48 (48) 56 (58) 76 (76) 54 (54) 234 (59) 
Number with new-
onset, rather than 
reactivated 
childhood asthma 
n (% of adult-onset 
asthmatics) 
44 (92) 53 (95) 74 (97) 52 (96) 223 (95) 
Occupational 
enquiry 
Occupation recorded 
n (%) 
6 (6) 20 (21) 11 (11) 18 (18) 55 (14) 
Occupation recorded 
at an asthma review 
n (%) 
5 (5) 6 (6) 7 (7) 1 (1) 19 (5) 
Number in high-risk 
occupations and with 
adult-onset asthma 
 
 
 
1 4 5 3 13 
 Automotive 
assembly 
 Soldering 
 Hairdressing 
 Glassware 
manufacturing 
 Animal 
husbandry 
 HCW x3 
 Cleaning 
 Food 
processing 
 Welding 
 HCW 
 Hairdressing 
Work-effect 
enquiry 
At diagnosis3 
n (%) 
3/26 (12) 0/22 (0) 1/47 (2) 0/22 (0) 4/117 (3) 
At most recent two 
asthma-reviews4 
n (% of those having 
asthma-reviews) 
2/72 (3) 3/66 (5) 1/92 (1) 0/71 (0) 6/301 (2) 
 
Table 3.3. Summary data of working-age asthmatics by practice sample.  HCW=health care 
worker.  14 patients from the sample were incorrectly coded as being asthmatic, thus n=96 rather 
than 100; 2age 16 or older; 3only 117/396 patients had visible records at diagnosis (otherwise (i) 
the diagnosis was in childhood, (ii) the patient had registered with practice after diagnosis, or (iii) 
the diagnosis was made before the introduction of electronic patient records); 4301/396 patients 
had undertaken at least two asthma-reviews. 
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In 301 out of 396 (76%) patients, at least two asthma reviews had been carried out, either by a 
nurse or a GP, and from documentation of the most recent attendance, 27% were urgent 
appointments and 73% were routine asthma reviews.  In 9 out of 396 (2%) patients, work-
effect was recorded, 7 out of 9 at the time when occupation was documented. 117 records had 
information available since the date of diagnosis, at which point only 4 (3%) had had a work-
effect enquiry.  In 6 out of 301 (2%), work-effect was enquired about at one of the two most 
recent asthma reviews, of which 3 had positive responses for which no demonstrable action 
was taken.  303 out of 396 (77%) patients had single peak-expiratory flow measurements, and 
70 out of 396 (18%) patients had spirometry measurement results documented since 
diagnosis.  39 (10%) patients had been Read-coded as ‘asthma-resolved’.  
 
3.5 Discussion 
3.5.1 Summary 
This study showed that the recorded prevalence of asthma in working-age adults (age 16-64) 
was 12% (8-15%) and the recorded prevalence of occupational asthma in working-age 
asthmatics was 0.3% (0-0.8%).  Occupation was recorded in only 55 out of 396 (14%) 
working-age asthmatics, and 13 out of those 55 were in high-risk occupations and had 
experienced the onset of asthma during working-age.  Only 9 out of 396 (2%) had any 
enquiry about work-effect on their asthma symptoms. 
 
3.5.2 Limitations 
This was a retrospective study, which is an appropriate study design for evaluating current 
and historical clinical practice.  It should be acknowledged that the sample size in this study 
was small with only 4 practices recruited, although these were broadly representative of UK 
practice populations.  Practices of varying size were recruited with a mean list size of 6824 
(range: 2687-11885); this equates to a mean list size in England of 6487 (Health and Social 
Care Information Centre, 2008).   64% of registered patients at the recruited practices were of 
working age, which is comparable to the national estimate of 62% for the proportion of 
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working-age adults registered in primary care (Office for National Statistics, 2010).  The 
point prevalence of Read-coded asthma was 8-15% in recruited practices, with a pooled 
figure of 12%.  This figure is higher than recent UK data, which estimate the prevalence of 
active asthma in all adults, that is, asthma requiring current treatment, as 5.9-8.7% (National 
Health Service Information Centre, 2011; Lung and Asthma Information Agency, 2011; 
Asthma UK, 2004).  This may be explained by over-representation in working-age adults 
under the age of 65, and also by historical diagnoses made in childhood where asthma may 
have resolved but coding had not been changed accordingly.   
 
All 4 primary care practices served urban populations in Birmingham, UK, each with low 
socio-economic status within the national distribution, and associated particularly with 
employment in manufacturing industries.  Indeed UK labour force figures revealed that the 
sample population slightly over-represented employment in skilled manual work and plant 
operations.  Therefore one might expect that the risk of developing occupational asthma in 
these areas would be higher than in more rural areas.  This is notwithstanding the risk to rural 
dwellers in high-risk occupations such as farming and saw milling, or those who commute to 
urban workplaces. 
 
The samples of 96-100 working-age asthmatics from each practice were shown to be similar 
to their parent practice populations in terms of gender representation. Four patients from 
Practice 2 who were identified prior to analysis as being incorrectly coded as asthmatic were 
removed from the analysis.  Beyond this, the study did not adjust for any coding errors; 
indeed no objective demonstration of asthma, such as peak expiratory flow or spirometry 
measurements, were required for inclusion in the sample. However each electronic patient 
record was searched comprehensively for all data from asthma-related consultations, and 
furthermore Read-coding has been demonstrated to accurately represent morbidity from a 
number of chronic diseases, including asthma, in primary care (Pearson et al., 1996).   
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3.5.3 Prevalence of occupational asthma 
The pooled prevalence of occupational asthma from the study sample of 0.3% of working-age 
asthmatics is a significant under-estimate of the true prevalence in primary care asthmatics.  
Estimates were low (0-0.8%) in all 4 practices.  59% of working-age asthmatics from the 
sample experienced onset of their asthma in adult life, and using a conservative estimate of 1 
in 10 cases of adult-onset asthma being due to a work-related cause (Nicholson et al., 2010), 
the expected prevalence should have been in the region of 6% of working-age asthmatics.  
One case of diagnosed but non-coded occupational asthma was found incidentally during the 
study, suggesting that under-reporting by lack of coding may contribute, but the degree of 
under-estimation in all 4 practices suggests that at least 5-fold under-recognition exists in 
primary care. 
 
3.5.4 Recording occupation  
A significant number of working-age asthmatics experienced the onset of asthma in adult life 
(59%) and the majority of these (95%) had new-onset disease rather than re-activated 
childhood disease.  The onset of asthma most frequently occurred in the 25-34 year age-band, 
although adult-onset disease was represented across all ages.  Despite the frequency of 
occurrence of incident asthma, there was sparse documentation of occupation (14% of cases).  
All 4 practices used their own electronic asthma review templates to record data on symptom 
severity and control, specific asthma triggers, treatment and peak-expiratory flow.  
Occupation was rarely documented within the template, and did not feature as a specific 
prompt; indeed the majority (65%) of occupational documentations were found elsewhere in 
the patient record, unrelated to asthma symptoms.  Where occupation was recorded, a 
significant number of those patients (13 out of 55; 24%) were in high-risk occupations for 
occupational asthma.  Only 3 of those had any enquiry about work-effect on symptoms, of 
whom 1, a circuit-board solderer was investigated further for occupational asthma by his 
occupational health department; the implication being that where risk is identified, it is not 
appreciated or action is not taken by the primary HCW.  The British Thoracic Society 
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guidelines (Fishwick et al., 2012) suggest that all adult onset asthmatics should be asked 
‘What is your current job?’ by their attending healthcare professional.  Furthermore, the 
British Occupational Health Research Foundation (BOHRF) guidance for general 
practitioners and practice nurses (BOHRF, 2010a) lists high-risk occupations in the aetiology 
of occupational asthma, and provides an aide memoire for health professionals, as part of the 
algorithm for assessing work-relatedness of symptoms.  The occupations listed are baking and 
pastry-making, chemical processing, farming, food processing, hairdressing, health care and 
dental care, laboratory animal work, spray painting, textile, plastics and rubber manufacture, 
welding, soldering and metalwork, woodwork, and other jobs with exposure to dusts and 
fumes.  There was evidence that other symptom triggers and allergens are routinely 
considered as part of an asthma review, as is illustrated in a typical asthma review template 
screenshot in Figure 3.2. 
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Figure 3.2.  A screenshot from an asthma review template from a study patient from 
Practice 1. Asthma triggers are listed, but do not include occupation, and there is no 
reference to work effect on symptoms.  The database used is Egton Medical Systems 
Ltd. (EMIS) LV 5.2. 
 
3.5.5 Recording work-effect 
Only 2% of patients had been asked any questions about work-related asthma symptoms, at 
any point since diagnosis.  However data from the point of diagnosis was only available in 
117 patients; for the other 279, the diagnosis was made in childhood, the patient had 
registered at the practice after diagnosis, or the diagnosis was made before the introduction of 
electronic patient records.  Thus from those with visible records only 4 out of 117 patients 
(3%) were asked work-effect questions at diagnosis. In 301 patients who had undertaken at 
least 2 asthma reviews, only 6 (2%) had work-effect enquiry documented recently, and 3 of 
those elicited a positive work effect (see Figure 3.3).  There was evidence of further 
investigation in only 1 of those patients, the circuit-board solderer described earlier.   
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Figure 3.3.  A screenshot from an asthma review template from a study patient from 
Practice 2. There is a reference to work effect on symptoms and more medication is 
prescribed, though no further action is taken to investigate the work effect.  The 
database used is Egton Medical Systems Ltd. (EMIS) LV 5.2. 
 
3.5.6 Context of findings 
These findings of a lack of appreciation of work-related symptoms and occupational risk in 
primary care validate the results from a cross-sectional study by Fishwick et al. (2007), which 
revealed that 50% of patients diagnosed with occupational asthma have seen their GP at least 
5 times with work-related asthma symptoms before specialist referral occurs.  The findings 
also complement those of two other small-scale studies, including a previous cross-sectional 
study in one primary care practice in Oxfordshire, UK, which aimed to assess the prevalence 
of occupational asthma in the community (de Bono and Hudsmith, 1999).  32% of adult new-
onset asthmatics were in jobs known to be at significant risk of occupational asthma, yet a 
potential link between occupation and symptoms had only been recorded in 18% of patients.  
Hoyle et al. (2010) reviewed cases of undetermined work-related respiratory illnesses that had 
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been reported to The Health & Occupation Reporting network in General Practice (THOR-
GP) at the University of Manchester, UK and found that only 26% were referred for specialist 
opinion and diagnostic clarification despite uncertainty over diagnosis, of those 85% were 
exposed to known asthmagens.   
 
Further study is required to establish whether or not the main barrier for healthcare 
professionals in identifying an occupational aetiology for asthma symptoms, is a lack of 
knowledge and clinical experience.  Barber et al. (2010) have already created an online 
learning module for occupational asthma, which was associated with positive feedback from 
primary care professionals, and improved knowledge and self-reported use of occupational 
asthma guidelines.   
 
3.6 Conclusion 
The recorded prevalence of occupational asthma in primary care is much lower than expected, 
which suggests that significant under-recognition exists, with some under-reporting also 
likely.  There is poor enquiry regarding occupation and work-effect of asthma symptoms in 
primary care, despite several national guidelines for identifying occupational asthma.   A 
further study is required to establish the reasons why healthcare professionals do not ask 
workers with asthma symptoms about their occupation and the relationship between their 
symptoms and work.  Furthermore, existing electronic templates for managing adult 
asthmatic patients could be modified to incorporate data entry and prompts for identifying 
occupational asthma. 
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CHAPTER 4: UNDERSTANDING HEALTH BELIEFS AND BEHAVIOUR IN 
WORKERS WITH OCCUPATIONAL ASTHMA 
 
4.1 Introduction 
Occupational asthma is a disease characterized by variable airflow limitation and/or hyper-
responsiveness, and caused by inhalation of an agent in the workplace (Baur et al., 2012).  
Most cases of occupational asthma have an allergic mechanism, where there is sensitization to 
an agent after a latent period of exposure.  In western industrialized populations occupational 
asthma is the most frequently reported occupational respiratory disorder (McDonald, 2000), 
and in the UK represents 1 in 6 cases of new-onset adult asthma (Nicholson et al., 2010).  
Occupational asthma costs the UK £1.1 billion each decade (Ayres et al., 2011). This cost is 
to some extent avoidable, since individuals with a short latency between symptom onset and 
diagnosis or removal from exposure to a sensitizing agent, have a better prognosis when 
considering lung function and quality of life (Nicholson et al., 2010).  However, in cohort 
studies from the UK and from Canada, mean delays of 3-4 years between symptom onset and 
diagnosis or referral to a specialist, have been identified (Fishwick et al., 2007; Santos et al., 
2007; Poonai et al., 2005). 
 
One fundamental reason for the delay in diagnosis of occupational asthma is a reluctance by 
the worker to report asthma symptoms (Poonai et al., 2005).  Fear of losing work time, 
income or employment, and a lack of awareness of respiratory hazards at work have been 
cited as potential reasons for this (Bradshaw et al., 2007; Poonai et al., 2005; Santos et al., 
2007; Gordon et al., 1997).  In addition, lay perceptions of health vary according to patients’ 
immediate cultural and social circumstances (Stacey, 1988).  Such lay health beliefs may be 
particular to workers with occupational asthma, a group that comprises predominantly, but 
not exclusively, skilled and unskilled manual workers.   
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4.2 Aim 
Qualitative research was considered particularly important, since there has been no in-depth 
study of health beliefs in workers with occupational asthma, and reports which cite barriers to 
diagnosis have been limited to closed-question data from cross-sectional studies.  Therefore 
the specific aim of this study was to explore in depth the health beliefs of workers with 
occupational asthma symptoms, and establish a theoretical framework for understanding 
workers’ beliefs and behaviour. 
 
4.3 Qualitative research 
It is more helpful to describe qualitative research by the overall aims of the study, rather than 
by the methods used to produce its data, since these methods do not distinguish it from 
quantitative research.  For example, although qualitative research is usually associated with 
language data, and quantitative research with numerical data, there are instances of qualitative 
studies using frequency counts, and quantitative studies using language data.  Thus a 
qualitative methodology is appropriate if the research aim is to understand the perspective of 
participants, explore meanings of a phenomenon or observe a process in-depth.  There are 
some concepts common to much qualitative research; these are a commitment to (i) 
naturalism, that is, studying phenomena in their natural environment, (ii) reflexivity, that is, 
subjecting researchers’ own values and practice to the same analysis as the topic of interest 
itself, (iii) a focus on meaning and understanding, and (iv) flexibility of research strategy 
(Green and Thorogood, 2014:p22-27).   
 
4.4 Methods 
The consolidated criteria for reporting qualitative research (COREQ) (Tong et al., 2007) were 
followed for structure and reporting of the methods section.  
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4.4.1 Study design 
An inductive, phenomenological qualitative methodology was selected as the most 
appropriate, given the study aims.  Data were generated through semi-structured interviews. 
 
4.4.2 Setting 
Workers were recruited from the Heart of England NHS Foundation Trust Occupational Lung 
Disease Unit, a tertiary referral unit based at the Birmingham Chest Clinic, Great Charles 
Street, Birmingham, UK.  Within this unit 3 occupational lung disease specialist physicians 
(including the primary author GW) have clinical responsibility for 50-70 new outpatient 
referrals per annum with suspected occupational asthma.  New referrals are taken from 
primary care, secondary care and occupational health services throughout the West Midlands.   
 
4.4.3 Eligibility criteria 
The eligible sample population included any adult of working age who had received a 
diagnosis of, or was undergoing confirmatory investigations for, occupational asthma.  
Workers whose first language was not English were eligible. 
 
4.4.4 Sample selection 
A purposive sample was chosen (Green and Thorogood, 2014), to include male and female 
workers of any working-age and ethnicity, with a variety of occupations, based on common 
exposures associated with occupational asthma (Diar Bakerly et al., 2008; BOHRF, 2010a).   
 
4.4.5 Participant recruitment 
Workers meeting the eligibility criteria for the study were approached directly by their 
attending clinician and referred to the primary author for recruitment and to provide written 
informed consent.  There were no monetary incentives for participants, therefore the consent 
process and interviews were undertaken at the same visit as the clinic appointment.  Only one 
invited worker declined to participate, as he needed to leave quickly following his clinic 
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appointment.  The patient information letter and consent form are shown in Appendix 1 and 
Appendix 2 respectively). 
 
4.4.6 Data collection 
Each participant underwent one face-to-face semi-structured interview with the primary 
author lasting between 10 and 30 minutes: all interviews took place in a dedicated clinic room 
at the unit.  A recording of each interview was made using a portable digital audio recorder, 
and field notes were taken during each interview to document any pertinent non-verbal 
responses. The initial questions confirmed basic demographic data (age, duration of 
employment) and thereafter the interview schedule contained five domains: (1) the patient’s 
understanding of their symptoms, (2) initial response to symptoms, (3) the general 
practitioner and occupational asthma, (4) social structure and occupational asthma, (5) the 
employer and occupational asthma.  Questions were generated from prevailing ideas within 
the background literature (Fishwick et al., 2007; Santos et al., 2007; Poonai et al., 2005; 
Gordon et al., 1997; Slater et al., 2000; Bradshaw et al., 2007), and through discussion with 
qualitative research and subject specialists (AS, SB, JA).   
 
4.4.7 Data transcription 
All interviews were transcribed by hand into Microsoft Word: Mac 2011 Documents (Mac 
version 14.1.4; Microsoft Corporation, Redmond, WA, USA) by the primary author. 
Grammar was left unchanged and spelling conventions of Standard UK written English were 
used.  The purpose of this was to aid the readability where there was linguistic variation, 
particularly where West Midlands’ English dialects were used. The meanings of words are 
shaped by the manner in which they are spoken (Bailey, 2008; Lapadat and Lindsay, 1999), 
therefore utterances such as ‘um’ or ‘er’, sighs and in-/out-breaths, emphasized words, 
laughing and coughing, and encouraging noises (such as ‘mm’), as well as verbal interactions 
such as false starts, repetitions, pauses and overlapping speech were included (Collins and 
Britten, 2010:p43-52; Bailey, 2008).   Non-verbal features were represented only when cited 
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in field notes, where it was felt that they aided the interpretation of accompanying speech.  
Interruptions were acknowledged but their content not transcribed, and social talk before and 
after each interview was excluded. The transcription conventions are shown in Table 4.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1. Transcription conventions. Taken from Bailey (2008), adapted from Jefferson 
(1984). 
 
4.4.8 Thematic analysis 
Thematic analysis is a common approach for qualitative data analysis that summarizes 
participants’ accounts, provides a map of the content across the dataset, including both 
variations and regularities (Pope and Mays, 2006:p69-70).  Themes are “recurrent concepts 
which can be used to summarize and organize the range of topics, views, experiences or 
beliefs voiced by participants” (Green and Thorogood, 2014:p210).  Analysis begins by 
identifying and coding themes in the data, and then examining the whole dataset to ensure 
Transcription conventions 
(?)  Talk too obscure to transcribe 
Hhhhh  Audible out-breath 
.hhh  Audible in-breath 
[ Overlapping talk begins 
] Overlapping talk ends 
(.) Silence, less than half a second 
(..) Silence, less than one second 
(2.8) Silence measured in 10ths of a second 
:::: Lengthening of a sound 
becau-  Cut off, interruption of a sound 
he says Emphasis 
= No silence between sounds 
LOUD Loud sounds 
? Rising intonation 
(left hand on neck) Body conduct 
[notes, comments]  
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that all manifestations of each theme have been accounted for.  Ryan and Bernard (2003) 
suggested that identifying repetition, metaphors, analogies, similarities or differences are all 
strategies that can be utilized.  These may be developed deductively at the outset of the study, 
or inductively by beginning analysis early on during data collection and then applying the 
coding scheme to the remaining dataset.  Once coded, the dataset can be viewed horizontally, 
by theme, in order to provide a rich and detailed understanding of the data.  Subsequently by 
moving the analysis beyond a descriptive exercise the researcher may try to identify 
relationships between the themes, developing classifications, taxonomies or models to express 
these connections (Pope and Mays, 2006;p69-70).   
 
Thematic analysis was undertaken by the primary author, with a co-investigator (AS) acting 
as a critical friend (Melia, 2000; Soundy et al., 2012).  Analysis commenced once data 
collection was underway, using empirical data driven codes in an inductive process.   An 
interim coding scheme was developed after 10 interviews and the semi-structured interview 
schedule was adapted to pertinent themes (Appendix 3 contains final interview schedule).  
Further interviews and analysis were undertaken simultaneously until no further new themes 
were identified (audit trail is available).  Typicality of response and deviant case analysis, as 
well as the role of the researcher in the research process (reflexivity) were all considered, in 
order to maximize trustworthiness (Green and Thorogood, 2014).   
 
4.4.9 Reflexivity 
The primary author (GW) is a 36-year old male White British specialist doctor in 
occupational lung diseases, who did not attend any of the participants as a clinician.  It was 
however necessary to quickly establish a rapport with interview participants, in order to 
encourage openness in response to sensitive questions about working and healthcare 
relationships, when workers feared that any criticism voiced might lead to negative 
employment consequences. The interview site was an empty clinic room in an NHS 
department, chosen in order that workers could undertake consent and interview in one visit.  
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The primary author explained that clinical judgments were not being made on the basis of 
participants’ responses, however the interview location can impact on data generation (Pope 
and Mays, 2006; Green and Thorogood, 2014): interviewing somebody in a public space, 
such as a hospital room, may stress different aspects of their identity rather than in their own 
home.  Although confidentiality was assured, effort was required to create a relaxed 
atmosphere and develop a rapport, by being non-judgmental and interested. 
 
4.4.10 Ethical approval 
Ethical approval for the study was granted by the North West (Haydock) National Research 
Ethics Service (NRES) Committee (REC reference: 13/NW/0035) and sponsorship was 
provided by Heart of England NHS Foundation Trust (R&D Code: 2012158RM). 
 
4.5 Results 
4.5.1 Descriptive analysis 
Twenty workers participated in the study (14/20; 70% male) and the median age was 52 
(interquartile range=49-57).  Sixteen out of 20 (80%) of workers were White British and the 
other 4 were Pakistani, British Asian (of Pakistani origin), Black Caribbean and White 
Eastern European (Polish).  Workers’ occupations and exposures were varied and these are 
shown in Table 4.2.  Five participants worked in the healthcare industry, and the most 
commonly encountered causative agents were isocyanates (n=4), wood dust (n=2), 
metalworking fluids (n=2) and solder flux (n=2).   
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Table 4.2. Summary of all workers undertaking semi-structured interviews, showing 
demographics, occupations and causative agents. 
 
 
4.5.2 Qualitative analysis 
Four themes concerning health beliefs and health-seeking behavior were identified: (1) the 
worker’s understanding of his/her symptoms, (2) working relationships, (3) the worker’s 
initial course of action, and (4) the worker’s negotiation of healthcare encounters.  Themes, 
sub-themes and codes are summarised in Table 4.3. 
Patient 
number 
Age Gender Ethnicity Occupation Exposure 
P1 64 Male White British Wood worker Wood dust 
P2 49 Male Pakistani Automotive assembly Metalworking fluid 
P3 49 Male White British Plumbing lecturer Acidic solder flux 
P4 52 Female White British Hospital cleaner Cleaning agents 
P5 36 Male White (Polish) Circuit-board repairer Colophony solder flux 
P6 57 Male White British Swimming pool supervisor Chloramines 
P7 55 Female White British Plastics moulder Polymer fume 
P8 48 Male Asian British Metalworker Metalworking fluid 
P9 48 Male White British Chemical engineer Vitamin E 
P10 52 Male White British French polisher Wood dust 
P11 55 Male White British Orthopaedic practitioner Methyl methacrylate 
P12 43 Male White British Metalworker Chromium 
P13 22 Female White British Anaesthetic nurse practitioner Anaesthetic gases 
P14 63 Male White British Adhesive development chemist Isocyanates 
P15 55 Male White British Car headliner assembler Isocyanates 
P16 58 Female White British Operating theatre nurse Diathermy 
P17 59 Female Black Caribbean  Hospital ward nurse Latex 
P18 52 Female White British Curtain blind manufacturer Isocyanates 
P19 64 Male White British Security van driver Diesel exhaust 
P20 50 Male White British Spray painter Isocyanates 
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Table 4.3. A summary of themes relating to the health beliefs and behaviours of workers 
with occupational asthma symptoms. 
Theme Sub-theme Code 
Theme 1: The worker’s 
understanding of his/her symptoms 
Lack of acceptance of symptoms 
as an illness 
Poor insight into onset 
Considered to be normal 
Ignoring symptoms 
Lack of association of symptoms 
with work 
Inability to see a pattern 
Noticed pattern but over-simplified 
Only makes link after significant event 
Failure to attribute symptoms to 
asthma 
Accepts something is wrong but no 
appreciation it may represent asthma 
Misattribution to another illness 
No knowledge of asthma as a disease 
Theme 2: Working relationships Relationships with colleagues Fear of talking between colleagues 
No culture of discussing health 
Relationships with management Company structure (the artificial person) 
Ineffective management 
Ineffective individuals  
Focus on productivity over health 
Intimidation 
Attention only in light of authority advice 
Fear of job and financial loss 
Theme 3: The worker’s initial course 
of action 
Proactive person response Goes to the GP 
Goes to another authority 
Prompted to act by family members 
Becomes the “go-to” person 
Passive person response Absenteeism 
Presenteeism 
Theme 4: The worker’s negotiation 
of healthcare encounters 
Failure to initiate action by the 
GP 
Failure to enquire about work at all  
Reliant on patient to offer work aspect 
Dismiss work effect on symptoms 
Oversimplify illness 
Misattribution of symptoms to another 
disease 
Proactive negotiation by the 
worker 
Makes link with work-aspect themselves  
Requests a second opinion 
Passive acceptance of authority 
by the worker 
Initial misunderstanding fuelled 
Initial understanding challenged 
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4.5.2.1 Theme 1: The worker’s understanding of his/her symptoms 
Five out of 20 (25%) workers lacked insight into the onset of their symptoms, with one 
worker [P5] suggesting that this was due to the intensity of shift work: 
 
[P5] “I don’t speak with anybody before with this problem [asthma symptoms] because 
I don’t see the problem… After eight hours I think it is a little bit hard to check on these 
things because you are working, you are tired”.   
 
Nine out of 20 (45%) workers considered asthma symptoms to be normal while working, that 
is, expected from working with dust or chemicals, normal for undertaking shift work, or part 
of ageing or deconditioning (Table 4.4).  Eight out of 20 (40%) workers appreciated their 
symptoms but ignored them, either because they appeared to be short self-limiting illnesses, 
or they were not perceived as serious enough to warrant further attention.  Indeed one worker 
[P12] sought medical assistance only when his symptoms began to impact on him: “I was 
leaving my shift early, so obviously I weren’t earning my normal wages, so it was starting to 
impact on my lifestyle, my job and my earnings”.  Six out of 20 (30%) workers initially failed 
to recognize the work-related pattern typical for occupational asthma symptoms, due to their 
gradual or indistinct onset.  In one case [P17] the reason for this was identified as the 
worker’s symptoms being masked by a hectic lifestyle.    Five out of 20 (25%) workers did 
recognize the work-related pattern but dismissed work as the cause because environments 
were not dusty, no colleagues were affected, or because there was a long latent exposure 
before symptom onset (Table 4.4).   
 
For 7/20 (35%) workers, suspicion of work causation was triggered only by a significant 
event such as a serious illness (pneumonia, hospital attendance) (3/20; 15%) or a discussion 
with a colleague regarding the meaning of their symptoms (4/20; 20%).   
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[P11] “There was a person at work who had to retire um: for the same reason, retired 
very early, working in the same theatre, and she said “this is what happened to me, I 
think it may be happening to you as well”. 
 
Ten out of 20 (50%) workers recognized their symptoms but misattributed them to recurrent 
self-limiting respiratory tract infections (4/20; 20%) or other serious illnesses (cancer (3/20; 
10%), tuberculosis (1/20; 5%), heart disease (2/20; 10%)); this was often based on previous or 
family experiences (Table 4.4).  Importantly 3/20 (15%) workers were unaware of asthma as 
a disease entity, either with no previous exposure (2/20; 10%) or believing it to be a 
childhood disease (1/20; 5%).  Conversely, one worker [P12] had previously suffered from 
allergic diseases which enabled him to recognize the symptoms rapidly: “Yeah well I’d had 
mild asthma as a child which had gone, I’ve also had, as a child, hay fever- sort of allergy 
type things so- no I was aware it was asthma- my partner’s got asthma as well=”.   
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Normalising symptoms 
P17 “I think I just thought the chemicals smelled strong (.) and I thought oh I’m just coughing because of 
the chemicals (.) I didn’t put it that I was coughing because something was wrong with my lungs, I 
just put it that I was reacting to a smell” 
P10 “I’d start feeling a little bit breathless and stuff but I was putting it down to maybe it’s the patterns, 
because I hadn’t done nights for a long time” 
P14 “I didn’t sort of feel (.) that I was ill and therefore that I’d got anything to talk about with the 
doctor, you know (.) I just thought I was unfit, compared with those eighty year olds running 
round” 
Ignoring symptoms 
P7  “I just thought oh I’ve got a cough, I’ve got a cold, and then when I thought I’ll go and see the 
doctor, it disappeared.  So I thought oh I’m alright”, 
P16 “Well I think when you’ve got progressive things like weight loss or other things going on, then you 
get concerned, but when it’s a cough you tend to ignore it=”. 
Not linking work-related symptoms with workplace hazards 
P1 “I just thought it can’t be [work-related], because everybody would have it, that was in my head. 
There’s people there who’ve been there as long as I’ve been there, twenty odd years and they’re not 
even affected”, 
P1 “I didn’t think it was work I didn’t…‘cos if you went down to where I worked and looked (.) you 
wouldn’t see that much dust” 
P6 “That was it, thinking why should- you know why should work be a problem, it hasn’t been a 
problem up to now? Why should it have sort of changed?” 
Failure to attribute symptoms to asthma 
P16 “I thought I’d got a chest infection… Or just (.) a cold or something so I sort of ignored it” 
P9 “I’ve had cancer before, a tumour on the back, so I was just worried if I’d got cancer on the chest” 
P7 “Well I just wondered what it was, didn’t know what it was, and because all my family have heart 
problems I just went and said to the doctor, I‘ve got this horrendous (.) pain in the middle of my 
chest and in the middle of my back” 
P3 “(.) That’s when the adverts- campaign started, if you’ve had a cough for more than three weeks, get 
it checked out, it could be the start of [lung] cancer, so it did worry me to be honest” 
P8 “I didn’t know asthma (.) and just the fact that I had- (.) couldn’t breathe, that’s what it was.  I don’t 
know, I’ve got no mates with asthma, no one that I can compare notes with or anything like that”.   
 
Table 4.4.  Workers’ responses showing examples of the variation in perception of 
occupational asthma symptoms. 
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4.5.2.2 Theme 2: Working relationships 
Workers frequently did not discuss their symptoms with work colleagues (see Table 4.5).  
Five out of 20 (25%) workers feared that “careless talk” about their ill health would reach 
management and have a detrimental effect on their employment, through which they might 
suffer financially.  Six out of 20 (30%) workers (all male) stated that health matters were 
never discussed at work, either because there was no prevailing culture for open discussion, 
because colleagues were not able to provide a solution, or if a worker was perceived as unfit 
by his/her colleagues this might cause antipathy.   
 
Seventeen out of 20 (85%) workers described poor relationships with their employers over 
health matters.  Many of those workers felt that management would not acknowledge their 
concerns (Table 4.5): this was either due to inaction from ignorance of workplace health and 
safety, or through mistrust of workers’ complaints of ill health.  In fact 6 workers suggested 
that their managements only took their concerns seriously once authoritative information was 
available, such as a report from occupational health or an occupational lung disease specialist.  
Four workers identified individual managers who they felt were unsympathetic or ineffectual 
in dealing with their concerns. Twelve workers believed that company productivity was 
considered more important than the health and safety of employees, and 2 workers felt they 
were being exposed to an avoidable risk of asthma because their employer would not pay for 
process control measures, such as local exhaust ventilation on soldering stations [P5].  One 
worker [P4] was intimidated after raising concerns: 
 
[P4] “I got warned at work for telling the other ward hostesses who do the same job as 
me (..) because I seen them at break and they had me in the office and they told me to 
stay (.) don’t come over the other side of the hospital”.   
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Therefore many workers were dissuaded from discussing their health issues with managers, 
mainly for fear of being seen as unfit for work and being dismissed, but also because they 
could not see that it would effect a workplace solution. 
 
However, 2/20 (10%) workers had more positive relationships with their employers; one 
worker [P2] found his employer to be both communicative and supportive due to trust 
developed through long service: “I’ve been with the company twenty-three years, and I’m 
quite happy to work there and they have supported me… I’m quite happy that the 
management know about my issues, and the job they’re giving me is suitable”; the other 
worker [P11] felt that his manager was supportive and proactive in finding a solution, and 
was almost being too cautious in redeploying him: “The theatre manager at the time was very 
concerned, he wanted to redeploy me to another department and take me out of theatres 
completely”.  
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Discussion with colleagues 
P19 “If you talked about anything like that you got the sack (..) ‘cos Company X [security company] in 
them days were a bullying company, and you daren’t talk about anything”.   
P7 “But everybody’s [work colleagues] frightened of losing their job aren’t they? And because I’m a 
bit more- well I’ll tell the management what I think, and they’re [colleagues] a bit oh God no, 
we’ll do it, you know, behind their back” 
P12 “Yeah well there was er:: a group- there was possibly half a dozen of us that were all 
experiencing the problems and we were talking within ourselves, but you tend- in the industry, in 
the current climate, you feel sort of quite scared to say too much because you don’t want it to 
impact on your future” 
P8 “They couldn’t give me a fix or anything, so it wasn’t worth asking the question”.   
P1 “Then you get the resentment from off the peers that you are working with, because some of them 
are covering your work, you know”.   
Discussion with management 
P8 “They weren’t helpful at all, because they don’t think that they could inflict asthma or anybody or 
nothing”, 
P1 “One of the managers (.) ended up with the same type of thing as what I got (..) and… it wasn’t 
until he got it himself he started to say “I didn’t know it was like this, you know”” 
P3 “My manager’s an absolute smashing bloke (..) but he’s not a manager. He was put in place as a 
‘yes man’.  He cannot make a decision without his manager telling him what to do basically” 
P20 “They’re totally unsympathetic, they’re interested in making a buck and that’s it… We live in a 
culture at the moment where we sue for this, that, and the other, they just wouldn’t want you on 
the premises any more… There would be no sympathy… I’ve never been offered light duties in all 
my life, they’re not going to say well we’ll get him to do this, that and the other, it’s just we’ll find 
someone else” 
P18 “I mean I had a heart attack and they didn’t really- (.) they were concerned, but is was more for 
the business side I think, than my personal (.) [health and safety]” 
P4 “You feel as if you um (.) if you don’t come into work when you are ill (.) you get penalized, you 
know” 
P19 “I mean the company pays for their own particular medical people, who’d say “that bloke is unfit 
for work, get rid of him” (.) just so I wouldn’t take it any further (.)” 
 
Table 4.5.  Workers’ responses showing examples of reluctance to talk with colleagues 
and management about their health problems. 
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4.5.2.3 Theme 3: The worker’s initial course of action 
Eight out of 20 (40%) workers responded proactively to seek an explanation or solution once 
they had acknowledged their symptoms.  Most workers consulted their GP, although one 
worker [P2] self-referred to his employer’s occupational health.  Eight out of 20 (40%) 
workers were prompted to take action by a family member, particularly when short-lived 
symptoms had recurred or become permanent: [P2] “They [patient’s family] thought that this 
coughing is getting regular and, you know, it needs sorting, you need to have a word with the 
doctor about it”.  Conversely 2 workers felt that their families gave no encouragement to 
them to seek help, due to lack of insight into work processes and the nature of asthma.  
Additionally one worker [P3] felt stigmatized by his asthma symptoms, which he felt were 
comparable with those of depression, and would be seen as unfit for work by his family.  Two 
workers described becoming a source of support or authoritative advice for their colleagues: 
 
[P4] “The girls [colleagues] were asking me how did I get on? You know with tests and 
that, and I said that er (.) .hhh you know, I said they ought to be careful and- and just 
watch out for symptoms” 
 
Six out of 20 (30%) workers sought little in the way of an explanation or a permanent 
solution.  This was manifested by repeated episodes of sickness absence: [P8] “I was finding 
that it was hard- I couldn’t do certain things… I was having a lot of time off as well, gave me 
a lot of hassle at work as well… if I feel that something’s not right in there I’ll go home”, or 
by presenteeism: [P13] “I’ve never liked taking time off work, so even when like I’ve 
struggled, I’ve kind of just like persisted and just carried on”.  A variety of reasons for 
persisting at work while unwell were given by workers, such as fear of financial loss: [P18] 
“I mean I could’ve really come out- really done with coming out of it, but (.) everybody needs 
to earn a living”, fear of being penalised: [P8] “If you have time off they still chuck the 
rulebook at you.  I was feeling ill right but I still had to go to work”, and a sense of 
responsibility to the employer: [P12] “I’m a [shift] manager, so I couldn’t really lose much 
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time, you know... I need to be there to run the show really, not sounding silly, you know but- 
they do rely on some of us”. 
 
4.5.2.4 Theme 4: The worker’s negotiation of healthcare encounters 
Sixteen out of 20 (80%) workers believed that their initial encounter with a healthcare 
professional, almost exclusively an appointment with their GP, was unhelpful, with 
inadequate action being taken to explain their symptoms or make a diagnosis. Seven workers 
believed that the GP failed to enquire about their occupation or whether their symptoms were 
work-related, indeed 3 workers stated that they had to prompt the GP in order to enable 
discussion about risk associated with their job, or the implication of a work-related 
symptoms: [P20] “It was me that mentioned work- it was me that said I’m a painter I can’t 
just say I got asthma, that’s me I can’t work anymore”.  Many workers felt that they were 
given an inadequate explanation for the work aspects of their symptoms either by being 
dismissed without further exploration or by over-simplifying the pathology: [P6] “All the 
time I’d be sort of struggling with this sort of wheezy sort of chesty cough sort of thing… and 
they [GPs] sort of went “oh post nasal drip””.  One worker [P15] believed that his GP 
dismissed his concerns about the work aspect of his symptoms because he thought that he was 
exaggerating for financial gain. Seven workers believed that their GP initially followed the 
wrong diagnostic line: [P7] “I just had what I call pain in the middle of my chest… so they 
[GP] always said “it’s your heart, it’s your heart” ‘cos it- at that time I wasn’t coughing 
constantly”; for some this exploration was understandable, though for others this was an 
unacceptable cause of delay. 
 
Many workers were proactive in negotiating the medical management of their illnesses, by 
questioning the explanations they were given, or simply asking for a second opinion.  Four 
workers recognized the limitations of their GP consultations and identified the work link 
themselves, through Internet research or by evolution of the symptom pattern:  
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[P20] “…and then she [practice nurse] just said “you got asthma” (..) and I said well 
(.) I’m not happy with you just telling me I’ve got asthma, I paint cars for a living (.) if 
I go in somewhere and I’ve got asthma, then that puts me out of work (.) er:: so (.) 
what sort of asthma have I got, you need to be a bit more specific than that? 
 
[P3] “I started to think, it’s actually at its worst (.) in the first few weeks of the course 
[plumbing course] and then sort of improves, and then it starts off again… when all the 
soldering were taking place… So then I start to put two and two together”, 
 
[P7] “I kept saying there’s no ventilation, there’s no extractor fan. I looked it all up, 
found out it could cause different types of cancer and that, and said I’m sure it’s works 
related”.   
 
Five workers accepted an initial inaccurate explanation for symptoms by their GP, or in one 
case by a respiratory physician, because they were seen as an authority.  One worker [P3] had 
his own misunderstandings fuelled: 
 
[P3] “I genuinely thought I’d got a chest infection um:  (..) Then as my GP sort of- (..) 
confirmed that (.) I believed him and I took the antibiotics and I took stronger 
antibiotics… and then I’m told there are six thousand viruses out there and- so you 
believe them, they’re the medics you know” 
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4.6 Discussion 
4.6.1 Summary 
This study used a qualitative approach to define the health beliefs and behaviour of working-
age adults with occupational asthma symptoms through semi-structured interviews and 
thematic analysis.  Four major themes were identified that were important in how workers 
behaved with regard to their asthma symptoms before diagnosis.  There was a variation in 
how workers perceived the onset, the timing and the seriousness of their symptoms, and the 
evolution of their understanding was heavily dependent on how actively they pursued advice 
or a solution for their symptoms. 
 
4.6.2 Understanding symptoms 
Understanding of symptoms varied between individuals from a lack of insight into the onset, 
pattern and nature of symptoms, through to misunderstanding of what they represented, or 
ignorance of the existence of asthma as a disease entity; indeed most workers who were 
interviewed failed to suspect or identify asthma as the cause for their symptoms initially.  
This is expected, since there is a variation in perception of asthma symptoms amongst non-
occupational asthmatics, with poor insight and under-appreciation of severity of symptoms 
described in male and female adults of all ages and socio-economic backgrounds (Smith et 
al., 2009; Scarno and Stendardi, 2006; Haughney et al., 2004).  This may account for 
significant delays in diagnosis in the occupational setting, where latencies of 8-months or 
more between the onset of asthma symptoms and consulting a physician have been reported 
(Poonai et al., 2005).  Many workers in the present study required a cue to action to change 
their health seeking behaviour, such as an illness event, a prompt by a family member or 
colleague, or a decline in physical function affecting their ability to work.  However, despite 
evidence that UK Health and Safety Executive educational campaigns have reduced the 
incidence of occupational asthma related to certain individual exposures like isocyanates in 
motor-vehicle repair (HSE, 2007a; Stocks et al., 2013), no worker in the present study 
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indicated that a workplace educational intervention had changed their understanding of their 
own symptoms.   
 
4.6.3 Working relationships 
Employers were perceived as ignorant of health matters, and ineffective or intimidating when 
dealing with workers’ concerns, often because workers believed that their focus was on the 
financial cost of asthma (loss of productivity) rather than the human cost of ill health. Indeed 
workers feared being seen as unfit for work, losing their employment and suffering 
financially; for many it was understandably more preferable to carry on in a job exposed to 
respiratory hazards, than to face unemployment or difficulties finding equivalent work.  In the 
study by Bradshaw et al. (2007), a significant proportion of workers with occupational asthma 
continued working with asthmagens that caused ongoing symptoms, since the fear of 
financial loss through job loss was greater than the concern for their own respiratory health.  
This is understandable, since 85% of workers who leave their employment (either become 
unemployed or find alternative work) suffer a loss of income of 22-50% (Vandenplas et al., 
2002; Moscato et al., 1999; Ameille et al., 1997; Larbanoir et al., 2002).  Additionally, a large 
proportion of the costs of occupational asthma are borne by the individual worker (49%) 
rather than the employer (3%), who therefore has little incentive to act (Ayres et al., 2011). 
 
4.6.4 Action, inaction and negotiation 
The current results highlighted that the evolution of a worker’s understanding of their 
symptoms depended upon how motivated they were to define them, or seek a solution.  
Proactive workers would seek help from an accessible authority, who was usually the GP; 
some workers later became a source of authority themselves for other affected workers (the 
‘go-to’ person).  Motivations for seeking medical help were from enhanced internal foci on 
symptoms as they worsened or recurred, from the inability to work and earn money while 
experiencing symptoms, or through pressure from family members.  Passive workers either 
took repeated episodes of sickness absence without further exploration of causation, or 
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persisted at work with symptoms through fear of losing their job, a sense of responsibility to 
colleagues or their employer, or simply because they felt that the symptoms they were 
experiencing did not impact on their function.  Indeed there is evidence that workers persist in 
work environments despite knowing they are being exposed to respiratory hazards, which in 
some cases actually cause them harm (Slater et al., 2000).   
 
Although there was more than one pathway for accessing healthcare (some routes were closed 
off to several workers if an employer had no formal occupational health provision, or there 
was no Trades Union representation) most workers saw their GP in the first instance.  
However, it was common for individuals to reflect on poor experiences, mainly generated by 
missed opportunities to identify work causation. The inability to identify causation was 
attributed to the GP’s lack of enquiry, dismissing work-related information, oversimplifying 
symptoms or misdiagnosing. This is supported by data that show GPs, who have an important 
role in screening for occupational asthma, fail to enquire about occupational exposure and the 
effect of work on asthma symptoms (Walters et al., 2012) despite recent guidance (BOHRF, 
2010). In cross-sectional studies, GPs have cited insufficient time, lack of expertise and poor 
access to specialist services as barriers to diagnosis (Parhar et al., 2011; Holness et al., 2007; 
Poonai et al., 2005).   
 
Proactive workers negotiated ineffective encounters by questioning poor explanations; 
however, passive workers repeatedly accepted poor explanations, even when their 
understanding of the work-symptom relationship was accurate.  The health belief model 
explains differences in behaviour by variations in workers’ health beliefs (Rosenstock, 1966; 
Rosenstock et al., 1988): these are core beliefs related to the perceived seriousness of, and 
susceptibility to a disease, personal costs and benefits of changing behaviour, and the 
presence of specific cues to action such as illness events.  Indeed, in this study there appear to 
be key influences motivating a worker to seek an explanation for their symptoms or a 
definitive solution (see Figure 4.1). 
 79 
 
 
 
 
 
 
Figure 4.1.  The major influences on workers’ health-seeking behaviour: (1) the belief 
that symptoms may represent asthma and the chronicity and pattern of symptoms is 
related to ongoing exposure at work, (2) whether disclosure of symptoms to colleagues 
or employers is likely to effect any change in the workplace or workplace procedures, or 
conversely result in financial loss, (3) a worker’s confidence in their GP (or other 
healthcare professional) that a consultation will result in an adequate diagnosis or 
solution, and (4) whether there are external drivers, such as a prompt by a concerned 
colleague or family member, occupational health surveillance, or an effective healthcare 
consultation.  The activity or passivity of workers’ health-seeking behaviour is 
determined by the nature and extent of their prevailing beliefs. 
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4.6.6 Limitations 
Participants had a variety of causative exposures, and were broadly representative of workers 
with occupational asthma in the West Midlands, UK (Diar Bakerly et al., 2008).  80% of 
workers interviewed were British males, the rest were English-speaking ethnic minority 
workers.  However some locally represented ethnicities, such as Irish, Somalian or Black 
African were not accounted for in the sample.  The sampling strategy accommodated workers 
already diagnosed with occupational asthma and undergoing clinical follow-up, which may 
have introduced recall bias, and excluded those workers who had not yet sought, or had no 
intention of seeking healthcare, who may have different health beliefs.  These biases limit 
generalizing the findings to all workers with work-related respiratory symptoms.  
Additionally data collection was not a purely inductive exercise because the interview 
schedule was determined beforehand, albeit loosely; a compromise was required to ensure 
that data collection was reasonably practicable.  In order to increase truthfulness and reduce 
subjectivity, strategies such as deviant case analysis and triangulation via a critical friend, 
were employed. 
 
4.7 Conclusion 
This study aimed to gain an in depth understanding of the beliefs and behaviour of workers 
with occupational asthma symptoms, and define the major barriers to diagnosis on the part of 
the worker.  Perceptions of asthma symptoms in the workplace varied, with some aspects 
such as lack of insight into symptom onset, and poor awareness of work-effect or the nature 
of chronic asthma, likely to predispose to a significant delay in diagnosis for many workers.  
These are basic insights that should be accounted for when designing workplace 
interventions, and should be considered in addition to the educational goals associated with 
work hazards and risk.  Many symptomatic workers were discouraged from taking action 
through a fear of financial loss, or a lack of confidence that disclosure of symptoms would 
effect either a healthcare or workplace solution.  Equipping workers with guidance on the 
diagnostic process and consequences of occupational asthma, along with strategies for 
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negotiating solutions with healthcare professionals and employers, could empower workers to 
make more informed choices about their health, at an earlier stage in the disease process.   
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CHAPTER 5:  BARRIERS TO IDENTIFYING OCCUPATIONAL ASTHMA FOR 
HEALTHCARE PROFESSIONALS 
 
5.1 Introduction 
Mean delays in the diagnosis of occupational asthma of 3-4 years have been reported in the 
UK and elsewhere (Fishwick et al., 2007; Poonai et al., 2005; Santos et al., 2007), which lead 
to avoidable societal cost (Ayres et al., 2011) and worse health outcomes and quality of life 
for affected workers (Nicholson et al., 2010).  One fundamental reason for this delay is lack 
of enquiry about an occupational cause for asthma symptoms by healthcare professionals; this 
is notwithstanding publication of guidelines for healthcare professionals on the management 
of workers with suspected occupational asthma (BTS/SIGN, 2012; Fishwick et al., 2012; 
BOHRF, 2010a), which suggest that adult workers with new onset or reactivated asthma 
symptoms should be asked about the nature of their work and whether their asthma symptoms 
are better away from work.  It is clear from the study in Chapter 3 and from previously 
published research that when consulting working-age asthmatics, GPs and practice nurses in 
the UK rarely enquire about the nature of work, or the effect of work on symptoms, even 
when the asthma is of new-onset (de Bono and Hudsmith, 1999; Fishwick et al., 2007; 
Walters et al., 2012).  In cross-sectional studies from elsewhere, GPs have cited insufficient 
time, lack of expertise and poor access to specialist services as obstacles to diagnosis (Parhar 
et al., 2011; Holness et al., 2007; Poonai et al., 2005); however, the nature of the barriers to 
enquiry by UK healthcare professionals have not been explored in any detail.  This 
specifically requires urgent investigation in order to inform the best strategy for improving 
identification of incident cases of occupational asthma. 
 
5.2 Aim 
The aims of this study were to define the important barriers that prevent healthcare 
professionals from identifying potential cases of occupational asthma, and to see whether 
these differ between healthcare professions and medical specialties.   
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5.3 Methods 
5.3.1 Methodology 
A cross-sectional questionnaire design was used to address the research aims of the study. 
The questionnaire was distributed by e-mail to clinicians in the UK attending working-age 
asthmatic patients as part of their practice.   
 
5.3.2 Questionnaire development 
A matrix of beliefs and attitudes hypothesized to delay identification of occupational asthma 
was developed and is shown in Appendix 4.  This was informed by focused discussion with 2 
occupational lung disease specialists, by reference to previously cited barriers to diagnosis 
(Poonai et al., 2005; Parhar et al., 2011; Barber et al., 2010; Lugtenburg et al., 2011), and 
from data gathered from the qualitative study in Chapter 4.  Using the matrix, simple and 
specific questionnaire items were written (Williams, 2003) and 5-point Likert ordinal scales 
(strongly agree, agree, neither agree nor disagree, disagree, strongly disagree) used for closed 
responses (Bowling, 1997): an opportunity for open comment was also included.  Questions 
asked whether participants enquired about the nature of work, the effect of work on asthma 
symptoms, and whether they followed guidelines, as well as a number of potential barriers to 
doing so (for example: motivations, perceived importance, experience).  Demographic 
questions referring to number of years’ experience, medical specialty (occupational health, 
general practice, general hospital medicine, respiratory medicine, occupational lung disease), 
role (doctor, nurse) and level of training (for doctors: trainee, consultant/GP) were also 
included.  
 
A case study-based section was then developed to follow the first set of questions, for which 
participation was optional.  A questionnaire designed and validated for assessing health-care 
professionals’ perceptions on reaching judgments about work-causation of asthma and 
musculoskeletal disease was modified with permission (Beach et al., 2012), in order to utilize 
the asthma case.  This consisted of 4 workplace scenarios based on a bakery worker with 
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asthma symptoms, with different combinations of strong or weak work- and non-work 
histories:  
 
 Type SW—strong work, weak non-work history/features (occupational asthma 
likely); 
 Type SS—strong work, strong non-work history/features (grey case); 
 Type WW—weak work, weak non-work history/features (grey case); 
 Type WS—weak work, strong non-work history/features (occupational asthma 
unlikely).   
 
Participants were randomized automatically by the online distribution tool to read one of the 4 
scenarios, in order that a similar number of each was distributed.  They were then given 
closed questions with 5-point Likert responses that measured confidence in allocation of 
causation.  An opportunity for open comment was included at the end.  The final version of 
the questionnaire is shown in detail in Appendix 5.  The questionnaire was then administered 
through the online cloud-based forms creator www.surveymonkey.com (Palo Alto, 
California, USA).   
 
5.3.3 Pilot phase 
The questionnaire was circulated to 10 healthcare professionals with clinical experience of 
managing working-age asthmatics, construct validity was tested by identification of any 
redundant or ambiguous items, and the questionnaire was modified accordingly.  The 
questionnaire (non-case study section only) was then completed by 17 healthcare 
professionals (7 hospital physicians, 4 general practitioners, 6 specialist respiratory nurses) on 
2 occasions, 3-weeks apart, and test-retest reliability of each item was assessed using 
Wilcoxon rank-sum tests and Cohen kappa statistics (Williams, 2003; Field, 2004).  Strength 
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of agreement by kappa statistic was rated as poor (<0.20), fair (0.21-0.40), moderate (0.41-
0.60), good (0.61-0.80), or very good (0.81-1.00) (after Landis and Koch, 1977). 
 
5.3.4 Study phase 
UK-registered nurses and doctors with clinical responsibility for working-age asthmatics, 
who were working in occupational health, general practice and general hospital medicine 
were targeted for the study through their professional organisations.  Estimates of the 
numbers of practising nurses and doctors from each specialty are shown in Table 5.1.   
Professional organisations were invited to sponsor the study via their national or regional 
offices by e-mail communication: those agreeing to do so were e-mailed a copy of the ethical 
approval letter, participant invitation letter (shown in Appendix 6) and a text insert with a 
hyperlink to the questionnaire, appropriate for an email or bulletin (Appendix 7).  Sponsoring 
organisations passed the invitation to participate to their members, either by e-mailing them 
directly or by inclusion in a bulletin, and subsequently sent out reminders 4-weeks after the 
initial contact to increase response rate.  Membership list sizes for sponsoring organisations 
are shown in Table 5.1.   The online questionnaire remained open for 10-weeks, at which 
point no further responses were collected.  There was no monetary incentive for organisations 
or their members to take part. 
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 Health professionals 
 
Professional organisations 
Professional 
group 
Estimated number of UK 
practitioners 
Representative professional 
organisation 
Number 
of 
members 
contacted 
Number 
of 
responses 
(%) 
Consultant 
(or GP) level 
Specialist 
trainee level 
Doctors Occupational 
lung disease 
specialists 
19 n/a  Group of Occupational 
Respiratory Disease 
Specialists (GORDS) 
19 17 (89) 
General 
hospital 
physicians 
11,2251 
Of which 
4367 are 
involved in 
acute 
medical take  
70491 
Of which 5,382 
in acute 
specialties / 
traditionally 
involved in 
acute take 
 
 Royal College of Physicians 
(RCP) East Midlands (North 
and South); 
 Postgraduate deaneries (West 
Midlands, East of England, 
Yorkshire and North West) 
1508 247 (16) 
Occupational 
medicine 
physicians 
15602 922  Faculty of Occupational 
Medicine (FOM); 
 Society of Occupational 
Medicine (SOM) 
1268 134 (11) 
General 
practitioners 
35,7743 81003  Royal College of General 
Practitioners (RCGP) faculties 
(North West Wales, North 
West England, Cumbria, 
Mersey, Humber, Yorkshire) 
7893 205 (3) 
Nurses GP practice 
nurses 
 
21,6344 n/a  UK Association of Respiratory 
Nurse Specialists (ARNS); 
 Primary Care Respiratory 
Society UK (PCRS-UK); 
 Society of Occupational 
Medicine (SOM) 
2270 209 (9) 
Occupational 
health nurses  
 
3,3325 n/a 
Clinical 
nurse 
specialists 
11,7906 n/a 
 
Table 5.1.  Overview of health professional groups with clinical responsibility for 
working-age asthmatics patients in the UK, showing response rates from sampled 
organisations. 1Royal College of Physicians, 2011; 2Faculty of Occupational Medicine, 
2011; 3Centre for Workforce Intelligence, 2011; 4Health and Social Care Information 
Centre, 2012; 5Nursing and Midwifery Council, 2010; 6Royal College of Nursing, 2012: 
this number refers to all clinical nurse specialists from any specialty, not just 
respiratory specialist nurses.  
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5.3.5 Data analysis 
Descriptive analysis was undertaken on the whole dataset in order to describe the range of 
responses to each variable and examine the data for skewness.  Data were categorized by role 
(nurse, doctor) and specialty (occupational health, general practice, general hospital medicine, 
occupational lung disease specialist) and cross-tabulated with response variables to identify 
any associations.  Analysis of variance was undertaken using Kruskal-Wallis tests and 
significance testing was undertaken using chi-squared tests for binary data and Mann-
Whitney U-tests for ordinal data.  All analyses were considered significant at the 5% level 
and were reported with 95% confidence intervals.   
 
Subsequent multivariate ordinal regression analyses were performed and examined for 
goodness of fit, where the outcome was considered to be participants’ responses to the 
following question: “I ask them about the effects of work on their asthma symptoms?”  
Explanatory variables considered were specialty, role grade of doctor, self-reported 
motivation, perceived importance of a diagnosis, confidence in diagnosis of occupational 
asthma, experience managing cases, background knowledge, and awareness of guidelines.     
 
For the optional case study descriptive analyses of doctors’ responses were undertaken as 
well as cross-tabulations to test differences in responses between medical specialties.  For 
responses to “grey cases” (type SS and type WW) a logistic regression analysis was 
performed with responses to the question “Do you think that the diagnosis is occupational 
asthma?” as the dependent variable.  Explanatory variables examined were medical specialty, 
grade of doctor, work factors (strong or weak work history, strong or weak non-work history), 
confidence, knowledge and experience.  All statistical analyses were undertaken using 
S.P.S.S. version 21(IBM, Armonk, New York).   
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5.3.6 Ethical approval 
Ethical approval for the study was granted by Heart of England NHS Foundation Trust (R&D 
Code: 2013013RM).  
 
5.4 Results 
5.4.1 Pilot phase 
On test-retest reliability testing of 14 questionnaire items by 17 raters, there was categorical 
agreement in 8-16 cases (Table 5.2) with a mean percentage agreement of 74% (range 47-94).  
Question 9 (“I follow occupational asthma guidelines when assessing a working-age 
asthmatic?”) required a binary response (yes/no), all other questions required ordinal 
responses by Likert scale (strongly agree, agree, neither agree nor disagree, disagree, strongly 
disagree).  All questions showed significant agreement using the Kappa statistic with Q1 and 
Q12 rated ‘very good’ (0.88-0.89), Q2, Q6, Q9 and Q11 rated ‘good’ (0.62-0.75), Q3, Q4, 
Q5, Q7, Q8, Q13 and Q14 rated ‘moderate’ (0.42-0.59), and Q10 rated ‘fair’ (0.29).  There 
were no significant differences between pre- and post- pilot test scores for any questionnaire 
items using Wilcoxon rank sum tests.   
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Table 5.2.  Test-retest reliability of 14 questionnaire items based on percentage agreements, Cohen kappa statistics and Wilcoxon rank-sum tests.  
1n=16 due to one non-response.   All analyses were considered significant at the 5% level.   
 
 Agreement 
 
Cohen kappa Wilcoxon Rank Sum 
Variable Number (%); 
n=17 
Value 95% CI Significance Z-score Significance 
Question 1:  I ask them about the nature of their work? 
 
16 (94) 0.89 0.70 to 1.08 p<0.001 -1 p=0.32 
Question 2:  I ask them about the effects of work on 
their asthma symptoms?  
13 (77) 0.62 0.29 to 0.95 p<0.001 -1.2 p=0.26 
Question 3:  I think it is important to recognize when 
work is the cause of asthma symptoms? 
14 (82) 0.56 0.16 to 0.97 p=0.01 -1.7 p=0.08 
Question 4:  I feel confident to screen patients for 
occupational asthma based on their clinical history? 
10 (59) 0.42 0.12 to 0.72 p=0.002 -0.4 p=0.7 
Question 5:  I have sufficient knowledge of patients’ 
work practices to screen for occupational asthma? 
11 (65) 0.52 0.20 to 0.84 p<0.001 -1.6 p=0.1 
Question 6:  I feel confident to make a diagnosis of 
occupational asthma? 
13 (77) 0.69 0.43 to 0.95 p<0.001 -2 p=0.05 
Question 7:  I have access to specialist input for 
occupational asthma when I feel I need it? 
12 (71) 0.46 0.09 to 0.83 p=0.02 -1.3 p=0.18 
Question 8:  I am aware of clinical guidelines for 
assessing patients with suspected occupational asthma? 
11 (65) 0.49 0.21 to 0.77 p<0.001 -0.3 p=0.74 
Question 9:  I follow occupational asthma guidelines 
when assessing a working-age asthmatic? 
14 (88)1 0.75 0.43 to 1.07 p=0.003 -0.6 p=0.56 
Question 10:  I lack the time to screen asthmatic 
patients for occupational asthma? 
8 (47) 0.29 -0.03 to 
0.61 
p=0.04 -1.1 p=0.25 
Question 11:  I have no incentive to screen asthmatic 
patients for occupational asthma? 
13 (77) 0.62 0.32 to 0.91 p<0.001 -0.38 p=0.71 
Question 12:  I am not motivated to screen patients for 
occupational asthma? 
16 (94) 0.88 0.64 to 1.11 p<0.001 -1 p=0.32 
Question 13:  I have experience of managing cases of 
suspected occupational asthma in my clinical practice? 
11 (65) 0.59 0.28 to 0.90 p<0.001 -0.7 p=0.48 
Question 14:  A diagnosis of occupational asthma can 
improve patient outcomes? 
13 (77) 0.54 0.19 to 0.89 p=0.01 -2 p=0.05 
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5.4.2 Demographics 
12,958 healthcare professionals were sent a hyperlink to the questionnaire by e-mail.  A 
breakdown of the total by role and specialty is shown in Table 5.1, along with response rates.  
Response rates were 3-89% amongst doctors and 9% for nurses.  603 participants completed 
the questionnaire (a further 142 participants started but did not complete enough demographic 
information or questions for analysis), of whom 394 (65%) were doctors and 209 (35%) were 
nurses.  234 responders were male (39%), and the mean number of years’ experience was 
19.8 years (SD=12).  Of the doctors, 222 (56%) were consultants or GPs, and 172 (44%) were 
trainees.  Demographics of responders, also grouped by specialty, are shown in Table 5.3.   
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Table 5.3.  Demographics of participants completing the questionnaire, including data grouped by role and specialty.   OH=occupational health.   
 All participants; 
n=603 
General Practice; 
n=189 (31%) 
 
General Practice 
undertaking OH 
sessions; 
n=16 (3%) 
Occupational 
Medicine; 
n=134 (22%) 
General 
Hospital 
Medicine; 
n=97 (16%) 
Respiratory 
Medicine; 
n=150 (25%) 
Occupational 
Lung Disease 
specialists; 
n=17 (3%) 
Gender; 
Number of males (%) 
234 (39) 39 (21) 11 (69) 88 (66) 37 (38) 47 (31) 12 (71) 
Role Doctors; 
 
Total; 
Number (%) 
394 (65) 62 (33) 14 (87) 123 (92) 96 (99) 82 (55) 17 (100) 
Consultants; Number 
(% of total doctors) 
222 (56) 54 (87) 13 (93) 112 (91) 6 (6) 20 (24) 17 (100) 
Trainees; Number 
(% of total doctors) 
172 (44) 8 (13) 1 (7) 11 (9) 90 (94) 62 (76) 0 (0) 
Nurses;  
Number (%) 
209 (35) 127 (67) 2 (13) 11 (8) 1 (1) 68 (45) 0 (0) 
Experience; 
Mean years (SD) 
19.8 (11.5); 
range 1-51 
23.2 (10.1) 23.0 (7.9) 26.8 (8.3) 6.4 (5.8) 16.8 (10.4) 27.4 (11.4) 
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5.4.3 Questionnaire responses by role  
A summary of all Likert responses to questions Q1-14 is shown in Table 5.4.   
573/603 (95%) of respondents strongly agreed (62%) or agreed (33%) with the question “I 
ask them [patients] about the nature of their work?”  The mean statistic was 1.49 (SD=0.69) 
where 1=minimum (strongly agree) and 5=maximum (strongly disagree).  Nurses were 
significantly more inclined to agree with the question (mean statistic=1.33; SD=0.54) than 
doctors (mean statistic=1.52; SD=0.75; Mann-Whitney U-test p=0.004).   
 
530/603 (88%) of respondents strongly agreed (51%) or agreed (37%) with the question “I 
ask them about the effects of work on their asthma symptoms?” and the mean statistic was 
1.66 (SD=0.82).  Again nurses were significantly more inclined to agree with the question 
(mean statistic=1.46; SD=0.6) than doctors (mean statistic=1.77; SD=0.89; Mann-Whitney U-
test p<0.001).   
 
Nurses were less confident to screen for occupational asthma than doctors (mean 
statistic=2.33; SD=0.98 vs. mean statistic=2.0; SD=0.95; Mann-Whitney U-test p<0.001), felt 
that they had less knowledge (mean statistic=2.62; SD=1.03 vs. mean statistic=2.28; 
SD=1.09; p<0.001) and less time to screen (mean statistic=3.13; SD=1.03 vs. mean 
statistic=3.47; SD=1.06; p<0.001) than doctors. 
 
374/603 (62%) participants followed occupational asthma guidelines, and there was no 
significant difference between doctors (239/394; 61%) and nurses (135/209; 65%) when 
tested (X2=0.99; p=0.34).  223/374 (60%) used the SIGN/BTS guidelines, 198/374 (53%) 
used the BOHRF guidelines, and only 47/374 (13%) used the ERS guidelines.  Guideline use 
varied between medical specialty and this is illustrated in Figure 5.1.   
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Table 5.4. Summary of Likert responses by all participants completing the questionnaire. 1Mean statistic based on 1=minimum (strongly agree) and 5=maximum 
(strongly disagree).  2Question 9 (“I follow occupational asthma guidelines when assessing a working-age asthmatic”) has a binary outcome (Yes/No). 
 
 Question Likert responses  
Strongly agree; 
number of 
responses (%) 
Agree; 
number of 
responses (%) 
Neither agree nor 
disagree; 
number of 
responses (%) 
Disagree; 
number of 
responses (%) 
Strongly disagree; 
number of 
responses (%) 
Mean statistic1 
(SD) 
Question 1:  I ask them about the nature of their work? 
 
374 (62) 199 (33) 16 (3) 11 (2) 3 (1) 1.46 (0.69) 
Question 2:  I ask them about the effects of work on 
their asthma symptoms?  
307 (51) 223 (37) 46 (8) 25 (4) 2 (0) 1.66 (0.82) 
Question 3:  I think it is important to recognize when 
work is the cause of asthma symptoms? 
456 (76) 145 (24) 2 (0) 0 (0) 0 (0) 1.25 (0.44) 
Question 4:  I feel confident to screen patients for 
occupational asthma based on their clinical history? 
174 (29) 260 (43) 100 (17) 64 (11) 5 (1) 2.11 (0.97) 
Question 5:  I have sufficient knowledge of patients’ 
work practices to screen for occupational asthma? 
142 (23) 203 (34) 144 (24) 103 (17) 11 (2) 2.4 (1.08) 
Question 6:  I feel confident to make a diagnosis of 
occupational asthma? 
105 (17) 208 (35) 139 (23) 131 (22) 20 (3) 2.6 (1.11) 
Question 7:  I have access to specialist input for 
occupational asthma when I feel I need it? 
232 (29) 201 (33) 79 (13) 80 (13) 11 (2) 2.07 (1.1) 
Question 8:  I am aware of clinical guidelines for 
assessing patients with suspected occupational asthma? 
192 (32) 227 (38) 65 (11) 106 (17) 13 (2) 2.21 (1.13) 
2Question 10:  I lack the time to screen asthmatic 
patients for occupational asthma? 
20 (3) 138 (23) 127 (21) 244 (41) 74 (12) 3.36 (1.06) 
Question 11:  I have no incentive to screen asthmatic 
patients for occupational asthma? 
11 (2) 46 (8) 94 (16) 256 (42) 195 (32) 3.96 (0.97) 
Question 12:  I am not motivated to screen patients for 
occupational asthma? 
6 (1) 28 (4) 66 (11) 270 (45) 233 (39) 4.15 (0.87) 
Question 13:  I have experience of managing cases of 
suspected occupational asthma in my clinical practice? 
112 (19) 220 (36) 94 (16) 138 (23) 37 (6) 2.61 (1.2) 
Question 14:  A diagnosis of occupational asthma can 
improve patient outcomes? 
298 (49) 247 (41) 34 (6) 3 (1) 14 (2) 1.64 (0.81) 
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Figure 5.1.  Occupational asthma guideline use by nurses and doctors completing the 
questionnaire.  Responders are grouped by medical specialty and results are displayed 
as a percentage of each specialty group as a whole.  GP=general practitioner; 
SIGN=Scottish Intercollegiate Guidelines network; BTS=British Thoracic Society 
(BTS/SIGN, 2012); BOHRF=British Occupational Health Research Foundation 
(Nicholson et al., 2010).   
 
5.4.4 Questionnaire responses by specialty group 
Grouping both doctors and nurses by medical specialty highlighted differences in responses to 
the questions about the nature of work (Q1) and work effect on asthma symptoms (Q2; see 
Table 5.5).  Using a comparison with occupational lung disease specialists as a reference 
group, only general hospital physicians enquired significantly less about the nature of work 
(p=0.03) or work effect on asthma symptoms (p=0.03).  There was a significant variation in 
response across all nursing groups to enquiry about nature of work (p=0.03) and work effect 
(p=0.02), though no single group was different to another on hypothesis testing.   
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Appendix 8 shows responses to Q1-14 grouped by medical specialty, where there was a 
variation in the degree to which professionals felt confident to diagnose or screen 
occupational asthma, and in their self-reported knowledge, awareness of guidelines, access to 
specialist input, and clinical experience.  Figure 5.2 illustrates the difference in response 
between general hospital physicians and occupational lung disease specialists to Q13 
regarding clinical experience: general hospital physicians reported significantly less 
experience in managing cases of suspected occupational asthma than occupational lung 
disease specialists (Mann-Whitney U-test; p<0.001).  
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Table 5.5.  Responses to questions regarding healthcare professionals’ enquiry about (1) the nature of patients’ work and (2) work-effect on their 
asthma symptoms.  SA=strongly agree; A=agree; N=neither agree nor disagree; D=disagree; SD=strongly disagree.  Analyses of variance measured 
using non-parametric Kruskal-Wallis tests, significance measured at the 95% confidence level.   
 
Doctors 
 
Nurses 
 
 
 
General 
Practice; 
n=62 
 
General 
Practice 
undertaking 
OH 
sessions; 
n=14 
Occupational 
Medicine; 
n=123 
General 
Hospital 
Medicine; 
n=96 
Respiratory 
Medicine; 
n=82 
Occupational 
Lung Disease 
specialists; 
n=17 
Analysis 
of 
variance 
 
Practice 
nurses; 
n=127 
Occupational 
health 
nurses; 
n=11 
Hospital 
respiratory 
nurse 
specialists; 
n=68 
Analysis 
of 
variance 
Asks about 
the nature 
of a 
patient’s 
work 
SA 
A 
N 
D 
SD 
21 (34) 
35 (57) 
2 (3) 
4 (6) 
0 (0) 
8 (57) 
6 (43) 
0 (0) 
0 (0) 
0 (0) 
109 (89) 
14 (11) 
0 (0) 
0 (0) 
0 (0) 
24 (25) 
55 (57) 
9 (9) 
5 (5) 
3 (3) 
50 (61) 
30 (37) 
1 (1) 
1 (1) 
0 (0) 
17 (100) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 81 (64) 
41 (32) 
4 (3) 
1 (1) 
0 (0) 
9 (82) 
2 (18) 
0 (0) 
0 (0) 
0 (0) 
55 (81) 
13 (19) 
0 (0) 
0 (0) 
0 (0) 
p=0.03 
Asks about 
the effects 
of work a 
patient’s 
asthma 
symptoms 
SA 
A 
N 
D 
SD 
13 (21) 
35 (56) 
8 (13) 
6 (10) 
0 (0) 
5 (36) 
8 (57) 
1 (7) 
0 (0) 
0 (0) 
103 (84) 
19 (15) 
1 (1) 
0 (0) 
0 (0) 
9 (9) 
44 (46) 
24 (25) 
17 (18) 
2 (2) 
37 (45) 
40 (49) 
4 (5) 
1 (1) 
0 (0) 
17 (100) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 68 (54) 
50 (39) 
8 (6) 
1 (1) 
0 (0) 
9 (82) 
2 (18) 
0 (0) 
0 (0) 
0 (0) 
46 (68) 
22 (32) 
0 (0) 
0 (0) 
0 (0) 
p=0.02 
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Figure 5.2.  Responses of general hospital physicians and occupational lung disease 
specialists to the question regarding clinical experience (Q13).  General hospital 
physicians reported significantly less experience in managing cases of suspected 
occupational asthma (Mann-Whitney U-test; p<0.001).  
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5.4.5 Ordinal regression analysis 
The ordinal regression analysis of doctors’ Likert responses to the question “Do you ask 
about the effect of work on asthma symptoms?” is shown in Table 5.6.  The model was a good 
fit (-2logL final-model=539.6) with a significant improvement over the intercept-only model 
(-2logL=873.8; p<0.001) and Nagelkerke r2=0.69.  Being a physician in any specialty other 
than general hospital medicine increased the likelihood of asking about work effect on 
symptoms (unadjusted OR=3.03; 95% CI=1.36 to 6.77) but no other factors had a significant 
effect.  Confidence in screening for occupational asthma was associated with greater odds of 
asking about work effect (unadjusted ORs=49.35-96.64) when compared with the baseline 
answer of “strongly disagree” though this did not reach statistical significance.   
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Table 5.6.  Ordinal regression analysis of factors associated with likelihood of agreement (by 
Likert response) with the question “Do you ask [them] about the effect of work on [their] asthma 
symptoms?” with unadjusted odds ratios and 95% confidence limits.  CL=confidence limit; 
GHM=general hospital medicine; SHO=senior house officer; GP=general practitioner; 
SA=strongly agree; A=agree; N=neither agree nor disagree; D=disagree; SD=strongly disagree.  
 
Explanatory variable Odds 
Ratio 
Lower 
95% CL 
Upper 
95% CL 
p-value 
Specialty Non-GHM 
GHM 
3.03 
1 
1.36 6.77 0.007 
Level of training Foundation year/SHO 
Registrar level 
Consultant/GP level 
0.66 
0.89 
1 
0.26 
0.48 
1.63 
1.62 
0.36 
0.68 
Self-reported 
experience in 
managing cases of 
occupational asthma 
SA 
A 
N 
D 
SD 
1.11 
0.95 
1.07 
0.91 
1 
0.26 
0.29 
0.31 
0.28 
 
4.70 
3.07 
3.74 
2.91 
0.88 
0.93 
0.91 
0.87 
Belief that a 
diagnosis of 
occupational asthma 
improves outcomes 
SA 
A 
N 
SD 
0.57 
0.67 
0.25 
1 
0.05 
0.06 
0.02 
6.47 
7.68 
3.48 
0.65 
0.75 
0.30 
Perceived 
occupational asthma 
as being important 
SA 
A 
N 
7.58 
1.95 
1 
0.39 
0.10 
146.22 
37.22 
0.18 
0.66 
Confident to screen 
for occupational 
asthma 
SA 
A 
N 
D 
SD 
96.64 
56.26 
95.58 
49.35 
1 
0.91 
0.58 
1.03 
0.54 
10259.92 
5458.89 
8883.94 
4500.75 
0.06 
0.08 
0.05 
0.09 
Sufficient knowledge 
to screen for 
occupational asthma 
SA 
A 
N 
D 
SD 
4.43 
1.22 
0.57 
0.55 
1 
0.12 
0.04 
0.02 
0.02 
158.54 
36.63 
16.46 
15.23 
0.41 
0.91 
0.74 
0.73 
Confident to diagnose 
occupational asthma 
SA 
A 
N 
D 
SD 
1.08 
1.72 
1.05 
1.67 
1 
0.03 
0.05 
0.05 
0.05 
43.68 
60.52 
58.56 
54.54 
0.97 
0.77 
0.78 
0.77 
Aware of 
occupational asthma 
guidelines 
SA 
A 
N 
D 
SD 
6.27 
2.99 
1.54 
1.07 
1 
0.97 
0.53 
0.26 
0.20 
40.45 
16.95 
9.16 
5.81 
0.05 
0.21 
0.63 
0.93 
No incentive to 
screen for 
occupational asthma 
guidelines 
SA 
A 
N 
D 
SD 
1.11 
0.92 
0.50 
0.40 
1 
0.16 
0.14 
0.07 
0.05 
7.83 
6.11 
3.55 
2.91 
0.91 
0.93 
0.49 
0.36 
Lacks time to screen 
for occupational 
asthma 
SA 
A 
N 
D 
SD 
1.76 
2.34 
1.34 
1.35 
1 
0.35 
0.64 
0.36 
0.37 
8.78 
8.62 
5.01 
4.98 
0.49 
0.20 
0.66 
0.65 
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5.4.6 Questionnaire open comment 
Several themes were identified from analysis of open comments at the end of the 
questionnaire: 
 
(1) Lack of knowledge and skill.  Some participants highlighted their own lack of skill and 
knowledge in assessing asthmatics for occupational asthma:  a GP: “I always consider this 
though feel lacking in skills to accurately diagnose and am unaware of specific guidelines to 
know whether I follow these”; a respiratory physician: “I am unaware that there are specific 
guidelines related to occupational asthma and hence do not apply them in clinical practice”; 
an occupational medicine physician: “in reality, I struggle to see enough cases of 
constitutional asthma to keep my clinical confidence and knowledge up to date, let alone in 
relation to the rarer cases with a work related or occupational link”.   
 
(2) Retained basic skills only and would refer on when necessary.  Some healthcare 
professionals felt that their practice was appropriate to their level of expertise:  a GP: “I might 
not read guidelines in detail but follow the appropriate approach. There are levels of 
assessment and I do a level appropriate to my generalist background”; some felt that 
screening for occupational asthma was not in their domain of expertise: a general hospital 
physician: “I work on acute admissions, I would request a respiratory review if I felt 
occupation was leading to problems”; some felt that they were limited by a lack of resources 
required to do a detailed investigation: a GP: “making a diagnosis is difficult as I do not have 
resources in my clinics to offer peak flow diaries and analysis of results - these presentations 
are quite rare and so I would simply refer to a specialist based on the clinical history of work 
exacerbated symptoms”. 
 
(3) Clinical experience.  General hospital physicians lacked clinical experience in managing 
suspected occupational asthma, and described (i) engaging asthmatics only during acute 
admissions where emergency treatments were prioritized over further investigation for work-
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causes: “patients mainly seen as acute exacerbation of asthma as medical registrar on call - 
therefore [I’m] more focused on acute management of known asthmatics rather than new 
diagnosis”, (ii) having never seen a case of occupational asthma: “I have received teaching 
on occupational asthma so I am aware of it but I have not diagnosed it before”, and (iii) 
lacking time for assessment while on-call. 
 
(4) Clinical experience amongst GPs with extended roles.  Comments concerning examples of 
good practice were mainly by individuals with an interest in asthma, for example a local 
community asthma clinical lead, a GP undertaking occupational medicine sessions, and a GP 
with a PhD in occupational asthma in the 1990s:“I completed my MD thesis as a GP on a new 
cause of occupational asthma… since then I have diagnosed several other people with that 
knowledge...  My GP partners and nurse are very aware of lung irritants and sensitizers 
following my work”.   
 
5.4.7 Responses to case study 
298 doctors completed the case study of whom 126/298 (42%) were trainees and 172/298 
(58%) were consultant or GP level doctors.  The numbers of scenarios allocated were as 
follows: SW=67, SS=73, WW=80 and WS=78.  52% (156/298) of all responders thought that 
their case represented occupational asthma, and there were no significant differences when 
overall response was grouped by medical specialty (Kruskal-Wallis p=0.55).    Table 5.7 
shows the responses for each scenario type (SW, SS, WW, WS) grouped by medical 
specialty.  Decreasing proportions of responders believed their case to represent occupational 
asthma moving through the scenarios, though 82% of occupational physicians designated 
their WS scenario as occupational asthma.   
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Scenario All 
doctors; 
n (% of all 
allocated 
to 
scenario) 
GPs; 
n=45 
 
GPs 
undertaking 
OH 
sessions; 
n=11 
Occupational 
Medicine; 
n=101 
 
General 
hospital 
medicine; 
n=68 
 
Respiratory 
medicine; 
n=17 
 
Occupational 
lung disease 
specialists; 
n=17 
 
SW 59 (88) 6 (100) 3 (75) 23 (92) 13 (93) 10 (77) 4 (80) 
SS 66 (90) 14 (93) 2 (100) 19 (100) 18 (95) 11 (73) 2 (67) 
WW 18 (23) 5 (42) 2 (50) 5 (18) 4 (20) 2 (14) 0 (0) 
WS 13 (17) 3 (25) 0 (0) 23 (82) 2 (13) 4 (29) 1 (14) 
 
 
Table 5.7.  Number of responders reporting that each scenario was occupational 
asthma, grouped by medical specialty.  Where percentages are given the denominator is 
the number of doctors from a specialist group who have been allocated to that 
particular scenario.  GP=general practitioners; OH=occupational health; SW=Strong 
work/weak non-work factors; SS=strong work/strong non-work; WW=weak work/weak 
non-work; WS=weak work/strong non-work. 
 
146/298 responders (49%) would refer the case to an occupational lung disease specialist, and 
no differences were observed between medical specialty groups (Kruskal-Wallis p=0.36) or 
level of training (Kruskal-Wallis p=0.79).  The majority of responders were confident in their 
diagnosis (very confident 31/298 (10%), confident 145/298 (49%), somewhat confident 
98/298 (33%), unsure 22/298 (7%), very unsure 2/298 (1%), and no differences between 
medical specialty groups (Kruskal-Wallis p=0.44) or level of training (Kruskal Wallis 
p=0.44) were observed.   
 
When deciding whether a case was occupational asthma or not, the timing of onset of 
symptoms (mean statistic=4.7; SD=0.57) and understanding the nature of the patient’s work 
(mean statistic=4.6; SD=0.58) [where 1=minimum (not at all important) and 5=maximum 
(extremely important)] were more important than the patient’s belief about work-relatedness, 
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presence/absence of non-work related risk factors, and whether other workers were affected. 
Factors contributing to decision-making are shown in Appendix 9, and grouped by medical 
specialty.   
 
5.4.8 Case study open comments 
An open-ended comments section, intended to ascertain whether any further information 
would be desirable for decision-making, revealed the following: 9 responders (8 occupational 
medicine physicians, 1 occupational lung disease specialist) wanted to obtain a history 
relating to cleaning agent exposure and/or safety-data sheets from cleaning agents in use; 19 
responders (5 GPs, 10 occupational physicians, 4 respiratory physicians) requested serial peak 
flow measurements; 3 responders (2 occupational physicians, 1 GP) requested more 
information about the smoking history; 5 responders (2 respiratory physician, 3 occupational 
physicians) requested serum-specific immunology or skin prick testing to flour/enzymes, and 
2 occupational physicians wanted to undertake workplace visits.   
 
5.4.9 Grey case scenarios (SS, WW) 
The 153 responses to grey case scenarios (either SS or WW) were analyzed separately, in 
order to determine the main factors that determine how doctors allocate causation when faced 
with diagnostic uncertainty.  Likert responses to the question “Do you think that the diagnosis 
is occupational asthma?” were transformed into the binary outcomes ‘yes’ (strongly 
agree/agree) and ‘no’ (neither agree nor disagree/disagree/strongly disagree) as a bimodal 
frequency distribution was seen in response to this question (shown in Figure 5.3).  The 
binary logistic regression analysis is shown in Table 5.8. The model was a good fit (-
2logL=113.5 intercept-only model; Chi2=97.13; p<0.001) and Nagelkerke r2=0.63.  
Allocation of a diagnosis of occupational asthma to a grey case was influenced by being a GP 
(unadjusted OR=47.2; 95% CI=2.3 to 967.18) or a GP with session in occupational health 
(unadjusted OR=84.18; 95% CI=2.7 to 2627.53), and also by strong work factors in the 
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medical history (unadjusted OR=66.49; 95% CI=18.98 to 232.94), but not by strong non-
work factors.   
 
 
 
 
 
 
Figure 5.3.  Bimodal distribution of responses to the question “Do you think that the 
diagnosis is occupational asthma?” for grey case scenarios SS and WW. 153 participants 
were allocated grey-case scenarios.  SS=strong work/strong non-work; WW=weak 
work/weak non-work.   
 
 105 
 
 
 
Explanatory variable Odds Ratio Lower 
95% CL 
Upper 
95% CL 
p-value 
Specialty GP 
GP-OH 
Occupational medicine 
General hospital medicine 
Respiratory medicine 
Occupational Lung Disease 
47.20 
84.18 
12.97 
33.64 
8.55 
1 
2.30 
2.70 
0.88 
0.97 
0.35 
967.18 
2627.53 
190.46 
1169.56 
207.10 
0.01 
0.01 
0.06 
0.05 
0.19 
Level of training Foundation year/SHO 
Registrar 
Consultant/GP 
0.34 
0.64 
1 
0.02 
0.09 
4.84 
4.44 
0.43 
0.65 
Work factors Strong work 
Weak work 
66.49 
1 
18.98 232.94 <0.001 
Non-work factors Strong non-work 
Weak non-work  
1 
1 
   
Self-reported 
confidence in 
diagnosing 
occupational asthma 
SA 
A 
N 
D 
0.42 
0.62 
0.97 
1 
0.04 
0.09 
0.17 
4.79 
4.17 
5.60 
0.48 
0.63 
0.98 
Experience in 
managing cases of 
occupational asthma 
SA 
A 
N 
D 
SD 
0.31 
0.18 
0.38 
0.42 
1 
0.03 
0.02 
0.04 
0.05 
3.78 
1.67 
3.82 
3.70 
0.36 
0.13 
0.41 
0.43 
Sufficient 
knowledge to screen 
for occupational 
asthma 
SA1 
A 
N 
D 
1 
0.45 
0.14 
0.20 
 
0.08 
0.02 
0.02 
 
2.57 
1.27 
2.37 
 
0.37 
0.08 
0.20 
 
Table 5.8.  Binary logistic regression analysis of yes/no responses to the question “Do 
you think that the diagnosis is occupational asthma?” with unadjusted odds ratios and 
95% confidence limits.  CL=confidence limit; GP=general practitioner; GP-OH=general 
practitioner with session in occupational health; SHO=senior house officer; SA=strongly 
agree; A=agree; N=neither agree nor disagree; D=disagree; SD=strongly disagree.  
1“SA” value used as baseline variable due to small number of responses (n=1) to “SD”.   
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5.5 Discussion 
5.5.1 Summary 
This study aimed to define the important barriers to identifying occupational asthma from the 
point of view of healthcare professionals (nurses and doctors) who attend working-age 
asthmatic patients in their clinical practice.  Response rates from most professional groups 
were disappointingly low, which introduces a significant non-response bias into the gathered 
data, and limits the strength of their interpretation.   
 
Most questionnaire responders asked asthmatic patients about the nature of their work (95%) 
and the effect of work on their asthma symptoms (88%).  Nurses were more inclined to do so 
than doctors, but were less confident, less knowledgeable, with less time to screen for 
occupational asthma.  The only medical specialty who enquired less about work and work-
effect than occupational lung disease specialists, were general hospital physicians, who were 
3 times less likely to enquire than other groups, and also reported a lack of experience 
managing cases of occupational asthma, less subject knowledge and awareness of guidelines, 
and lower perceived importance of the subject matter.  62% of all responders followed 
occupational asthma guidelines, mainly SIGN/BTS (60%) and BOHRF (53%) guidance, 
though use varied between medical specialties (4-100%).   
 
In this sample of survey responders there was no difference in the allocation of causation to 
the different scenarios, or confidence in that allocation, by medical specialty.  Timing of the 
onset of symptoms and the nature of patients’ work were the most important factors in 
deciding whether a case was occupational or not.  In cases of diagnostic uncertainty (grey 
cases) GPs and GPs with sessions in occupational health were more likely than other groups 
to describe a case as occupational asthma, and strong work-factors were more important in 
that decision than the absence or presence of non-work factors in the history. 
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5.5.2 Limitations 
This is the first study that has aimed to understand barriers to diagnosis of occupational 
asthma on the part of a variety of UK healthcare professionals in detail.  However it has a 
number of limitations that require further discussion.  It is necessary initially to consider 
whether all of the important barriers to diagnosis were included in the questionnaire: barriers 
were identified from two Canadian cross-sectional studies – a telephone interview study of 42 
workers with asthma symptoms (Poonai et al., 2005) and a postal questionnaire of 201 
Canadian pulmonologists (Parhar et al., 2011).  In order to increase the sensitivity of the 
questions included, ideas generated from the Canadian studies were augmented by discussion 
with 2 occupational lung disease clinical experts, and by review of a cross-sectional survey of 
Dutch GPs with regard to guideline adherence (Lugtenburg et al., 2011).  Furthermore, an 
evaluation of an educational module for GPs on occupational asthma, from Sheffield, which 
is to date the only UK-based study to have addressed barriers to diagnosis, highlighted 
deficiencies in background knowledge and clinical experience in primary care (Barber et al., 
2010); both of these aspects were addressed in the questionnaire.   
 
Guidance was followed in order to construct and sequence questionnaire items (Williams, 
2003) and avoid the cognitive biases associated with surveys.  The questionnaire was then 
piloted to establish construct validity and test-re-test reliability, which showed all items to be 
at least “fair” or greater using the Cohen kappa statistic (Field, 2004; Landis and Koch, 1977).  
A number of strategies adapted from the Dillman method (Dillman, 2007) were employed to 
increase response rate, including (1) using Likert responses (Bowling, 1997), which are quick 
to complete, easy to code and avoid non-committal (“don’t know”) answers (Williams, 2003), 
(2) using an Internet based survey tool, which has fewer steps to completion, gathers and 
codes data automatically, and is more cost-effective than a postal questionnaire (Rosenbaum 
and Lidz, 2007), and (3) using e-mail reminders 4-weeks after the initial contact.  However 
despite these strategies response rates varied and were very low for most groups: GPs (3%), 
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respiratory-oriented nurses (9%), occupational physicians (11%) and hospital physicians 
(16%).   
 
One might expect a low response to Internet-based questionnaires; certainly postal 
questionnaires are associated with lower response rates than interview-led ones (Cartwright 
1986).  In general practice a number of reasons for increasing lack of engagement with 
surveys have been cited, including increasing workload and stress, hostility from service 
providers towards academic general practice, disinterest in research, and perceived threats to 
professional activity (McDonald, 1993).  Furthermore GPs will not complete studies if they 
disagree with, or are not interested in, the research topic (Cartwright, 1978; Herbelein and 
Baumgartner, 1978; Sibbald et al., 1994).  However, low response rates do not necessarily 
affect the validity of questionnaire data, particularly when the target population is a group 
with homogenous opinions, attitudes or demographics (Leslie, 1972).  Indeed in studies that 
have evaluated research questionnaires distributed to GPs, the demographics and disease-
related beliefs of non- or late responder GPs did not differ significantly from early responders 
(Cockburn et al., 1988; Bostick et al., 1992).  Nonetheless the response rates in the current 
study are disappointing and much lower than a pooled estimate for published questionnaire 
studies (mean response rate=57.5%, 95%CI: 55.2% to 59.8%; Cook et al., 2009): therefore 
there is likely to be significant non-response bias.  This probably manifests as a bias towards 
interested or motivated individuals with experience of managing cases of work-related 
respiratory diseases, as reflected in both the open comments section and the fact that GPs 
were more inclined to call a grey case occupational asthma than other professionals.  With the 
exception of general hospital physicians and notwithstanding the fact that trainees were well 
represented in the sample (44%), responders tended to be experienced nurses and doctors 
(mean number of years’ clinical experience across specialties=16.8-27.4).   
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5.5.3 Interpretation of findings 
Results would indicate that most healthcare professionals ask about the nature of work and 
work effect regardless of role or specialty, and to the same extent as a group of occupational 
lung disease specialists.  Equally with the case study, physicians across all specialties allocate 
work causation to the same extent and with the same degree of confidence as occupational 
lung disease specialists (with the exception of GPs with grey cases).  Despite this, non-
occupational lung disease specialists appeared to display lower confidence in diagnosing and 
screening for occupational asthma, and specific guideline use was low amongst GPs (10-
39%), general hospital physicians (4-16%) and respiratory physicians (24-43%). Therefore it 
is perhaps surprising that non-specialists report high levels of screening activity, and there 
was such homogeneity of response.  This certainly does not reflect established data from a 
range of other sources: (1) inactivity and low prevalence of recorded occupational asthma in 
the primary care audit (Walters et al., 2012; chapter 3), (2) the inadequate healthcare 
consultations experienced by the majority of interviewed workers with occupational asthma 
symptoms (chapter 4), (3) previous reports of low identification rates (de Bono et al., 1999) 
and low- or delayed referral activity in UK primary care (Hoyle et al., 2010; Fishwick et al., 
2007), and (4) poor enquiry by attending doctors seen in two Canadian studies (Poonai et al., 
2005; Parhar et al., 2011).  Therefore a significant proportion of the responses to questions 
about screening should be explained by non-responder bias, and by cognitive biases (response 
bias) associated with answering “suggestive” questionnaire items.  Indeed, as previously 
stated, there is further evidence of this in the enthusiastic allocation of work causation to grey 
cases by GPs and GPs with an interest in occupational health. 
 
It is not surprising that general hospital physicians asked less about work and work effect, 
since the group was made up of mostly trainees (94%) with less average clinical experience 
(6.4 years) than other specialties.  Respiratory medicine doctors comprised a high percentage 
of trainees (76%) but one would expect them to have greater clinical experience and subject 
knowledge, since occupational lung diseases form a significant part of their training 
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curriculum in the UK (Joint Royal Colleges of Physicians’ Training Boards, 2010).  Lack of 
background knowledge and skill amongst general medicine trainees is reflected in open 
comments that suggest they retain very little subject knowledge and would expect to seek 
specialist help for screening.  In the case of nurses, all those sampled would be expected to 
have an interest and clinical experience in respiratory disease, due to the nature of the 
organizations recruited.  Practice nurses who attend adult asthmatics were a difficult group to 
target and reach in their entirety, and this necessitated contacting specialist respiratory groups, 
which meant sampling individuals motivated enough to join a professional society.  Therefore 
one might anticipate high levels of enquiry about work and work effect, which probably 
overestimates the performance of practice nurses generally.  This is notwithstanding the 
relatively lower self-reported confidence in screening, background knowledge and time 
available to screen, when compared to doctors.  
 
5.6 Conclusion 
In the sample of responders included in this study, GPs, non-specialist physicians and nurses 
report high levels of patient enquiry about the nature of work and work effect on their asthma 
symptoms; however this is likely to overestimate practice generally due to an over-
representation of enthusiasts in the sample.  However, low awareness and adherence to 
guidelines is reported amongst non-specialists, which better reflects other data suggesting that 
there is poor enquiry about occupational asthma, particularly in primary care.  A group 
represented predominantly by trainee general physicians report less screening activity, 
confidence, awareness of guidelines and background knowledge than other specialties.  
Therefore there is some evidence of low knowledge, guideline use and clinical experience of 
screening for occupational asthma amongst non-specialists.  
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CHAPTER 6: FEASIBILITY STUDY OF A PRIMARY CARE SCREENING TOOL FOR 
OCCUPATIONAL ASTHMA 
 
6.1 Introduction 
6.1.1 Background 
Occupational asthma is associated with a societal cost to the UK of £100 million per annum 
for each year of incident cases, and most of the financial burden falls on the taxpayer and the 
employee rather than the employer (Ayres et al., 2011).  This cost is somewhat avoidable 
since those individuals with a short latency between symptom onset and diagnosis or removal 
from exposure to a sensitizing agent have a better prognosis in terms of lung function and 
quality of life (Nicholson et al., 2010).  However, in cohort studies from the UK and from 
Canada, mean delays of 3-4 years between symptom onset and diagnosis or referral to a 
specialist have been identified (Fishwick et al., 2007; Santos et al., 2007; Poonai et al., 2005).  
There is evidence that primary healthcare professionals (GPs and practice nurses) do not ask 
asthmatic patients about the effect of work on their symptoms (Poonai et al., 2005; Fishwick 
et al., 2007; Walters et al., 2012) or take action when there a high probability of work 
causation (Hoyle et al., 2010; de Bono and Hudsmith, 1999).  This is notwithstanding the 
publication of guidance for physicians, GPs and primary care nurses on assessment of patients 
with suspected occupational asthma (BTS, 2012; BOHRF, 2010): these suggest that all 
working-age patients with new onset or re-activated asthma symptoms should be asked their 
occupation (to highlight high-risk work) and whether the symptoms are related to their work 
(Fishwick et al., 2008; Nicholson et al., 2010). Those patients whose symptoms are work-
related or concur with a high-risk occupation should be referred for specialist assessment 
(Fishwick et al., 2012). 
 
6.1.2 Efficacy of screening questions for occupational asthma 
Two simple questions (“Are your symptoms better on days away from work?” and “Are your 
symptoms better on holiday?”) have a sensitivity of between 58-100% in identifying 
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occupational asthma, sensitivity being below 90% in only two studies (Malo et al., 1991; 
Vandenplas et al., 2005).  Specificity can be lower however (45-100%), being over 70% in 
one small study only (Nicholson et al., 2010). UK guidelines recommend that these two 
questions be used for screening in primary care and elsewhere (SIGN/BTS, 2012; Fishwick et 
al, 2012) with subsequent referral to a specialist if either question is answered in the 
affirmative.   
 
The positive predictive value of a screening or diagnostic test is the probability that an 
individual with a positive test result actually has the disease (Altman and Bland, 1994).  
Positive predictive value is affected by the baseline prevalence of the disease in a population 
of interest; thus, the same diagnostic test will have a different predictive accuracy according 
to the population in which it is tested.  Screening questions for occupational asthma have been 
validated in tertiary clinic populations with high disease prevalence, and have been 
demonstrated to have relatively low specificity (45-70% in all but one study).  Therefore 
when applied to a population of working-age asthmatics in primary care with low baseline 
prevalence (0.3% using data from chapter 3) they may lead to a large number of false positive 
tests (Altman and Bland, 1994).  The efficacy of these screening questions in a primary care 
population has not been demonstrated, nor is it known whether they are clinically effective in 
terms of case identification, reducing diagnostic latency and improving health outcomes.   
 
6.1.3 Aim 
The aims of this study were to evaluate the feasibility of initiating an electronic screening tool 
for primary healthcare professionals, its utility in collecting data on work-effect and the 
willingness of individual healthcare workers to use it.   
 
6.2 Methods 
A prospective feasibility study was undertaken over a 3-month period in 4 primary care 
practices in Birmingham, UK. 
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6.2.1 Practice recruitment 
Four practices were recruited purposively by the primary author by direct approach to a group 
of Birmingham GPs who had recently collaborated with Heart of England NHS Foundation 
Trust respiratory physicians on commissioning respiratory services in the region, or worked 
in secondary care respiratory medicine.  There were no specific inclusion criteria for 
individual patients since recruitment was at the cluster (practice) level.  All 4 practices were 
undertaking asthma reviews with working-age patients, both formally as part of the Quality 
Outcomes Framework (NHS Information Centre, 2011) and opportunistically, for patients 
with urgent appointments due to symptomatic asthma, medication reviews, or at consultations 
for other medical problems.   
 
6.2.2 Asthma template modification 
Recruited practices used different electronic health records [Vision (INPS, Battersea, London, 
UK): practice A and B, SystmOne [sic] (TPP, Horsforth, Leeds, UK): practice C, EMIS 
(Egton Medical Information Systems, Yeadon, Leeds, UK): practice D]: each practice 
running a customized electronic template for asthma reviews, where data were captured using 
searchable Read codes.  Practices were required to modify their existing templates to embed a 
screening tool consisting of the following questions: 
 
1. What is your occupation? 
2. Are your asthma symptoms better on days away from work? 
3. Are your asthma symptoms better away from work on holiday? 
 
A statement about the efficacy of the questions was included in the template with the 
questions (see Figure 6.1) but no further training or incentives were provided for staff.  The 
lead GPs from each practice were instructed to alert all practice staff to the template changes, 
though only 2 did so (Practices A and D).  Each practice was given the telephone and email 
contact details of the primary author to enable clinical advice from the Heart of England NHS 
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Foundation Trust occupational lung disease unit if required during use of the tool.  As this 
was a feasibility study, no clinical outcomes for individual patients were measured.  The 
study ran for 3 months from the start date and data were collected at the end of that period.   
 
6.2.3 Data gathering 
Baseline practice-level data were gathered including: (i) list-size, (ii) number of Read-coded 
asthmatics, (iii) number of asthmatics of working-age (16-64 year old), and (iv) current 
prevalence of Read-coded occupational asthma.  At the end of the study period all exposed 
healthcare professionals (GPs, practice nurses) were invited to complete an online 
questionnaire intended to evaluate utility and willingness to use the tool. The online 
questionnaire was administered through the cloud-based forms creator 
www.surveymonkey.com (Palo Alto, California, USA).  Questionnaire items were developed 
through discussion with occupational lung disease specialists, 5-point Likert ordinal scales 
(strongly agree, agree, neither agree nor disagree, disagree, strongly disagree) were used for 
closed responses (Bowling, 1997) and opportunities for open comments were also included.  
The questionnaire is shown in Appendix 10.   
 
6.2.4 Data analysis 
Baseline practice-level data were tabulated for comparison between practices.  Descriptive 
analyses were undertaken using questionnaire data.  Data were categorized by role (doctor, 
nurse) and cross-tabulated with response variables to identify any associations.  Analysis of 
variance was undertaken using Kruskal-Wallis tests for ordinal data.  All analyses were 
considered significant at the 5% level.   
 
6.2.5 Ethical approval 
Ethical approval for the study was granted by the Yorkshire and The Humber - South 
Yorkshire National Research Ethics Service (NRES) committee (REC reference number: 
13/YH/0291) and NHS Assurance for Research in Primary Care was granted by Birmingham 
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and the Black Country Comprehensive Local Research Network (Consortium Reference: 
consortium 372.129572).   
 
 
6.3 Results 
6.3.1 Practice level data 
Practice-level data from each of the 4 primary care practices are shown in Table 6.1.  List 
sizes varied between 3,475 (small practice with 4 GPs) and 24,660 (large practice with 3 
separate clinical sites) and asthma prevalence was 5.6-8.2% at all practices. Across all 4 
practices 56.3-65.2% of asthmatics were of working age, amongst whom the prevalence of 
Read-coded occupational asthma was 0-0.7%.   
 
 Practice A Practice B Practice C Practice D 
Location Small Heath Small Heath Harborne Moseley 
List size 16,019 11,193 24,6601 3,475 
Number (and 
prevalence %) of Read-
coded asthmatics 
966 (6) 919 (8) 1383 (6) 248 (7) 
Number (and % of all 
asthmatics) of Read-
coded asthmatics of 
working-age 
544 (56) 599 (65) 879 (64) 152 (61) 
Number (and 
prevalence % amongst 
working-age asthmatics) 
of Read-coded 
occupational asthma 
4 (0.7) 3 (0.5) 3 (0.3) 0 (0) 
 
Table 6.1.  Practice-level data gathered from each of 4 participating primary care 
practices.  1Across 3 clinical sites. 
 
6.3.2 Feasibility of initiating screening tool 
A GP from Practice A with background clinical experience in occupational lung disease 
created two buttons within the practice’s existing asthma review template for acknowledging 
where an occupational enquiry had been undertaken (current employment) and questions 
regarding work effect on symptoms had been asked, together with opportunities for recording 
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responses in free text entry (shown in Figure 6.1).  Any recorded data then appeared on a 
patient’s electronic health record and was automatically Read coded making it auditable via a 
specific database search.  Twelve GPs and 7 practice nurses at Practice A undertook adult 
asthma reviews and were informed of the template modification by the lead GP through 
opportunistic face to face discussion and by email circulation.    
 
 
Figure 6.1.  Screenshot of occupational asthma screening tool incorporated into the 
existing asthma review template on a Vision dummy patient healthcare record at 
Practice A.  This is the screen image seen by a practice healthcare professional when 
undertaking an asthma review.  When a grey button marked “Patients [sic] 
Occupation” or “Effect of work on symptoms” is pressed each patient is labelled with an 
auditable Read code.  Free text can then be entered underneath to clarify the responses - 
the example occupation shown here is a “GU nurse”.  Once entered this information 
appears on a patient’s health record.   
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A GP with no direct clinical experience in occupational lung disease at Practice B made the 
same modifications as Practice A to the existing practice asthma review template on their 
Vision electronic health database.  Only 1 GP and 2 practice nurses were exposed to the 
changes and the nurses were not informed that the changes to the template had been made.   
 
A GP at Practice C with lead responsibility at the practice for chronic respiratory diseases 
management and commissioning local respiratory services modified the existing asthma 
review template on the SystmOne electronic health record at Practice C.  Read-coded buttons 
for occupational enquiry and 2 questions regarding work effect were created in a similar 
manner to Practice A and B (Figure 6.2).  19 doctors and 9 nurses undertaking asthma 
reviews were exposed to the template modifications though were not informed of the changes 
made.   
 
A GP at Practice D with responsibility within the practice for chronic respiratory diseases 
management, and with experience working as a clinical assistant in a secondary care asthma 
clinic modified an existing asthma review template on the EMIS Web electronic health record 
at the practice to include (i) a tick box for occupational history enquiry and (ii) closed 
(yes/no) responses for questions about work relatedness of symptoms, all with opportunities 
for free text entry (Figure 6.3).  Auditable Read codes were assigned to each closed response, 
and free text comments also appeared in an individual patient’s electronic health record 
(Figure 6.4).  Only the aforementioned GP and one practice nurse were exposed to the 
screening tool.   
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Figure 6.2.  Printout of occupational asthma tool screenshot on SystmOne electronic 
record at Practice C as seen by healthcare professionals during an asthma review.  The 
documentation of the presence of work-related symptoms in the text boxes is Read-
coded and auditable, and the data appear in an individual’s health record.   
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Figure 6.3.  Screenshot of the occupational asthma screening tool incorporated into 
existing asthma review template on EMIS Web database at Practice D, as seen by 
practice healthcare professionals.  Ticking the “occupational history” box or responding 
(yes/no) to either or both of the 2 questions about work relatedness of asthma symptoms 
automatically creates auditable Read codes.  Free text entry boxes are also seen. 
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Figure 6.4.  Screenshot of an electronic health record for an individual adult patient 
with asthma at Practice D.  An opportunistic asthma review has been undertaken on the 
9th April 2014 using the modified asthma template after the patient has attended 
Practice D with a cough.  Occupational history and presence of a work effect on 
symptoms have been coded and free text entered regarding occupation (community 
occupational therapist) entered.   
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6.3.3 Exposure to screening tool 
Practices ran the feasibility study for 3-4 months and there was a variation in the number of 
asthma reviews undertaken during the study periods (71-425).  Practices varied in the number 
of healthcare professionals engaged in undertaking asthma reviews (2-28 professionals per 
practice), and therefore in the number exposed to the screening tool (shown in Table 6.2).     
 
 
 Practice A Practice B Practice C Practice D 
Location Small Heath Small Heath Harborne Moseley 
Database used Vision Vision SystmOne EMIS Web 
Number of staff exposed to 
template 
Total 
Nurses 
Doctors 
 
 
19 
7 
12 
 
 
3 
2 
1 
 
 
28 
9 
19 
 
 
2 
1 
1 
Number returning study 
questionnaires (%) 
Total 
Nurses 
Doctors 
 
 
16 (84) 
7 
9 
 
 
1 (33) 
0 
1 
 
 
6 (21) 
2 
4 
 
 
1 (50) 
0 
1 
Length of exposure to 
template (months) 
3 3 4 3 
Number of asthma reviews 
undertaken during study 
period 
71 271 425 114 
Number (%) of times 
occupation/work effect 
questions used 
60 (85) 0 (0) 4 (1) 64 (56) 
 
Table 6.2.  Number of asthma reviews undertaken and use of the screening tool at each 
recruited practice during the feasibility study period.   
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6.3.4  Questionnaire responses 
Questionnaires were returned by 24 healthcare professionals exposed to the screening tool (15 
GPs, 9 practice nurses) and response rate was 46% (21-84% across all 4 practices; see Table 
6.2).  One practice nurse registered a response but failed to answer any questions.  Of the 
remaining 23 professionals 13 did not use the screening tool (10 GPs, 3 practice nurses) and 
reasons given for non-use are shown in Table 6.3.   
 
 
Reasons given for not using occupational asthma screening tool 
 
 “Not involved in asthma management” 
 “Didn't notice it/ was not informed about it” 
 “Not seen relevant patients and did not know it was there” 
 “New to practice [and not aware]” 
 “Great idea - probably not use because of the skew distribution of patients I 
see, lack of awareness and the pressure of QOF [Quality Outcomes 
Framework] at the end of March 2014” 
 “Not required” 
 “Don’t see pt [patients] with regard to asthma, book into respiratory clinic” 
 “Seen only young children recently!!” 
 “The few I did ask were not work related and mostly used alternative 
asthma template so questions missed” 
 “Wasn't aware of it!” 
 “Unaware” 
 “Not seen it yet - think not had many asthma reviews lately” 
 “I did not see it in the template- although have now had a look and it is 
there” 
 
Table 6.3.  Responders’ reasons for not using occupational asthma screening tool, taken 
from questionnaire open comments.   
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Nine professionals who did use the screening tool (n=10 screening tool “users”, but 1 nurse 
did not enter any further responses) responded to 10 Likert statements about the screening 
tool (5 GPs, 4 nurses).  These responses are summarized in Table 6.4.  There were no 
statistically significant differences between responses when grouped by job role (GP, practice 
nurse).  Responders did not experience technical or procedural difficulties with the screening 
tool and its use did not add significantly to their workload during an asthma review (Figure 
6.5).  Responders were less confident (44% agreed or strongly agreed) about how to act when 
patients had work-related asthma symptoms (Figure 6.6) and 78% agreed/strongly agreed that 
further training in managing health aspects of suspected occupational asthma would improve 
the screening tool.  All responders agreed that if the screening tool was rolled-out they would 
continue to use it (Figure 6.7) with 78% identifying no further potential problems with its use.  
67% of responders felt that the screening tool had added something beneficial to the asthma 
review though no further open comments were offered. 
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Table 6.4.  Healthcare professionals’ responses to questions regarding the use of an occupational asthma screening tool categorized by job role (GP, nurse).  
SA=strongly agree; A=agree; N=neither agree nor disagree; D=disagree; SD=strongly disagree; IT=information technology.  Analyses of variance were measured 
using non-parametric Kruskal-Wallis tests, significance measured at the 95% confidence level.   
 
 
 
 
Practice nurses; 
n=4 
General practitioners; 
n=5 
TOTAL; 
n=9 
Analyses of 
variance 
Q1.  I experienced difficulties asking patients 
questions about their occupation and whether 
their symptoms were better away from work 
SA 
A 
N 
D 
SD 
0 (0) 
0 (0) 
0 (0) 
3 (75) 
1 (25) 
0 (0) 
0 (0) 
0 (0) 
3 (60) 
2 (40) 
0 (0) 
0 (0) 
0 (0) 
6 (67) 
3 (33) 
P=0.66 
Q2.  The screening tool was user-friendly (clear, 
concise, logical) 
SA 
A 
N 
D 
SD 
1 (25) 
3 (75) 
0 (0) 
0 (0) 
0 (0) 
1 (20) 
4 (80) 
0 (0) 
0 (0) 
0 (0) 
2 (22) 
7 (78) 
0 (0) 
0 (0) 
0 (0) 
P=0.87 
Q3.  I experienced (technical/IT) difficulties 
using the screening tool in the asthma review 
template 
SA 
A 
N 
D 
SD 
0 (0) 
0 (0) 
0 (0) 
3 (75) 
1 (25) 
0 (0) 
0 (0) 
0 (0) 
3 (60) 
2 (40) 
0 (0) 
0 (0) 
0 (0) 
6 (67) 
3 (33) 
P=0.66 
Q4.  Using the template added significantly to my 
workload during the consultation 
SA 
A 
N 
D 
SD 
0 (0) 
0 (0) 
0 (0) 
3 (75) 
1 (25) 
0 (0) 
0 (0) 
2 (40) 
1 (20) 
2 (40) 
0 (0) 
0 (0) 
2 (22) 
4 (44) 
3 (33) 
P=0.69 
Q5.  I am confident in how to act on the results of 
these screening questions 
SA 
A 
N 
D 
SD 
0 (0) 
2 (50) 
1 (25) 
1 (25) 
0 (0) 
1 (20) 
1 (20) 
3 (60) 
0 (0) 
0 (0) 
1 (11) 
3 (33) 
4 (44) 
1 (11) 
0 (0) 
p=0.70 
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Table 6.4 continued.. 
 
  
 
 
Practice nurses; 
n=4 
General practitioners; 
n=5 
TOTAL; 
n=9 
Analyses of 
variance 
Q6.  Would training for you in how to manage 
the heath aspects of cases of suspected 
occupational asthma improve the use of the 
screening tool? 
SA 
A 
N 
D 
SD 
1 (25) 
3 (75) 
0 (0) 
0 (0) 
0 (0) 
1 (20) 
2 (40) 
0 (0) 
2 (40) 
0 (0) 
2 (22) 
5 (56) 
0 (0) 
2 (22) 
0 (0) 
P=0.34 
Q7.  Would further training for you in how to 
advise the employer / manage the work situation 
in cases of suspected occupational asthma 
improve the use of the screening tool? 
SA 
A 
N 
D 
SD 
1 (25) 
0 (0) 
1 (25) 
2 (50) 
0 (0) 
1 (20) 
1 (20) 
1 (20) 
2 (40) 
0 (0) 
2 (22) 
1 (11) 
2 (22) 
4 (44) 
0 (0) 
P=0.80 
Q8.  If this tool was kept in your asthma template 
would you keep using it? 
SA 
A 
N 
D 
SD 
1 (25) 
3 (75) 
0 (0) 
0 (0) 
0 (0) 
1 (20) 
4 (80) 
0 (0) 
0 (0) 
0 (0) 
2 (22) 
7 (78) 
0 (0) 
0 (0) 
0 (0) 
P=0.87 
Q9.  If this tool was kept do you envisage any on-
going or emergent problems with its use? 
SA 
A 
N 
D 
SD 
0 (0) 
0 (0) 
1 (25) 
3 (75) 
0 (0) 
0 (0) 
0 (0) 
1 (20) 
3 (60) 
1 (20) 
0 (0) 
0 (0) 
2 (22) 
6 (67) 
1 (11) 
P=0.56 
Q10.  Do you think this tool has added anything 
beneficial to your asthma reviews? 
SA 
A 
N 
D 
SD 
0 (0) 
3 (75) 
1 (25) 
0 (0) 
0 (0) 
1 (20) 
2 (40) 
2 (40) 
0 (0) 
0 (0) 
1 (11) 
5 (56) 
3 (33) 
0 (0) 
0 (0) 
p=1.00 
 126 
 
 
 
 
 
 
Figure 6.5.  Responses to Q4 regarding the burden of additional questions regarding 
occupation and work relatedness of asthma symptoms by job role.   
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Figure 6.6.  Responses to Q5 regarding healthcare professionals’ confidence in acting on 
patients’ replies to occupational asthma screening questions, categorized by job role.   
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Figure 6.7.  Responses to Q8 regarding healthcare professionals’ opinions on ongoing 
use of a screening tool, categorized by job role.   
 
 
 129 
6.4 Discussion 
6.4.1 Summary 
A screening tool for occupational asthma was successfully incorporated into existing 
electronic templates for asthma disease monitoring using 3 different patient management 
software systems (Vision, SystmOne, EMIS Web).  The template modification at each 
practice was made rapidly (less than 30 minutes) and in each case by a GP with no new 
resources for the task or incentive to do so.  When healthcare professionals were given 
information about the addition of a screening tool for a 3-4 month feasibility study, its uptake 
during asthma reviews was high (85% of reviews), but where no further information was 
offered uptake was lower (0-56% of reviews).  Questionnaire responses suggested that the 
principal barrier to use of the tool was lack of awareness of its existence.  Healthcare 
professionals who did use the screening tool found it to be user-friendly (clear, concise, 
logical) with no perceived procedural or IT difficulties.  However they did identify a need for 
concurrent training in managing the health aspects of occupational asthma. 
 
6.4.2 Limitations 
It is necessary to consider the limitations of this feasibility study, particularly when 
considering the design of a future cluster trial of the clinical effectiveness of a screening tool.  
The study was undertaken in 4 practices in Birmingham, UK (2 city centre, 2 suburban) and 
therefore is not representative of the whole of the West Midlands or indeed the UK.  The GPs 
contacted from 2 of the recruited practices had worked as clinical assistants in respiratory 
medicine in secondary care and 1 contact GP was the nominal lead clinician for respiratory 
diseases in his practice, so were therefore more experienced with asthma than many GPs.  
The practices were recruited directly by the primary author and contact GPs gave their time 
and resources through goodwill alone, which may have introduced an “enthusiasm bias” 
where any difficulties encountered recruiting healthcare professionals and practices less eager 
to help, are not appreciated.  Questionnaire response rates were variable across the 4 practices 
(although similar for nurses and GPs) – low at practice C (21%) where no information about 
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the screening tool was given at the outset, and high at Practice A (84%) where all 
professionals were informed about the template change at the outset by an enthusiastic GP.  
This may have produced a non-response bias, and given that half of those who did complete 
the questionnaire did not use the tool at all, most lack of response is likely to be prompted by 
unawareness of its existence or being dismissed as unimportant.   
 
6.4.3 Interpretation 
Baseline prevalences of diagnosed occupational asthma at recruited practices (0-0.7%) were 
low and consistent with prevalence estimates in Birmingham, UK from earlier work (Walters 
et al., 2012), suggesting that none of the recruited practices in this study were outliers (ie. 
high performers in identifying occupational asthma cases).    List sizes, the number of 
registered asthmatics (6-8% of practice patient populations) and proportion of asthmatics of 
working age (56-65%) at recruited practices were consistent with previous estimates (Walters 
et al., 2012; National Health Service Information Centre, 2011; Lung and Asthma 
Information Agency, 2011; Asthma UK, 2004). 
 
Modifying the asthma review template with additional questions using 3 software 
programmes in common usage in NHS primary care proved to be technically straightforward 
and was undertaken by GPs with little difficulty.  Therefore it is reasonable to predict that this 
could be achieved in most NHS primary care practices in the UK by clinical or non-clinical 
staff with IT administration rights.  The application of Read codes to data entered into the 
individual patient record when using the screening tool would make searching for, and 
gathering trial data, simple and rapid, as well as providing a straightforward tool for clinical 
audits. 
 
The main barrier to the use of an occupational asthma screening tool was a lack of awareness 
of it as a feature in the asthma template, and so changing the format of a template, where 
visible statements on the screen merely act as prompts for the professional, and 
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documentation is not a mandatory requirement, does not predict its use.  The utility of the 
screening tool increased when healthcare professionals were given brief instruction on its use 
(at Practice A).  However no occupational asthma disease-specific education was given to any 
staff member and screening tool use was high despite this.   The questionnaire responses did 
suggest that further education on managing the health aspects of occupational asthma would 
be welcomed at all practices and improve the usefulness of the tool, and this finding is 
consistent with the educational barriers identified in the previous studies in chapters 4 and 5.   
 
Two other reasons for non-use of the tool were identified: (i) some healthcare professionals 
were not involved in adult asthma management and had not undertaken asthma reviews (this 
would not preclude GPs from seeing asthmatic patients with urgent problems and completing 
an annual review opportunistically however), and (ii) one professional had by chance not seen 
an asthmatic patient of late and therefore not been exposed to the tool.  Two reasons for the 
observed low use of the screening tool in Practices B and C (identified by the contact GPs in 
both practices) were (i) including annual asthma medication reviews in the coding of asthma 
consultations, and (ii) the prioritization of documenting key disease indicators in patient 
records (eg. peak flow measurements, asthma control questions) at the expense of questions 
about work and occupation, as a requirement for the Quality Outcomes Framework (QOF; 
National Health Service Information Centre, 2011) in the run up to the end of the 2014 tax 
year (the study ran between January and April).     
 
6.5 Conclusion 
In conclusion the electronic screening tool for occupational asthma can be easily and quickly 
incorporated into existing asthma disease management systems in a variety of software 
programmes.  It can be used by the healthcare professional without technical difficulty and is 
acceptable without adding any great extra burden to the current asthma review.  Its utility 
could be greatly improved by user instruction and training in further clinical management of 
the patient with work related asthma symptoms.  
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CHAPTER 7: GENERAL DISCUSSION 
 
7.1 Summary 
The overall aim of this work was to identify the main barriers to the diagnosis of occupational 
asthma for affected workers and attending healthcare professionals.  Many workers with 
occupational asthma symptoms exhibited health beliefs that predisposed to delayed disclosure 
of symptoms to health professionals and employers, such as poor insight into the onset of 
symptoms, misattribution of symptoms to other illnesses, fear of financial loss due to illness, 
or low confidence in their GP to make a diagnosis.  Some workers were unable to negotiate 
inadequate healthcare consultations to get to a diagnosis or find a workplace solution.  
 
Occupational asthma was not well recognized in primary care, despite the publication of 
national guidance to aid assessment of adults with new-onset or recurrent asthma in terms of 
the risk of respiratory sensitization attached to their work, and the effect of work on their 
asthma symptoms.  The rate of documented occupational asthma in primary care was very 
low when compared to UK estimates for prevalence of the disease, and a retrospective 
analysis of electronic patient records revealed that enquiry about occupational risk and the 
effect of work on asthma symptoms by GPs and practice nurses was very poor.  In a cross-
sectional questionnaire study of GPs, respiratory nurses, and occupational, general and 
respiratory physicians, only general medicine physicians reported lower rates of enquiry into 
work and the effects of work on asthma than occupational lung disease experts.  However a 
poor questionnaire response rate led to an over-representation of occupational asthma 
enthusiasts amongst the sample of physicians, severely limiting generalizability of the results.  
Despite this, general medicine physicians and respiratory nurses were deficient in subject 
knowledge, awareness of guidelines and experience in managing cases of suspected 
occupational asthma, when compared with experts.   
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An electronic tool for GPs and practice nurses to screen working-age asthmatics for 
occupational asthma was developed, and incorporated into a variety of software patient 
management systems in common usage, for use at asthma review consultations.  The uptake 
of the tool by GPs and nurses was higher when instruction for its use was given by the lead 
GP, and those that did use it found it to be user-friendly with no perceived procedural or 
technical difficulties.  A need for further training in managing the health aspects of 
occupational asthma was also identified in those using the screening tool.  
 
7.2 Hypothesis 1: That poor recognition of occupational asthma in primary care is because 
primary healthcare professionals do not follow UK guidance for occupational asthma by 
asking working-age asthmatics about their work or the effect of work on their symptoms. 
The first point of contact with a healthcare professional for the majority of workers with 
work-related asthma symptoms is the GP, and 50% of patients referred for suspected 
occupational asthma have seen their GP >5 times before referral occurs (Fishwick et al., 
2007).  Therefore the burden of identifying potential cases of occupational asthma, in 
individuals with new adult-onset asthma symptoms, falls heavily on primary care 
professionals.   
 
The data from primary care in this thesis, which showed a 5-fold underestimation of the 
prevalence of occupational asthma, and a clear lack of enquiry about occupational risk and 
work-relatedness of symptoms, shows that there has been no improvement in case 
identification 15 years after a study which reported under-recognition of occupational asthma 
in primary care to be approximately 50% (de Bono and Hudsmith, 1999).  The implication is 
that the publication of concise guidance for healthcare professionals in assessing working-age 
asthmatics and screening for occupational asthma, either as part of general asthma guidelines 
(BTS/SIGN, 2012), or specific occupational asthma guidelines for GPs and practice nurses 
(BOHRF, 2010a) and any physician (Fishwick et al., 2012), have had no impact whatsoever 
 134 
on improving case recognition in primary care.  Indeed from the questionnaire study in this 
thesis, self-reported BOHRF guideline use amongst general and respiratory physicians and 
GPs was very low (4-24%), and use of the section on occupational asthma in the general 
BTS/SIGN asthma guideline was less than expected for all specialty groups studied (16-
57%).  This supports questionnaire data from the study by Barber et al. (2010), which 
demonstrated very limited awareness of the BOHRF guidelines, with 72% of respondents 
stating either that they had never heard of them, or had heard of them but had never seen 
them.   
 
There is a perception that clinical guidelines are not popular with GPs and physicians, and 
although some authors have described them as anti-intellectual, as averaging practice, 
discouraging person-centred medicine, cost-saving, and encouraging litigation (Deutsch et al., 
1998; Delmothe, 1998), surveys of healthcare professionals including GPs have consistently 
reported high levels of satisfaction and few barriers to their use (Farquhar et al., 2002; 
Lugtenberg et al., 2011).  GPs in the UK have found clinical guidelines to be useful means of 
accessing subject-specific information, where key factors in their uptake are brevity, 
perceived authority and a resonance with daily practice (Watkins et al., 1999).  Cabana et al. 
(1999) systematically reviewed published studies and texts of barriers to physician adherence 
to clinical guidelines, and after concluding that these were setting-specific and not 
generalizable, produced a framework of guideline-related knowledge, attitudes and behaviour 
(Figure 7.1) that could be used to identify barriers and improve guideline adherence.   
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Figure 7.1.  Barriers to physician adherence to practice guidelines in relation to behaviour change (taken from Cabana et al., 1999). 
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7.3 Hypothesis 2: That delay in diagnosis of occupational asthma is partly due to multiple 
societal factors affecting whether an individual worker will disclose his or her occupational 
asthma symptoms to a healthcare professional or employer. 
Workers with occupational asthma symptoms revealed a broad range of important beliefs 
relating to how they perceived their occupational asthma symptoms, how they sought medical 
help, and how they handled employment issues such as sickness absence or presenteeism.  
Varied and poor understanding of the nature of symptoms, fear of job loss on disclosing 
symptoms, lack of confidence in a solution, as well as external motivating factors such as lack 
of supportive family, colleagues or employer, and poor occupational health provision may all 
contribute towards delayed diagnosis.  These findings are not unexpected, indeed previous 
studies have cited a variety of barriers to engagement with healthcare services and employers, 
such as fear of financial loss through unemployment or absenteeism (Bradshaw et al. 2007), 
loss of status and working relationships (Gordon et al., 1997) and a lack of awareness of 
workplace hazards (Poonai et al., 2005; Santos et al., 2007).  These are basic insights and 
fundamental beliefs for many workers that should be accounted for by all clinicians engaged 
with workers with occupational asthma symptoms, and by specialists and policy makers 
planning educational interventions in the workplace to increase identification of occupational 
asthma. 
 
HSE-initiated workplace interventions have been undertaken in the motor-vehicle repair 
industry (HSE, 2007a), baking and food processing industry (HSE, 2008) and manufacturing 
industry (HSE, 2007b), and there is evidence that these have been successful in reducing the 
incidence of occupational asthma due to certain agents (for example, glutaraldehyde and latex 
in the NHS; Stocks et al., 2013b; Walters et al. 2013).  However these interventions have 
been multi-modal in nature, for example those aimed at flour and baking enzymes in craft 
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bakeries (employer training, inspection, introduction of workplace exposure limits for flour 
and baking enzymes), isocyanates in spray painting at motor vehicle repairers (awareness 
days, inspection and enforcement of process improvements) and rosin-based solder flux fume 
(colophony) in manufacturing (inspection, guidance pack for employers, introduction of work 
exposure limits for colophony), with little emphasis on worker education, whose impact has 
not been studied in any detail.   
 
7.4 Hypothesis 3:  That healthcare professionals lack knowledge and experience in managing 
cases of occupational asthma, which prevents them from screening and diagnosing 
occupational asthma in working-age adults. 
There is evidence from this work that healthcare professionals lack knowledge and experience 
in dealing with work-aspects of asthma.  Educational deficits were observed in the 
questionnaire study where respiratory nurses (in primary and secondary care) were less 
knowledgeable and confident than doctors at screening and managing occupational asthma; 
general hospital physicians (mainly trainees) reported a lack of subject knowledge and little 
clinical experience in screening and managing occupational asthma.  One might hypothesize 
that a lack of background knowledge and awareness, due to a deficit in formal undergraduate 
and/or postgraduate occupational lung disease education, alongside poor clinical involvement 
with workers with occupational asthma during postgraduate training are major barriers to 
diagnosis in subsequent clinical practice.  Indeed in the feasibility study the majority of 
healthcare professionals using the screening tool identified a need for further education in 
managing health aspects of occupational asthma.   
  
Barber et al. (2010) evaluated a new e-learning tool based on key statements from BOHRF 
(2010a) and BTS guidelines (Fishwick et al., 2012) for occupational asthma by administering 
a post-module questionnaire, which was returned by 32% of 1041 total users.   This is a low 
response rate, but typical for evaluations for e-learning modules in the opinion of the authors 
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(Barber et al., 2010).  The majority of responders stated that the module had significantly 
improved their subject knowledge, and although pre-module awareness and use was low, they 
reported that they were likely to use the evidenced-based guidelines in the future.  The 
authors cited a paucity of undergraduate and postgraduate occupational lung disease training 
for current GPs as potential reasons for underlying knowledge deficiencies.  Similar 
experiences have been reported in the USA (Glazer et al., 2008) and Canada (Tarlo et al., 
2009) where case-based learning has been used to improve evidence-based practice.   
 
7.5 Hypothesis 4:  That there are a number of motivating factors (for example: perceived 
importance, resource constraints) which predispose to lack of consideration of the diagnosis 
of occupational asthma in adults. 
There was no evidence from the questionnaire study that healthcare professionals’ 
motivations (internal motivations: perceived benefit to patient, practice or society of making a 
diagnosis of occupational asthma, current routine, perceived self-motivation; external 
motivations: perceived background prevalence of the disease, time pressure, access to 
specialist services, reimbursement) impacted on work-related enquiry and guideline use.  It is 
worth restating that the study was biased towards occupational asthma enthusiasts, and in 
addition closed questions predispose to certain cognitive biases that may have led to 
underestimation of these factors as barriers in screening and diagnosis.  However, the 
feasibility study showed that screening guidance, which was reproduced from UK national 
guidelines (Fishwick et al., 2012), was clear and concise, with both nurses and GPs using it 
with little observed difficulty. 
 
It appears that GPs do not act on patients’ concerns about work-related symptomatology or 
high-risk work processes when information is offered, either by further enquiry or referring 
for specialist advice.  Interviews with patients with occupational asthma symptoms revealed 
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inadequacies in primary care consultations, where in addition to complete lack of enquiry, 
GPs were perceived as dismissive of crucial work-related observations about symptoms, with 
a tendency to oversimplify or trivialize symptoms, or mis-diagnose patients particularly with 
repeated benign infections.  Interviewed workers often thought that this was due to the GP 
being unfamiliar with work processes, but occasionally they believed they were being seen as 
malingerers, out for financial gain, and therefore the GP was reluctant to investigate further.  
It should be stated that this was not always the case, and a few workers felt that their GP took 
a systematic approach and carefully explored a number of diagnoses leading to delayed 
diagnosis.  However, there is evidence elsewhere that crucial information is missed or ignored 
in primary care.  In the primary care audit, where patients with new adult-onset asthma had an 
occupation documented, a large minority of those (32%) was employed in a high-risk 
occupation with no demonstration of any further enquiry or action taken.  Indeed in the study 
by Hoyle et al. (2010) only 26% of patients with respiratory illnesses and exposed to 
asthmagens were referred for specialist opinion.  Given that healthcare professionals in 
primary care do not appear to lack motivations to identify occupational asthma, this suggests 
a deficit in occupational asthma subject knowledge, ignorance of occupational risk, and a lack 
of experience in assessing and managing patients with work-related asthma symptoms. 
 
7.6 Future direction 
Two simple questions (“Are your symptoms better on days away from work?” and “Are your 
symptoms better on holiday?”) have been validated for identifying cases of occupational 
asthma (Malo et al., 1991; Vandenplas et al., 2005), and they are recommended for use as 
screening questions for general physicians and in primary care (Fishwick et al., 2012; 
BOHRF, 2010a).  It is clear from this work that although they are not currently well used in 
primary care, these simple questions are easy to use and incorporate into existing patient 
management systems.  It is not yet known whether such a screening tool is clinically effective 
in primary care populations in terms of increasing case identification, reducing diagnostic 
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latency and improving health outcomes such as serial FEV1 decline.  Therefore in order to test 
such hypotheses, a randomized controlled clinical effectiveness trial in a primary care 
population is warranted.   
 
The poor response rate to the Internet based questionnaire limited the conclusions that could 
be drawn about healthcare workers’ barriers to diagnosing occupational asthma, as described 
above.  A number of strategies were employed to maximize response rate, and apart from 
occupational lung disease specialists who had a high rate of response (89%), this resulted in a 
disappointing response from other specialty groups of interest (3-16%).  Therefore rather than 
repeating the same experiment and expecting a better response rate, a different study design 
would be recommended to test the hypothesis that educational deficits amongst healthcare 
professionals are their most significant barriers to diagnosis.  Despite the purported evidence 
that both subject knowledge and clinical experience are low amongst generalist physicians, 
particularly GPs, it is not known whether the use of educational programmes to remedy 
deficiencies can lead to better guideline adherence in practice, increased case recognition, 
reduced latency to diagnosis and better health-related outcomes for workers.   
 
Workers’ beliefs about occupational asthma vary substantially: specifically how their 
symptoms are perceived, how they react to their presence, and subsequently how they behave 
and negotiate with healthcare professionals and employers.  It has been seen that lack of 
accurate understanding about asthma symptoms, lack of confidence or knowledge that 
symptom disclosure will effect a solution, and fear of financial loss from disclosure are all 
major barriers to diagnosis, and are likely to contribute to delayed diagnosis.  It is not known 
whether workplace interventions that focus on addressing workers’ variation in understanding 
of symptomatology, and their barriers to symptoms disclosure, can equip them with the 
knowledge and skills to reach a diagnosis with good health and employment outcomes.  This 
specifically needs urgent investigation. 
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7.7 Conclusion 
The burden from occupational asthma is a suitable and urgent target for intervention.  There 
are clearly significant financial and health costs for workers, and also great costs to the rest of 
society in the UK.  There is also a clear case for improving diagnosis, as there are significant 
delays that have been shown to lead to poor health and financial outcomes for the worker.  
Despite the availability of guidelines for healthcare professionals, valid tools for screening, 
and clear pathways to diagnosis, little progress has been made with respect to case 
recognition in working age populations, and a better understanding of the barriers to diagnosis 
will now enable design of targeted interventions to increase diagnosis.  Future interventions 
for healthcare professionals should focus on subject knowledge and management of the 
affected worker with occupational asthma symptoms, and this should start at undergraduate 
level for healthcare professionals with a clear theme through ongoing professional 
development.  For workers, any workplace intervention strategy should take into account the 
variation in their basic insights about asthma and asthma symptoms.   
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APPENDIX 1 
PATIENT INFORMATION SHEET VERSION 1.0; 16TH DECEMBER 2012 
 
Study Title:  Health-seeking behaviour of workers with occupational asthma   
symptoms 
 
Principal Investigator: Dr. Gareth Walters, Research Associate and Specialist 
Registrar, Occupational Lung Disease Unit, Heart of 
England NHS Foundation Trust 
 
Patient Information Sheet:   Version 1.0.  Date: 16th December 2012 
 
We would like to invite you to take part in our research study.  Before you decide we 
would like you to understand why the research is being done and what it might 
involve for you.  This information sheet explains the purpose and the conduct of this 
study and what will happen to you if you take part. One of our research team will go 
through the information sheet with you and answer any questions you might have.  
They can also you provide you with any additional information you might require.  
This should take about 15 minutes in total.    
 
Why are we doing the study? 
 
When asthma is caused by work we call that occupational asthma (OA).  There are 
many materials in the workplace that can cause asthma, and work is a common cause 
of new asthma symptoms (breathlessness, wheeze, cough and chest tightness) in 
adults in the UK.  However, there is often a long delay in the diagnosis of OA after 
symptoms start, and up to half of cases go undiagnosed. This is partly because the 
sufferer is reluctant to seek help from a healthcare professional.  It is not known why 
workers with asthma symptoms delay seeing a doctor or nurse, and so the aim of this 
study is to explore the reasons why that might be and find out which factors are more 
important. 
 
What sort of study are we going to undertake? 
 
We are planning to use a ‘qualitative method’ for the study.  This means that we will 
ask you questions about your asthma symptoms, your workplace and your GP and you 
can give any answer you wish.  When we look at the answers you give we will 
compare your answers with those of other participants and look for patterns (themes).  
We hope that when we put these together, they will tell us how workers think and 
behave when they develop asthma symptoms at work. 
 
What will happen to me if I take part? 
 
You would be invited to a 10- to 30-minute interview at the Occupational Lung 
Disease Unit, Heart of England NHS Trust with Dr. Gareth Walters (principal 
researcher).  You will be asked about your asthma symptoms, the effect on your work 
and the care you have received from your employer and from your GP.  There are no 
correct or incorrect answers and so we would value any responses that you give to 
questions.  You do not have to answer every question if you don’t wish to.  We will 
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record the interview with a Dictaphone (handheld digital audio recording device).  
You will then be free to leave and we will analyze a transcript of the answers that you 
give, in order to look for themes.   
 
Why have I been invited? 
 
We have invited you because you are a worker with asthma symptoms and there is a 
possibility you might have OA.  Therefore we are interested in how you came to seek 
help for your condition, and the relationship you had with your employer and your 
doctor when the symptoms started. 
 
Do I have to take part? 
 
No, you can decide not to take part if you don’t want to.  This won’t affect your 
routine care in any way.  
 
What are the possible disadvantages and risks of taking part? 
 
Some patients feel anxious when talking about their own health problems or how their 
asthma symptoms affect their work.  Some patients feel uncomfortable when talking 
about relationships with their employer or GP, for fear of their opinions being 
reported back to either party.  However we would not tell your GP or employer about 
your participation in the research.  There are no monetary payments for you for taking 
part in the study. 
 
What are the possible benefits of taking part? 
 
This study is looking at the process of diagnosis and so there is no intended benefit to 
your health from taking part.  Taking part in this research would not change your 
routine NHS care in any way at all.   Some participants may feel they have a better 
understanding of OA, merely by taking part in the research and thinking about their 
own health. 
 
Will my taking part in the study be kept confidential? 
 
Yes, Dr. Gareth Walters will code your data so that your personal details are removed 
and you can’t be identified. If you make reference to a particular workplace or GP 
practice in your responses to questions, these will also be removed when the recording 
is transcribed.  The data will be stored securely at the Heart of England NHS Trust, 
and then archived following Trust guidelines once the study is completed.  The only 
people who will have access to your data are members of the research team.  
 
Will you tell my GP about the answers I gave to study questions? 
 
No, we would not tell your GP either that you are participating in the study, or about 
the responses you give to questions.   If you particularly wanted us to inform your GP 
about your participation then we would do so in writing.  The specialist doctor 
responsible for your care at the Occupational Lung Disease Unit would know about 
your participation in the study, but only the principal researcher (Dr. Gareth Walters) 
would be able to identify you, as your details are anonymized.   
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Will you tell my employer about the study? 
 
No, we would not communicate with your employer, either about your participation, 
or about the responses you give to questions 
 
What will happen to the results of the study? 
 
We will send you a summary of the results if you wish.  This will be a detailed 
account of the anonymized responses from all the participants.  We also intend to 
publish the results of the research in a peer-reviewed medical journal.  Your personal 
details would not be identified in any publication or communication.   
 
Who is organizing the research? 
 
The research is being organized through the Heart of England NHS Foundation Trust, 
of which the Birmingham Chest Clinic and Occupational Lung Disease clinic is a 
part.  
 
What will happen if I wish to take part? 
 
If you agree to take part, Dr. Gareth Walters will check your understanding and ask 
you to sign a consent form.  You will also be given a copy of this to keep for your 
own records. 
 
What will happen if I don’t want to carry on with the study? 
 
You may decide you do not wish to participate in the study at all.  Also, if you do 
decide to take part, you are then free to change your mind at any point during the 
study and withdraw your consent.   No further information for the study would be 
sought after this point.  Be assured that this will not affect your routine NHS care in 
any way. 
 
Further information and contact details 
 
Further information about the study can be found by contacting the principal 
investigator: 
 
Principal Investigator: Dr. Gareth Walters MB ChB MRCP (UK), Specialist 
Registrar in Respiratory Medicine, at the Occupational Lung Disease clinic, 
Birmingham Chest Clinic, 151 Great Charles Street, Birmingham, B3 3HX  
  More information 
for patients about clinical research can be found on the National Institute for Health 
Research website at http://www.crncc.nihr.ac.uk/. 
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APPENDIX 2 
CONSENT FORM VERSION 1.0; 16TH DECEMBER 2012 
 
       
Study Title: Health-seeking behaviour of workers with occupational asthma symptoms 
 
Principal Investigator: Dr. Gareth Walters MRCP BSc (Hons.) 
   Specialist Registrar in Respiratory Medicine 
   Heart of England NHS Foundation Trust 
 
 
Participant Identification Number for this study: 
 
 
 
 
I have had time to read the Patient Information Sheet and I understand it.    
 
 
The study has been fully explained to me and my questions about it have been 
answered. 
 
 
I understand what the study involves and what I am expected to do. 
 
 
I am willing to allow access to my medical records for the purposes of the study.   
However, I understand that personal details, such as my name or address will not be 
published. 
 
I am free to stop being in the study at any time. If I wish to stop, this will not affect 
the quality of care that I receive in the future. 
 
 
I understand that the Heart of England NHS Trust will keep my data in accordance 
with principles of confidentiality and ethical research set out for the NHS. 
 
 
I agree to take part in the above named study. 
 
 
 
 
            
Name of Patient   Signature   Date 
 
 
            
Researcher   Signature   Date 
 
 
 
1 copy for medical notes; 1 copy for site file; 1 copy for patient.  
 
Please initial 
box 
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APPENDIX 3 
SEMI-STRUCTURED INTERVIEW SCHEDULE VERSION 2.0; 18/07/2013 
 
Demographics  
How old are you please? 
How long have you been working for your current employer? 
When were you diagnosed with occupational asthma? 
 
Patient’s understanding of their symptoms 
When did you first realize you had problems with your breathing?   
What symptoms or problems did you notice that caused you concern?  
Did you understand that the symptoms might be asthma?   
(If not) Prompt: What did you think the symptoms might represent? Did you think that the 
symptoms might represent a disease? 
Did you see a pattern between the symptoms and your work? 
Did you think that work might be causing your symptoms? 
 
Patient’s initial response to symptoms 
What course of action did you take when you first noticed your symptoms?  
Did you take time off work or did you continue at work whilst having symptoms?  
Prompt: Could you justify why you decided this? Why did you continue at work? 
Did you seek any help either at work, from health and safety or from your General Practitioner or other 
health care professional with your symptoms initially? 
When did you first seek medical assistance? 
Was there a distinct event (illness event) that caused you to seek help? 
 
The General Practitioner and occupational asthma 
How long have you known your General Practitioner / Practice Nurse? 
Can you describe your relationship with them? 
 Prompt: Do you trust them? 
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 Prompt: Do you feel able to share information with them? 
Did they ask you about your job and the effect of work on your symptoms? 
Did they make the link between work and your symptoms? 
Did they make a diagnosis from your symptoms? 
What actions resulted from consulting your General Practitioner? 
 Prompt: Did your General Practitioner communicate with the specialist? 
 
Social structure and occupational asthma 
Were there people or factors that helped you seek a diagnosis?  
Prompt: Do you have family, relatives or close friend that you spoke with about your 
symptoms? 
Is there any one in particular that you have shared your diagnosis or problems with? If so, why? 
Are there any colleagues at work who you could share it with and why? 
Are there any colleagues at work you wouldn’t share it with and why? 
 
The employer and occupational asthma 
Do your employers know about your occupational asthma? 
Did they have any input into diagnosing your symptoms? 
Did you communicate with them about the symptoms before your diagnosis of occupational asthma?  
(If not) Prompt: If not, why not? 
(If so) Prompt: If so, how did you find their reaction, and how did that make you feel about 
your symptoms? 
Prompt: Did you feel that your doctor (Occupational Health Professional, General 
Practitioner, medical specialists) communicated well with you? 
Do you feel that there was good communication between all parties involved in your care? 
Did you think that there was delay in the process of diagnosis? 
 Prompt: If so, where do you think that was? 
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APPENDIX 4 
QUESTIONNAIRE DOMAINS: BELIEFS AND ATTITUDES HYPOTHESIZED TO BE 
BARRIERS TO IDENTIFYING OCCUPATIONAL ASTHMA ON THE PART OF THE 
HEALTHCARE WORKER 
 
Knowledge and experience 
 Awareness of occupational asthma 
 Disease-specific declarative knowledge for occupational asthma 
 Knowledge of work processes and occupations 
 Procedural knowledge on screening and diagnosing occupational asthma 
 Knowledge and experience in managing cases of occupational asthma 
 Awareness of guidelines for occupational asthma 
 
Attitudes 
 Perceived confidence in clinical diagnosis of occupational asthma 
 Perceived confidence in managing cases of occupational asthma 
 Perceived importance of a diagnosis of occupational asthma 
 Perceived prevalence of occupational asthma 
 Outcome expectancy (benefit to patients) 
 Inertia (internal motivation, changing habits) 
 
External barriers 
 Guideline-related (clarity, complexity, access) 
 Time pressure with existing routines (complexity, occupational history) 
 Access to specialist services 
 Reimbursement 
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APPENDIX 5 
FINAL QUESTIONNAIRE VERSION 1.0; 5TH FEBRUARY 2013 
 
Questionnaire title: Wheezy while you work 
“This is a short anonymous questionnaire for healthcare professionals who attend to adult 
asthmatics of working-age in their clinical practice.  It will take you 3- 5 minutes to complete.  
All questions are multiple choice in nature, and there is an opportunity for open comment at 
the end.  You may also choose to go on and complete an optional case study of a worker with 
asthma after the questionnaire” 
 
I see asthmatic patients of working age (16-64 years old) in my clinical practice? 
Yes       /        No 
Participants who answer ‘No’ do not need to continue with the questionnaire, and are 
forwarded to a page that thanks them for their participation, and says ‘As you do not see 
working-age asthmatic patients in your clinical practice, you do not need to continue with the 
questionnaire’.  Those who answer yes continue to the rest of the questionnaire below: 
 
Please respond to the following statements, by circling the response that best reflects how 
you feel: 
 
I ask them about the nature of their work? [Likert response] 
Strongly Agree        Agree Neither agree nor disagree   Disagree   Strongly 
disagree 
I ask them about the effects of work on their asthma symptoms? [Likert] 
I think it is important to recognize when work is the cause of asthma symptoms [Likert] 
I feel confident to screen patients for occupational asthma based on their clinical history 
[Likert] 
I have sufficient knowledge of patients’ work practices to screen for occupational 
asthma [Likert] 
I feel confident to make a diagnosis of occupational asthma [Likert] 
I have access to specialist input for occupational asthma when I feel I need it [Likert] 
I am aware of clinical guidelines for assessing patients with suspected occupational 
asthma [Likert] 
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I follow occupational asthma guidelines when assessing a working-age asthmatic 
[Yes/No] 
 [If answer Yes only: Which guidelines do you use?   SIGN-BTS;   BOHRF-BTS;  ERS] 
I lack the time to screen asthmatic patients for occupational asthma [Likert] 
I have no incentive to screen asthmatic patients for occupational asthma [Likert] 
I am not motivated to screen patients for occupational asthma [Likert] 
I have experience of managing cases of suspected occupational asthma in my clinical 
practice [Likert] 
A diagnosis of occupational asthma can improve patient outcomes [Likert] 
Do you wish to comment on anything here? (Leave blank if not) [Blank box for 
comments] 
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A little bit about you, please respond to the following statements 
You are a…          Nurse     /     Doctor 
[…If answer ‘doctor’ What grade of doctor are you? (pick the answer that best fits) 
Foundation / SHO level;       Registrar / ST3+ / Staff grade;         GP / Consultant / Associate specialist] 
You are…             Male     /     Female 
How many years clinical experience do you have? [open question] 
Which area do you work in mainly? (Pick the answer that best fits) 
General Practice;     General Practice + Occupational Medicine sessions;     Occupational Medicine 
General Hospital Medicine;      Respiratory Medicine (ie. Chest physician or Respiratory Specialist Nurse) 
 
“Thank you for your responses, we are very grateful for your participation.  You can finish 
here, or you can go on and complete an optional case study about a 42-year old bakery worker 
with asthma symptoms.  Obviously we would like you to complete the case study if you have 
the time.  Once you have read the case, there are some multiple choice questions to answer.  It 
will take another 3-5 minutes of your time” 
I wish to complete the case study  Yes    / No 
Those answering ‘no’ finish the questionnaire at this point. 
Those answering ‘yes’ are taken to the case study and greeted with the phrase: ‘Please read 
the following short case study and answer the questions’.   
The participant is randomised to one of the four case studies, but all participants receive the 
same multiple-choice questions that follow. 
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CASE STUDY: SCENARIO 1 = SW; strong work, weak non-work (definite occupational 
asthma) 
 
A 42-year old man comes to see you in your clinic complaining of intermittent wheeze and 
shortness of breath.  This has come on gradually over the last 12 weeks.  He has noticed that 
on some nights he will wake up and feels short of breath, and he has a discomfort in his chest 
when he plays football on a cold morning.  He has noticed that his symptoms tend to improve 
at weekends.  He has also noticed that he tends to get a runny nose while he is at work.  At 
first he thought this was due to a cold but he has not really had any other symptoms to suggest 
this.  Examination, including chest examination, is essentially normal.  
 
You send him for pulmonary function testing which shows an FEV1 3.14L (75% predicted) 
and FVC 5.09L (98% predicted), FEV1/FVC ratio=62%. Post-bronchodilator his FEV1 is 
4.11L (an increase of 31%).   His Peak expiratory flow pre-bronchodilator is 8.34L/sec (90% 
predicted) and post-bronchodilator is 10.33L/sec (an increase of 24%).  He also has a positive 
methacholine test (non-specific bronchial reactivity) with a PC20 of 0.88 mg/ml.   
 
He currently works as a baker in the bakery department of a local superstore.  This involves 
him in mixing and preparing raw ingredients for the products to be baked, then putting the 
mixed ingredients into baking tin or on a baking tray.  The job is quite dusty at times.  
Another person will then usually do the baking of the products and take them out to be put on 
display.  He also helps with cleaning.  He has done this job for about 6 months.  Prior to this 
he has had a number of other jobs in the catering and food preparation industry but this is his 
first time working as a baker. 
 
He has no previous history of chest problems or other illnesses in the past.  Nobody in the 
family has any problems with previous chest problems or allergies that he is aware of.  He has 
never smoked regularly.  When talking with the other people at work he has been told that the 
person who previously did his job had to leave because of similar problems.  The patient feels 
his current problems are caused by work and wants your advice. 
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CASE STUDY: SCENARIO 2 = SS; strong work, strong non-work (intermediate probability 
occupational asthma) 
 
A 42-year old man comes to see you in your clinic complaining of intermittent wheeze and 
shortness of breath.  This has come on gradually over the last 12 weeks.  He has noticed that 
on some nights he will wake up and feels short of breath, and he has a discomfort in his chest 
when he plays football on a cold morning.  He has noticed that his symptoms tend to improve 
at weekends.  He has also noticed that he tends to get a runny nose while he is at work.  At 
first he thought this was due to a cold but he has not really had any other symptoms to suggest 
this.  Examination, including chest examination, is essentially normal. 
 
You send him for pulmonary function testing which shows an FEV1 3.14L (75% predicted) 
and FVC 5.09L (98% predicted), FEV1/FVC ratio=62%. Post-bronchodilator his FEV1 is 
4.11L (an increase of 31%).   His Peak expiratory flow pre-bronchodilator is 8.34L/sec (90% 
predicted) and post-bronchodilator is 10.33L/sec (an increase of 24%).  He also has a positive 
methacholine test (non-specific bronchial reactivity) with a PC20 of 0.88 mg/ml.   
 
He currently works as a baker in the bakery department of a local superstore.  This involves 
him in mixing and preparing raw ingredients for the products to be baked, then putting the 
mixed ingredients into a baking tin or on a baking tray.  The job is quite dusty at times.  
Another person will then usually do the baking of the products and take them out to be put on 
display.  He also helps with cleaning.  He has done this job for about 6 months.  Prior to this 
he has had a number of other jobs in the catering and food preparation industry but this is his 
first time working as a baker. 
 
He did have asthma as a child and he thinks his current symptoms feel similar to that, 
although he has not been troubled with chest symptoms since he was 10 or 11.  He has also 
had hay fever intermittently since he was a child and this has been a little more noticeable in 
the last 3 or 4 years.  He has two brothers and two sisters, and one of his brothers has asthma, 
one sister has hay fever.  He has two children, one of whom has asthma.  He smoked between 
the ages of 18 and 35 approximately one pack of cigarettes a day.  When talking with the 
other people at work he has been told that the person who previously did his job had to leave 
because of similar problems.  The patient feels his current problems are caused by work and 
wants your advice. 
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CASE STUDY: SCENARIO 3 = WW; weak work, weak non-work (intermediate probability 
occupational asthma) 
 
A 42-year old man comes to see you in your clinic complaining of intermittent wheeze and 
shortness of breath.  This has been worse over the last 12 weeks, but has probably been 
present for about 18 months.  He has noticed that on some nights he will wake up and feels 
short of breath, and he has a discomfort in his chest when he plays football on a cold morning.  
He has not noticed any real improvement at weekends or while on holiday.  Examination, 
including chest examination, is essentially normal. 
 
You send him for pulmonary function testing which shows an FEV1 3.14L (75% predicted) 
and FVC 5.09L (98% predicted), FEV1/FVC ratio=62%. Post-bronchodilator his FEV1 is 
4.11L (an increase of 31%).   His Peak expiratory flow pre-bronchodilator is 8.34L/sec (90% 
predicted) and post-bronchodilator is 10.33L/sec (an increase of 24%).  He also has a positive 
methacholine test (non-specific bronchial reactivity) with a PC20 of 0.88 mg/ml.   
 
He currently works behind the bakery counter of a local superstore dealing with customers.  
He is not involved in baking bread or other bakery products as these arrive at the store pre-
prepared and cooked.  He also helps with cleaning.  He has done this job for about 6 months.  
Prior to this he has had a number of other jobs in the catering and food preparation industry 
but this is his first time working in a bakery. 
 
He has no previous history of chest problems or other illnesses in the past.  Nobody in the 
family has any problems with previous chest problems or allergies that he is aware of.  He has 
never smoked regularly.  None of his colleagues at work have noticed any problems with dust 
or had similar symptoms.  The patient feels his current problems are caused by work and 
wants your advice. 
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CASE STUDY: SCENARIO 4 = WS; weak work, strong non-work (definitely not 
occupational asthma) 
 
A 42-year old man comes to see you in your clinic complaining of intermittent wheeze and 
shortness of breath.  This has been worse over the last 12 weeks, but has probably been 
present for about 18 months.  He has noticed that on some nights he will wake up and feels 
short of breath, and he has a discomfort in his chest when he plays football on a cold morning.  
He has not noticed any real improvement at weekends or while on holiday.  Examination, 
including chest examination, is essentially normal. 
 
You send him for pulmonary function testing which shows an FEV1 3.14L (75% predicted) 
and FVC 5.09L (98% predicted), FEV1/FVC ratio=62%. Post-bronchodilator his FEV1 is 
4.11L (an increase of 31%).   His Peak expiratory flow pre-bronchodilator is 8.34L/sec (90% 
predicted) and post-bronchodilator is 10.33L/sec (an increase of 24%).  He also has a positive 
methacholine test (non-specific bronchial reactivity) with a PC20 of 0.88 mg/ml.   
 
He currently works behind the bakery counter of a local superstore dealing with customers.  
He is not involved in baking bread or other bakery products as these arrive at the store pre-
prepared and cooked.  He also helps with cleaning.  He has done this job for about 6 months.  
Prior to this he has had a number of other jobs in the catering and food preparation industry 
but this is his first time working in a bakery. 
 
He did have asthma as a child and he thinks his current symptoms feel similar to that, 
although he has not been troubled with chest symptoms since he was 10 or 11.  He has also 
had hay fever intermittently since he was a child and this has been a little more noticeable in 
the last 3 or 4 years.  He has two brothers and two sisters, and one of his brothers has asthma, 
one sister has hay fever.  He has two children, one of whom has asthma.  He smoked between 
the ages of 18 and 35 approximately one pack of cigarettes a day.  None of his colleagues at 
work have noticed any problems with dust or had similar symptoms.  The patient feels his 
current problems are caused by work and wants your advice. 
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Questions for all case studies 
Do you think that the diagnosis is occupational asthma?  [Likert] 
Strongly Agree        Agree Neither agree nor disagree   Disagree   Strongly disagree 
How confident are you? [Likert] 
Very confident  Confident   Somewhat confident             Unsure  Very unsure 
Would you refer this case to a specialist in occupational lung diseases? 
Yes     /     No  /     I am a specialist in OLD 
 
Which of the following factors was important in contributing to your decision that this was or was not 
a work-related illness? 
Your understanding of the nature of his work? [Likert] 
Not at all important Low importance       Neutral      Somewhat important      Extremely important 
The timing of onset of symptoms in relation to work [Likert] 
His report that other workers were affected or not [Likert] 
His belief about whether the illness was work-related or not [Likert] 
The presence or absence of other potential causes and risk factors outside work [Likert] 
Do you wish to comment on anything here? (Leave blank if not) [open question] 
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APPENDIX 6 
 
INVITATION LETTER VERSION 2.0; 13TH MAY 2013 
 
Invitation letter to participants for the study: 
ǲWhat are the barriers to the identification of occupational asthma by the healthcare 
professional?ǳ 
 
Dear Colleague, 
 
I am a Respiratory Medicine Specialist Registrar in the West Midlands and a Research Associate at the 
Institute of Occupational and Environmental Medicine, University of Birmingham. I am undertaking this 
study as part of my doctoral research at the Institute, and would be very grateful if you could take 5 
minutes to complete an online questionnaire concerning your clinical practice with working-age 
asthmatic patients.  Your responses do not require you to enter personal details, beyond your age and 
current professional role, and results will be linked anonymously and automatically to a database for 
analysis.  In addition to appearing in my thesis, results will be disseminated by publication in a peer-
reviewed journal. 
 
The study can be accessed online via the following link:  
https://www.surveymonkey.com/s/Wheezy 
The questionnaire contains a number of statements, each of which is followed by a list of potential 
responses that reflect how you might feel about the statement. You will generally be required to pick one 
from the list. There are opportunities for more open-ended answers as well.  There is no obligation for 
you to complete all of the questions, give open-ended answers, or indeed undertake the questionnaire at 
all if you do not wish to.  There is also an optional case scenario with associated questions that you will be 
invited to complete at the end of the study. 
 
Local R&D approval for the study has been granted by Heart of England NHS Foundation Trust Research 
and Development Directorate (R&D Code: 2013013RM).  If you have any questions I can be contacted by 
email at gareth.walters@heartofengland.nhs.uk.  The British Occupational Health Research Foundation 
produces guidance for health professionals on work-related asthma, and this guidance can be found 
online at: http://www.bohrf.org.uk/projects/asthma.html.  More general information about the effect of 
work on asthma symptoms can be found at www.occupationalasthma.com. 
 
Thank you in anticipation, 
Dr. Gareth Walters MRCP(UK);  Specialist Registrar and Research Associate, University of Birmingham 
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APPENDIX 7 
TEXT INSERT VERSION 1.0; 16TH MAY 2013 
 
Calling all West Midlands physicians who see working-age patients with asthma in their clinical practice!  
I would like you to take 3-5 minutes to complete an anonymous online survey about your practice with 
working-age asthmatic patients please.  There is also an optional case study after the survey.  It is part of my 
research into occupational asthma at the Institute of Occupational and Environmental Medicine, University of 
Birmingham, and the survey will also be going to other physicians, nurses and GPs as well as their trainees 
elsewhere in the UK.  The study is sponsored by the Heart of England NHS Foundation Trust, and the study can 
be accessed online via the following link:  
https://www.surveymonkey.com/s/Wheezy 
 
Thank you in great anticipation 
Gareth Walters 
SpR and Research Associate Respiratory Medicine,  
Heart of England NHS Foundation Trust 
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APPENDIX 8: Q1-Q14 RESPONSES BY SPECIALTY 
 
Table A1.  Responses to questions regarding healthcare professionals’ practice with working-age asthmatics, grouped by medical specialty.  SA=strongly agree; 
A=agree; N=neither agree nor disagree; D=disagree; SD=strongly disagree.  Analyses of variance measured using non-parametric Kruskal-Wallis tests, 
significance measured at the 95% confidence level.   
 
Doctors Nurses 
 
 
General 
Practice; 
n=62 
 
General Practice 
undertaking OH 
sessions; 
n=14 
Occupational 
Medicine; 
n=123 
General 
Hospital 
Medicine; 
n=96 
Respiratory 
Medicine; 
n=82 
Occupational 
Lung Disease 
specialists; 
n=17 
Analysis of 
variance 
Practice 
nurses; 
n=127 
Occupational 
health nurses; 
n=11 
Hospital 
respiratory nurse 
specialists; 
n=68 
Analysis of 
variance 
Q1. Asks about 
the nature of a 
patient’s work 
SA 
A 
N 
D 
SD 
21 (34) 
35 (57) 
2 (3) 
4 (6) 
0 (0) 
8 (57) 
6 (43) 
0 (0) 
0 (0) 
0 (0) 
109 (89) 
14 (11) 
0 (0) 
0 (0) 
0 (0) 
24 (25) 
55 (57) 
9 (9) 
5 (5) 
3 (3) 
50 (61) 
30 (37) 
1 (1) 
1 (1) 
0 (0) 
17 (100) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 81 (64) 
41 (32) 
4 (3) 
1 (1) 
0 (0) 
9 (82) 
2 (18) 
0 (0) 
0 (0) 
0 (0) 
55 (81) 
13 (19) 
0 (0) 
0 (0) 
0 (0) 
p=0.03 
Q2. Asks about 
the effects of 
work a patient’s 
asthma 
symptoms 
SA 
A 
N 
D 
SD 
13 (21) 
35 (56) 
8 (13) 
6 (10) 
0 (0) 
5 (36) 
8 (57) 
1 (7) 
0 (0) 
0 (0) 
103 (84) 
19 (15) 
1 (1) 
0 (0) 
0 (0) 
9 (9) 
44 (46) 
24 (25) 
17 (18) 
2 (2) 
37 (45) 
40 (49) 
4 (5) 
1 (1) 
0 (0) 
17 (100) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 68 (54) 
50 (39) 
8 (6) 
1 (1) 
0 (0) 
9 (82) 
2 (18) 
0 (0) 
0 (0) 
0 (0) 
46 (68) 
22 (32) 
0 (0) 
0 (0) 
0 (0) 
p=0.02 
Q3. Thinks it is 
important to 
recognize when 
work is the 
cause of asthma 
SA 
A 
N 
D 
SD 
38 (61) 
23 (37) 
1 (2) 
0 (0) 
0 (0) 
10 (71) 
4 (29) 
0 (0) 
0 (0) 
0 (0) 
115 (94) 
9 (6) 
0 (0) 
0 (0) 
0 (0) 
48 (50) 
48 (50) 
0 (0) 
0 (0) 
0 (0) 
65 (79) 
16 (20) 
1 (1) 
0 (0) 
0 (0) 
17 (100) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 95 (75) 
32 (25) 
0 (0) 
0 (0) 
0 (0) 
10 (91) 
1 (9) 
0 (0) 
0 (0) 
0 (0) 
58 (85) 
10 (15) 
0 (0) 
0 (0) 
0 (0) 
p=0.006 
Q4. Feels 
confident to 
screen for 
occupational 
asthma based 
on history 
SA 
A 
N 
D 
SD 
9 (15) 
30 (48) 
13 (21) 
9 (14) 
1 (2) 
4 (29) 
7 (50) 
1 (7) 
2 (14) 
0 (0) 
73 (59) 
40 (33) 
8 (6) 
2 (2) 
0 (0) 
7 (7) 
47 (49) 
24 (25) 
17 (18) 
1 (1) 
26 (32) 
39 (48) 
11 (13) 
6 (7) 
0 (0) 
16 (94) 
1 (6) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 14 (11) 
59 (47) 
31 (24) 
21 (16) 
2 (2) 
8 (73) 
2 (18) 
1 (9) 
0 (0) 
0 (0) 
17 (25) 
32 (47) 
11 (16) 
7 (10) 
1 (2) 
p=0.001 
Has sufficient SA       Kruskal-    Kruskal-
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Table A1 continued.  Q5 to Q10.    
 
 
 
  
Q5. Has 
sufficient 
knowledge to 
screen for 
occupational 
asthma 
SA 
A 
N 
D 
SD 
4 (7) 
15 (24) 
25 (40) 
15 (24) 
3 (5) 
4 (29) 
6 (43) 
3 (21) 
0 (0) 
1 (7) 
79 (64) 
33 (27) 
10 (8) 
1 (1) 
0 (0) 
5 (5) 
27 (28) 
30 (31) 
33 (34) 
1 (1) 
13 (16) 
32 (39) 
27 (33) 
10 (12) 
0 (0) 
13 (76) 
3 (18) 
1 (6) 
0 (0) 
0 (0) 
p<0.001 5 (4) 
53 (42) 
31 (24) 
33 (26) 
5 (4) 
8 (73) 
3 (27) 
0 (0) 
0 (0) 
0 (0) 
11 (16) 
30 (44) 
16 (24) 
10 (15) 
1 (1) 
p<0.001 
Q6. Feels 
confident to make 
a diagnosis of 
occupational 
asthma 
SA 
A 
N 
D 
SD 
6 (10) 
18 (29) 
20 (32) 
15 (24) 
3 (5) 
3 (21) 
8 (57) 
1 (7) 
1 (7) 
1 (7) 
50 (41) 
52 (42) 
16 (13) 
4 (3) 
1 (1) 
5 (5) 
25 (26) 
30 (31) 
35 (37) 
1 (1) 
12 (15) 
37 (45) 
25 (30) 
8 (10) 
0 (0) 
14 (82) 
3 (18) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 6 (5) 
35 (27) 
28 (22) 
48 (38) 
10 (8) 
0 (0) 
4 (36) 
1 (9) 
5 (46) 
1 (9) 
9 (13) 
25 (37) 
17 (25) 
14 (21) 
3 (4) 
p=0.023 
Q7. Has access to 
specialist input 
for occupational 
asthma 
SA 
A 
N 
D 
SD 
9 (15) 
30 (48) 
8 (13) 
11 (18) 
4 (6) 
3 (21) 
7 (50) 
1 (7) 
2 (14) 
1 (7) 
79 (64) 
34 (28) 
5 (4) 
5 (4) 
0 (0) 
17 (18) 
38 (40) 
27 (28) 
13 (13) 
1 (1) 
39 (48) 
26 (32) 
8 (10) 
9 (11) 
0 (0) 
15 (88) 
1 (6) 
0 (0) 
1 (6) 
0 (0) 
p<0.001 34 (27) 
43 (34) 
21 (16) 
25 (20) 
4 (3) 
6 (55) 
4 (36) 
0 (0) 
1 (9) 
0 (0) 
30 (44) 
16 (24) 
8 (12) 
13 (19) 
1 (1) 
p=0.13 
Q8. Is aware of 
clinical 
guidelines for 
occupational 
asthma 
SA 
A 
N 
D 
SD 
9 (14) 
28 (45) 
7 (11) 
14 (23) 
4 (7) 
5 (36) 
6 (43) 
1 (7) 
0 (0) 
2 (14) 
81 (66) 
36 (29) 
4 (3) 
2 (2) 
0 (0) 
4 (4) 
14 (15) 
17 (18) 
57 (59) 
4 (4) 
23 (28) 
36 (44) 
12 (15) 
11 (13) 
0 (0) 
17 (100) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
p<0.001 25 (20) 
65 (51) 
19 (15) 
15 (12) 
3 (2) 
5 (45) 
6 (55) 
0 (0) 
0 (0) 
0 (0) 
23 (34) 
34 (50) 
5 (7) 
6 (9) 
0 (0) 
p=0.009 
Q10. Lacks time 
to screen for 
occupational 
asthma 
SA 
A 
N 
D 
SD 
6 (10) 
20 (32) 
12 (19) 
22 (36) 
2 (3) 
0 (0) 
5 (36) 
3 (21) 
5 (36) 
1 (7) 
1 (1) 
10 (8) 
17 (14) 
59 (48) 
36 (29) 
4 (4) 
23 (24) 
25 (26) 
42 (44) 
2 (2) 
2 (2) 
15 (18) 
21 (26) 
36 (44) 
8 (10) 
0 (0) 
1 (6) 
1 (6) 
5 (29) 
10 (59) 
p<0.001 4 (3) 
48 (38) 
30 (24) 
39 (31) 
6 (5) 
0 (0) 
1 (9) 
1 (9) 
6 (55) 
3 (27) 
3 (4) 
15 (22) 
14 (21) 
30 (44) 
6 (9) 
p=0.009 
Lacks time to SA 6 (10) 0 (0) 1 (1) 4 (4) 2 (2) 0 (0) p<0.001 4 (3) 0 (0) 3 (4) p=0.009 
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Table A1 continued.  Q11 to Q14.  
 
Q11. Has no 
incentive to 
screen for 
occupational 
asthma 
SA 
A 
N 
D 
SD 
2 (3) 
11 (18) 
12 (19) 
27 (44) 
10 (16) 
0 (0) 
5 (36) 
2 (14) 
4 (29) 
3 (21) 
1 (1) 
0 (0) 
7 (6) 
37 (30) 
77 (63) 
2 (2) 
15 (16) 
23 (24) 
51 (53) 
5 (5) 
1 (1) 
3 (4) 
12 (15) 
42 (51) 
24 (29) 
1 (6) 
0 (0) 
0 (0) 
3 (18) 
13 (76) 
p<0.001 2 (2) 
10 (8) 
23 (18) 
58 (45) 
34 (27) 
0 (0) 
0 (0) 
2 (18) 
4 (36) 
5 (46) 
2 (3) 
2 (3) 
11 (16) 
29 (43) 
24 (35) 
p=0.26 
Q12. Is not 
motivated to 
screen for 
occupational 
asthma 
SA 
A 
N 
D 
SD 
1 (2) 
4 (6) 
11 (18) 
30 (48) 
16 (26) 
0 (0) 
2 (14) 
2 (14) 
4 (29) 
6 (43) 
3 (2) 
3 (2) 
4 (3) 
35 (29) 
78 (63) 
1 (1) 
9 (9) 
22 (23) 
53 (55) 
11 (12) 
0 (0) 
1 (1) 
8 (10) 
43 (52) 
30 (37) 
0 (0) 
0 (0) 
0 (0) 
1 (6) 
16 (94) 
p<0.001 1 (1) 
7 (5) 
10 (8) 
65 (51) 
44 (35) 
0 (0) 
0 (0) 
2 (18) 
4 (36) 
5 (46) 
0 (0) 
2 (3) 
5 (7) 
34 (50) 
27 (40) 
p=0.26 
Q13. Has 
experience of 
managing cases 
of suspected 
occupational 
asthma 
SA 
A 
N 
D 
SD 
6 (10) 
17 (27) 
9 (14) 
24 (39) 
6 (10) 
3 (23) 
6 (46) 
1 (8) 
2 (15) 
1 (8) 
54 (44) 
51 (41) 
7 (6) 
6 (5) 
5 (4) 
6 (6) 
19 (20) 
18 (19) 
45 (47) 
8 (8) 
10 (12) 
35 (43) 
19 (23) 
15 (18) 
3 (4) 
13 (76) 
2 (12) 
0 (0) 
1 (6) 
1 (6) 
p<0.001 11 (9) 
51 (40) 
21 (17) 
32 (25) 
11 (9) 
3 (27) 
8 (73) 
0 (0) 
0 (0) 
0 (0) 
6 (9) 
31 (46) 
18 (26) 
11 (16) 
2 (3) 
p=0.005 
Is not motivated SA       Kruskal-    Kruskal-Q14. A diagnosis 
of occupational 
asthma can 
improve patient 
outcomes 
A 
N 
D 
SD 
31 (50) 
25 (40) 
5 (8) 
0 (0) 
1 (2) 
9 (64) 
5 (36) 
0 (0) 
0 (0) 
0 (0) 
72 (59) 
35 (29) 
6 (5) 
1 (1) 
7 (6) 
34 (35) 
58 (60) 
4 (4) 
0 (0) 
0 (0) 
45 (56) 
31 (38) 
3 (4) 
1 (1) 
1 (1) 
15 (88) 
1 (6) 
1 (6) 
0 (0) 
0 (0) 
p=0.004 
 
55 (44) 
55 (44) 
12 (10) 
0 (0) 
2 (2) 
3 (27) 
7 (64) 
0 (0) 
1 (9) 
0 (0) 
34 (51) 
27 (40) 
3 (4) 
0 (0) 
3 (5) 
p=0.54 
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APPENDIX 9:  FACTORS CONTRIBUTING TO ATTRIBUTION OF OCCUPATIONAL 
CAUSATION 
 
 Overall; 
n=298 
GPs GP with 
sessions in 
OH 
Occupational 
medicine 
General 
hospital 
medicine 
Respiratory 
medicine 
OLD 
specialist 
Analysis of 
variance 
Your 
understanding 
of the nature of 
his work 
NAAI 
LI 
N 
SI 
EI 
0 (0) 
1 (0) 
13 (4) 
76 (26) 
208 (70) 
0 (0) 
1 (2) 
1 (2) 
11 (24) 
32 (71) 
0 (0) 
0 (0) 
0 (0) 
2 (18) 
9 (82) 
0 (0) 
0 (0) 
2 (2) 
12 (12) 
87 (86) 
0 (0) 
0 (0) 
6 (9) 
30 (44) 
32 (47) 
0 (0) 
0 (0) 
4 (7) 
18 (32) 
34 (61) 
0 (0) 
0 (0) 
0 (0) 
3 (18) 
14 (82) 
p<0.001 
1Mean statistic 
(min=1; max=5; 
SD) 
4.6 
(0.58) 
4.6 
(0.65) 
4.8 (0.40) 4.8 (0.42) 4.4 (0.65) 4.5 (0.63) 4.8 
(0.63) 
The timing of 
onset of 
symptoms in 
relation to work 
NAAI 
LI 
N 
SI 
EI 
1 (0) 
1 (0) 
8 (3) 
68 (23) 
220 (74) 
0 (0) 
0 (0) 
2 (4) 
12 (27) 
31 (69) 
0 (0) 
0 (0) 
1 (9) 
0 (0) 
10 (91) 
1 (1) 
1 (1) 
1 (1) 
26 (26) 
72 (71) 
0 (0) 
0 (0) 
2 (3) 
17 (25) 
49 (72) 
0 (0) 
0 (0) 
1 (2) 
10 (18) 
45 (80) 
0 (0) 
0 (0) 
1 (6) 
3 (18) 
13 (76) 
p=0.613 
Mean statistic 
(min=1; max=5; 
SD) 
4.7 
(0.57) 
4.6 
(0.57) 
4.8 (0.6) 4.6 (0.65) 4.7 (0.53) 4.8 (0.46) 4.7 
(0.59) 
His report that 
other workers 
were affected or 
not 
NAAI 
LI 
N 
SI 
EI 
31 (10) 
58 (20) 
72 (24) 
103 (35) 
34 (11) 
5 (11) 
12 (27) 
11 (24) 
13 (29) 
4 (9) 
2 (18) 
1 (9) 
2 (18) 
4 (36) 
2 (18) 
5 (5) 
17 (17) 
22 (22) 
42 (42) 
15 (15) 
9 (13) 
15 (22) 
21 (31) 
18 (27) 
5 (7) 
9 (16) 
12 (21) 
11 (20) 
18 (32) 
6 (11) 
1 (6) 
1 (6) 
5 (29) 
8 (47) 
2 (12) 
p=0.03 
Mean statistic 
(min=1; max=5; 
SD) 
3.2 
(1.18) 
3.0 (1.2) 3.3 (1.4) 3.4 (1.1) 2.9 (1.2) 3.0 (1.3) 3.5 (1.0) 
His belief about 
whether the 
illness was 
work-related or 
not 
NAAI 
LI 
N 
SI 
EI 
11 (4) 
42 (14) 
111 (37) 
119 (40) 
15 (5) 
1 (2) 
4 (9) 
14 (31) 
26 (58) 
0 (0) 
2 (18) 
1 (9) 
4 (36) 
2 (18) 
2 (18) 
5 (5) 
17 (17) 
43 (43) 
31 (31) 
5 (5) 
1 (1) 
12 (18) 
23 (34) 
27 (40) 
5 (7) 
2 (4) 
6 (11) 
21 (37) 
25 (45) 
2 (4) 
0 (0) 
2 (12) 
6 (53) 
8 (47) 
1 (6) 
p=0.28 
Mean statistic 
(min=1; max=5; 
SD) 
3.29 
(0.90) 
3.4 
(0.76) 
3.1 (1.4) 3.1 (0.9) 3.3 (0.9) 3.3 (0.9) 3.5 (0.9) 
The presence or 
absence of other 
potential causes 
and risk factors 
outside work 
NAAI 
LI 
N 
SI 
EI 
0 (0) 
12 (4) 
26 (9) 
163 (55) 
97 (33) 
0 (0) 
2 (4) 
4 (9) 
24 (53) 
15 (33) 
0 (0) 
0 (0) 
1 (9) 
4 (36) 
6 (55) 
0 (0) 
2 (2) 
9 (9) 
52 (51) 
38 (38) 
0 (0) 
2 (3) 
3 (4) 
47 (69) 
16 (24) 
0 (0) 
3 (5) 
6 (11) 
29 (52) 
18 (32) 
0 (0) 
3 (18) 
3 (18) 
7 (41) 
4 (23) 
p=0.18 
Mean statistic 
(min=1; max=5; 
SD) 
4.16 
(0.74) 
4.2 (0.8) 4.5 (0.7) 4.2 (0.7) 4.1 (0.6) 4.1 (0.8) 3.7 (1.0) 
 
Table A2.   Responses to the question “Which of the following factors was important in contributing to your 
decision that this was or was not a work-related illness?” grouped by medical specialty.  1Mean statistic based 
on 1=minimum (NAAI) and 5=maximum (EI).  GP=general practitioner; OH=occupational health; 
OLD=occupational lung disease; NAAI=not at all important; LI=low importance; N=neutral; SI=somewhat 
important; EI=extremely important.  Analyses of variance measured using non-parametric Kruskal-Wallis 
tests, significance measured at the 95% confidence level.  
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APPENDIX 10. QUESTIONNAIRE FOR HEALTHCARE PROFESSIONALS 
Occupational asthma pilot study 
You probably know this already, but your practice has been taking part in a feasibility (pilot) study of a 
screening tool for identifying occupational asthma in working-age asthmatics that was developed by 
me (Dr Gareth Walters, respiratory registrar) at the Institute of Occupational and Environmental 
Medicine, University of Birmingham and Heartlands Hospital and by Professor Jon Ayres.  You may 
have used the occupational asthma screening-template when seeing a patient with asthma over the last 
few months.  We now need to get a feel for how the tool has worked and so we would be grateful if 
you could answer a few questions about the pilot which will take you less than 3 minutes to complete.  
We would be very grateful for your feedback.  Thank you, GW 
 
Practice     
 
Role (please tick)  Nurse   GP  Other  
 
 
Please answer the following question/statements by circling one of the responses: 
1. Did you use the occupational asthma template? 
Yes  No 
If not, why not?   
 
2. When using the template, I experienced difficulties asking patients questions about their 
occupation and whether their symptoms were better away from work. 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
 
If you did experience difficulties, what were they? 
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3. The screening tool was user friendly (clear, concise, logical). 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
 
 
4. I experienced (technical/IT) difficulties using the screening tool in the asthma review 
template. 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
 
If so, what were they? 
 
 
5. Using the template added significantly to my workload during the consultation. 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
If so, in what way? 
 
6. I am confident in how to act on the results of these screening questions. 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
 
 
7. Would training for you in how to advise patients / manage the heath aspects of cases of 
suspected occupational asthma improve the use of the screening tool? 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
 
 
8. Would further training for you in how to advise the employer / manage the work situation in 
cases of suspected occupational asthma occupational asthma improve the use of the screening 
tool? 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
 
 
9. If this tool was kept in your asthma template would you keep using it? 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
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10. If this tool was kept do you envisage any ongoing or emergent problems with its use?  
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
If so, what are they? 
 
11. Do you think this tool has added anything beneficial to your asthma reviews? 
 
Strongly agree   Agree        Neither Agree nor disagree            Disagree            Strongly disagree 
Please tell me more: 
 
 
Many Thanks 
Gareth Walters, SpR and research associate 
 
